pmid,doi,publicationTitle,year,journal,novel_animal_models,novel_antibodies,novel_cell_lines,novel_genetic_reagents,novel_computational_tools,novel_advanced_cellular_models,novel_patient_derived_models,novel_clinical_assessment_tools,existing_tools,total_novel_tools,nf_specific_count,max_priority
PMID:31558455,10.1136/bmjopen-2019-030601,Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study.,2019,BMJ open,,,,,,,,Social Responsiveness Scale 2nd Edition; Autism Diagnostic Observation Scale 2nd Edition; Autism Diagnostic Interview-Revised; WPPSI-IV; WISC-V; TEA-Ch Sky Search; TEA-Ch Score!; Shape School; NEPSY-II Inhibition; Tower of Hanoi; TEA-Ch Creature Counting; WIAT-II Abbreviated; NEPSY-II Affect Recognition; Benton Facial Recognition Test; NEPSY-II ToM; Reading the Mind in the Eyes Test-Child; Faux Pas Task; Strange Stories; CELF-Preschool-2; CELF-4 Formulated Sentences; NEPSY-II Comprehension of Instructions; SRS-2; CADS; Conners 3; BRIEF-Preschool; ABAS-3: 0–5 years; ABAS-3: 5–21 years; SSIS Rating Scale; Sensory Profile 2; CBCL: 1.5–5 years; CBCL: 6–18 years; CCC-2; MEGA-PRESS,,33,3,High
PMID:33078583,10.1002/jcsm.12632,Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis.,2020,"Journal of cachexia, sarcopenia and muscle",,collagen IV; MyHC type 1; MyHC type 2A; laminin; Pax7; myosin heavy chain; beta III tubulin; perilipin A/B; PPARG; phosphor (pThr172) AMPKa; AMPKα; phosphor (s235/236) S6; MyHC type 2B; phosphor (Ser473) AKT; phospho (Ser1101) IRS-1; phospho (Ser636/639) IRS-1; DIG-Fab,,,STAR 2.4.2a; GSEA software 4.0.1; DAVID 6.8; MaxQuant (v1.5.3.30); AxioVision 4.6 software,,,,,22,6,High
PMID:36322658,10.1126/sciadv.abo5442,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,2022,Science advances,NF1 fl/fl Tp53 fl/fl Eed fl/fl;Dhh-Cre,PDGFRβ; α-SMA; VEGFA; ZEB1; IGFBP2; EYA4; YAP/TAZ,hTERT NF1 ipn02.3 2λ; ipn95.11bC; MPNST642,ZEB1,Drop-seq tools (version 1.12); Cellranger v5.0.1; Seurat (version 3.1.0); scREF; CIBERSORTx; VECTOR; CytoTRACE version 0.3.3; ArchR; DGIdb (version 3.0.2),,,,,21,15,High
PMID:31015291,10.1126/scisignal.aau8749,Proximity biotinylation identifies a set of conformation-specific interactions between Merlin and cell junction proteins.,2019,Science signaling,,YAP1,immortalized mouse Nf2 Schwann cells,mApple; ZO-1; GFP-NMHC II-B; GFP-vinculin; venus-Scrib; EGFP-hYAP1; EGFP-Lats1; HA-AMOT p130; NLuc; 4XBS2WT-Luc; 8xGTIIC-luciferase; p53 WT; ZsGreen; Tet3G,g:Profiler; BioVenn; PathVisio software,,,,,19,5,High
PMID:40025578,10.1186/s40478-025-01965-6,Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment.,2025,Acta neuropathologica communications,,HER1; HER2; VEGFR2; B7H3; CD171; EGFRvIII; TGFβ1; CD8a; CD45RO; CCR7,HFFs; NCI-H266,anti-HER1 CAR 806; anti-HER1 CAR E2; anti-HER1 CAR NEC,BWA version 0.7.15; GATK MuTect2 (version 4.1); ANNOVAR (version 2016-02-01),3D tumor spheroid model,,,,19,8,High
PMID:33273014,10.1074/jbc.RA120.014960,mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition.,2021,The Journal of biological chemistry,,ERBB3 Y1197; EPHA2 S897; NDRG1 T346; Akt S473; Akt T308; p70S6K T389; ribosomal S6 S240/244; IGF1R Y1135/36/IR Y1150/51; IGF1R; FOXO1/3a T24/T32; FOXO3; EPHA2; secreted form of NRG1,AC-CRISPR; MN1-LF,V-CSCW2; MM-121,,,,,,17,8,High
PMID:35789380,10.1158/2159-8290.CD-21-1671,PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.,2022,Cancer discovery,PLP-CreERT:: Nf1 f/f ; Cdkn2a f/f,,"M14 (ST88-14, RRID:CVCL_8916); M10 (MPNST1)",psPAX2; VSV-G; SUZ12,"FastQC (RRID:SCR_014583); TrimGalore (RRID:SCR_011847); STAR v2.6 (RRID:SCR_004463); HTSeq v0.9.1 (RRID:SCR_005514); deepTools v3.1 (RRID:SCR_016366); Homer v4.5 (RRID:SCR_010881); featureCounts (v1.5.0-p1, RRID:SCR_012919); pheatmap (v.1.0.12, RRID:SCR_016418); Partek Genomics Suite (v 7.0, RRID:SCR_011860); FCS Express 7 Research Edition (De Novo Software, Inc.; RRID:SCR_016431)",,MPNST PDX-1,,,17,14,High
PMID:36730269,10.1371/journal.pone.0277305,Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas.,2023,PloS one,NPcis,pCHEK1 S296; BMI1; H3K27Ac; H3; CDK9; CPNase; MAG; pS2 RNApol II,TM-31; LN319; 17; 5653; 5746,nuclear RFP,Incucyte S3 Live-Cell Analysis System,spheroid culture system,,,,17,9,High
PMID:40191916,10.1093/g3journal/jkaf067,"The draft genome of the Wisconsin Miniature SwineTM, a valuable biomedical research tool.",2025,"G3 (Bethesda, Md.)",,,,,Filtlong v0.2.0; Porechop v0.2.4; Flye v2.5; GCpp v1.0.0-1807624; purge_haplotigs; Juicer v1.6.2; 3D-DNA v180114; BUSCO v5.7.0; QUASTv5.0.2; Liftoff v1.6.3; SnapGeneTM Version 7.2.1; PyMOL Version 3.0.5; Skewer v0.2.2.b; Tassel pipeline version 2; VCFtools v.0.1.16; Beagle v4.1; itol v6.9.1,,,,,17,17,High
PMID:32383545,10.15252/embr.201949117,Hexokinase 2 displacement from mitochondria-associated membranes prompts Ca,2020,EMBO reports,,HK2; MPP2; ATP5A; UQCRC2; TOM20,MDA-MB-231 cells; PN 04.4 cells; 4T1 cells; RAW 264.7 cells; COLO 741 cells; MEC1 cells,HK2; D4ER; GCAMP6f; mit-Aeqmut; GFP-PHD,,,,,,16,1,High
PMID:35511749,10.1158/1535-7163.MCT-21-0947,A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.,2022,Molecular cancer therapeutics,,Cdk1; phospho-Cdk1 Tyr15; Histone H3; Acetyl-Histone H3 Lys18; SAPK/JNK; phospho-SAPK/JNK Thr183/Tyr185; p70S6 Kinase; phospho-p70 Thr389 S6 Kinase,MPNST-SP-01; MPNST-NF1-08; MPNST-NF1-9; HS-PSS; Human Foreskin Fibroblast (HFF),,GraphPad Prism Version 6,,MPNST-SP-01 PDOX; MPNST-NF1-09 PDOX,,,16,5,High
PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,2023,Cancer discovery,,MYF-4; HMB45; Melan-A,,truXTRAC FFPE DNA; Kapa HyperPlus; HumanMethylationEPIC; EZ DNA methylation Gold,SvABA; MuSE; MSIprofiler; FACETS; ascatNGS; ShatterSeek; TopHat-fusion; EricScript; survival,,,,,16,9,High
PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,2024,Molecular metabolism,Nf1-IF; Nf1-PS; Nf1-IFPS,pERα S118; pERK T202/Y204,,NF1 gRNA,Agilent Seahorse XF-96; STAR v2.7.8a; iDEP 9.1; Trim Galore v0.6.0; LipidSearch v5.0; Compound Discoverer v3.2; SynergyFinder R package; CEAS R Package; FactoMineR R package,Matrigel spheroids,,,,16,15,High
PMID:38502231,10.1172/JCI176748,STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy.,2024,The Journal of clinical investigation,,STING; TBK1; p-TBK1; IRF3; p-IRF3; NF-κB; p-NF-κB; CTLA-4; CD8α; iNOS; mannose receptor; PD-1,H358 cells; HTS-Luc MPNST cell line,SA3,ImageJ Cell Counter extension,,,,,16,4,High
PMID:35589737,10.1038/s41467-022-30466-6,Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.,2022,Nature communications,Nf1 c.5425 C > T ; Arg1809Cys; R681X Nf1; Nf1 flox/flox ; Hoxb7-Cre; Nf1 f/neo ; hGFAP-Cre,Peripherin; ISL1,BJFF.6; Normal human Schwann cells (Sciencell),shNF1; shCOL1A2,"AXION Biosystems integrated studio (AxIS) version 2.5.1; Offline sorter x64 version 4; ImageJ 1.53a; Partek Flow software, version 10.0; STAR version 2.7.8a",,,,,15,10,High
PMID:38203448,10.3390/ijms25010277,FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells.,2023,International journal of molecular sciences,,XBP1; XBP1u; XBP1s; Parkin; PINK1; ATP5H,Normal human Schwann cells (HSC),,HISAT2 version 2.2.1; StringTie version 2.2.1; DEGseq version 1.48.0; ClusterProfiler version 4.2.2; STRING version 11.5; FlowJo™ software v10.8; Seahorse Wave Pro software; GraphPad Prism version 9,,,,,15,8,High
PMID:38714355,10.1158/1535-7163.MCT-23-0510,MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.,2024,Molecular cancer therapeutics,,phospho-MEK; RAD51; BRCA2; MGMT; yH2AX,HSR-GBM1; JHU-0879; JHU-1016B; JHH-136; B76; NGT-41; NMCG-1; DBTRG; T98G,NucLight red,,,,,,15,9,High
PMID:40507334,10.3390/cancers17111852,Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs.,2025,Cancers,,BIM; b-tubulin,BL21 (DE3) E.coli; H929; U266B1; U2932; HT229; HCC1937,pGEX 4T-1; SpCas9,FACSDiva v6.1; FlowJo software v10.0.8; GraphPad Prism v8.3; HALO image analysis software v3.2; ZEN imaging software v2.3,,,,,15,5,High
PMID:23328114,10.18632/oncotarget.793,Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition.,2013,Oncotarget,,RHAMM; TPX2; AURKA; phospho-AURKA (Thr288); p-histone H3 (Ser10); p-RHAMM (Thr703),2884 cell line; 2885 cell line,pLKO.1; shRHAMM; shTPX2,Feature Extraction 10.5; Agilent Genomic Workbench 6.5,S462 spheres,,,,14,4,High
PMID:26219339,10.18632/oncotarget.4858,A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.,2015,Oncotarget,,phospho-S6 (Ser240/244); phospho-S6 (S240/244); phospho-p70 S6K (T389); phospho-NDRG1 (T346); SGK1; phospho-PAK1 (S144); 4EBP1; Rac1; Rheb,AC007-hTERT; AC028,SGK1; PAK1; RHEB,,,,,,14,3,High
PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,2020,The Journal of biological chemistry,,pEGFR,DH10Bac cells; BL21(DE3); Sf9 cells; Tni-FNL cells; NF1-null HEK293T cell line,Gateway entry vector; baculovirus expression vector; E. coli expression vector,SEDFIT 16.1; SEDPHAT 14.0; EMAN2 e2boxer; Sphire; ATSAS,,,,,14,7,High
PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,2024,Clinical cancer research : an official journal of the American Association for Cancer Research,DhhCre; Nf1flox/flox;Arf flox/flox;PostnCre+,Survivin; CENPF,hTERT NF1 ipNF95.6 cell line,,nCounter Sprint Profiler; nSolver Advanced Analysis Software version 4.0; Omics Playground v2.7.18; UCSC Xena browser; IDEP.92; ComplexHeatmap R/Bioconductor package; Scanpy; infercnvpy package; HALO Image Analysis software version 2.0.5,,,,,14,12,High
PMID:38744290,10.1016/j.crmeth.2024.100772,A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening.,2024,Cell reports methods,,CD56; CD117/c-kit; S100A11,,,Salmon v1.4; BWA-MEM2 v2.1; GATK v4.1.9.0; BSBolt; metilene v0.2-8; DELLY v1.1.3; InterVar; rare disease workflows; cNFOrganoidAnalysis,cNF organoids,Cutaneous neurofibroma samples,,,14,13,High
PMID:29941005,10.1186/s13023-018-0843-1,Increased extracellular matrix deposition during chondrogenic differentiation of dental pulp stem cells from individuals with neurofibromatosis type 1: an in vitro 2D and 3D study.,2018,Orphanet journal of rare diseases,,CD13; CD14; CD105; CD146; CD271,NF37; NF87; CT10; CT11; CT12,,"FlowJo 7.6.5; ImageJ software v.1.49 (NIH, USA); SPSS v. 20.0",,,,,13,5,High
PMID:30192842,10.1371/journal.pone.0203520,Use of machine learning to predict cognitive performance based on brain metabolism in Neurofibromatosis type 1.,2018,PloS one,,,,,Statistical Parametric Mapping toolbox (SPM8); Matlab 7.12.0; kernlab R library,,,WAIS-III; WISC-III; Nine-Hole Peg Test; Rey-Osterrieth Complex Figure Test; Rey Auditory-Verbal Learning Test (RAVLT); Category Fluency Test; Lexical Fluency Test; Five Digits Test (FDT); Tower of London Test; GE Discovery 690,,13,3,High
PMID:31462295,10.1186/s40478-019-0792-5,Telomere alterations in neurofibromatosis type 1-associated solid tumors.,2019,Acta neuropathologica communications,,Cy3/Cy5; DAXX,,telomere repeat sequence probe; centromeric DNA repeats probe; 644 cancer gene panel,Illumina bcl2fastq v1.8.4 software; Burrows-Wheeler Aligner v0.7.10; Picard Tools v1.119; MDLVC v5.0; HaplotypeCaller (Genome Analysis Tool Kit 3.3); Integrated Genomics Viewer v2.3.4 (IGV); GraphPad Prism version 8.0; R version 3.3.2,,,,,13,8,High
PMID:33025139,10.1007/s00401-020-02230-x,"Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.",2021,Acta neuropathologica,,,,Microsatellite markers; MLPA probe set,conumee; Haplotype Caller; MuTect1; Variant Effect Predictor; Sequenza; MAVIS; FusionCatcher; STAR aligner; AutoAnnotate; Enrichment Map; GeneMapper software,,,,,13,11,High
PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,2020,Cancer research,,DUSP6,H1838; WM3918; M308; NF10.1; NF11.1,PTPN11,BioNavigator software V.6.3,,JH-2–009; JH-2–055; JH-2–060; JH-2–074; JH-2–077,,,13,12,High
PMID:35614131,10.1038/s41418-022-01020-0,The mitochondrial chaperone TRAP1 regulates F-ATP synthase channel formation.,2022,Cell death and differentiation,,ATP50/OSCP; ATPB; SDHA; Cyclophilin,U87 glioblastoma cells,CRISPRv2; lentiCRISPRv2; Cyclophilin D; mito-GFP1-9; TRAP1-GFP10; CyPD-GFP11; ATP50-GFP11,Prism 6.0,,,,,13,1,High
PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,2025,Scientific reports,,,ipn97.4 immortalized human Schwann cells,StrepII tag; M-PER; BCA,"Trim Galore (version 0.6.10); Broad's Genome Analysis ToolKit (version 4.6.0); BWA (version 0.7.17-r1188); Picard tools (version 3.2.0); ReAdW v. 3.5.1; MzXML2Search (included in TPP v. 3.5); Scaffold (Protein Sciences, Portland Oregon); Human Protein Atlas (proteinatlas.org); QIAGEN Ingenuity Pathway Analysis (IPA)",,,,,13,10,High
PMID:40590220,10.1172/JCI188932,A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice.,2025,The Journal of clinical investigation,,neurofibromin/NF1; FBXW11/bTrCP2; pERK Thr202/Tyr204,LUVA cells,human neurofibromin; human FBXW11; Cre-GFP,AnyMaze software; GraphPad Prism version 5.0d,,,3-chamber social preference task; Open field test; Delay discounting task; Cliff avoidance reaction test,,13,6,High
PMID:31545171,10.7554/eLife.48983,Optical dopamine monitoring with dLight1 reveals mesolimbic phenotypes in a mouse model of neurofibromatosis type 1.,2019,eLife,129T2/SvEmsJ::C57Bl/6NTac Nf1+/- and Nf1+/+,tyrosine hydroxylase,,dLight1.2; hChR2(H134R)-EYFP; eNpHR3.0-eYFP; mCherry; tTA; mRuby; mTurquoise; iCAP-PHP.eB; dLight1,Fiber Photometry Trace Processing,,,,,12,2,High
PMID:33436083,10.1186/s13072-020-00380-6,Distinctive epigenomic alterations in NF1-deficient cutaneous and plexiform neurofibromas drive differential MKK/p38 signaling.,2021,Epigenetics & chromatin,,MKK3; p38; phospho-p38,,,ChAMP; glmmTMB; DMRcate; compartmap; missMethyl; PAMES; SeSAMe; betareg; emmeans,,,,,12,9,High
PMID:34040258,10.1038/s41586-021-03580-6,NF1 mutation drives neuronal activity-dependent initiation of optic glioma.,2021,Nature,Nf1fl/fl; OPG Nf1fl/mut (Nf1+/−),NLGN3; ADAM10,optic glioma cells,,Partek Flow software (v.9.0); STAR (v.2.7.3a); ImageJ (v.2.0.0); Cell Profiler (v.3.1.9); Stereo Investigator software (mbfbioscience v2019); Image Lab software (v.6); Image Studio Lite (v.5.0.21),,,,,12,10,High
PMID:36148553,10.1093/brain/awac342,Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma.,2023,Brain : a journal of neurology,Periostin-CRE;NF2 fl/fl; Periostin-CRE;NF2 fl/fl YAP fl/fl; Periostin-CRE;NF2 fl/fl TAZ fl/fl; P0-CRE,Neurofilament; Pan-TEAD; CTGF,KT21-MG1; 293FT,TAZ; YAP; Scramble,,,,,,12,6,High
PMID:38000020,10.1126/sciadv.adg8876,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,2023,Science advances,,,JH-2-031; JH-2-079c,Tet-pLKO-puro; TTIGFP-MLUEX; shPTPN11,FlowJo 10.8,,JH-2-079c PDX; WU-225 PDX; WU-386 PDX; WU-545 PDX; MN-2 PDX; MN-3-002 PDX,,,12,9,High
PMID:38216572,10.1038/s41467-024-44755-9,Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.,2024,Nature communications,,beta tubulin; pMEK; MEK; pPAK; Caspase-7,NF95.11b; NF95.6; SNF94.3; JW18.2; JW23.3,dCas9-BFP-KRAB,Clustree,,,,,12,9,High
PMID:38475852,10.1186/s13023-024-03093-1,Pilot study of the effectiveness of a telehealth group for improving peer relationships for adolescents with neurofibromatosis type 1.,2024,Orphanet journal of rare diseases,,,,,"IBM SPSS for Windows, version 28; GPower 3.1",,,PEERS® intervention; Kaufman Brief Intelligence Test– Second Edition (KBIT-2); Wechsler Individual Achievement Test– Third Edition (WIAT-III) Word Reading subtest; Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version– Attention Deficit/Hyperactivity Disorder module (KSADS-ADHD); Social Communication Questionnaire (SCQ); Social Skills Improvement System Social-Emotional Learning (SSIS-SEL); Social Responsiveness Scale– Second Edition (SRS-2); Friendship Qualities Scale (FQS); Quality of Socialization Questionnaire (QSQ); Test of Adolescent Social Skills Knowledge (TASSK),,12,2,High
PMID:38907342,10.1186/s40478-024-01821-z,"snRNA-seq of human cutaneous neurofibromas before and after selumetinib treatment implicates role of altered Schwann cell states, inter-cellular signaling, and extracellular matrix in treatment response.",2024,Acta neuropathologica communications,,Nuclear Pore Complex Proteins,,KCNMA1; PRKCE; OPCML; GRIK2; CADM2; CREB5; CAMK1D; ITGB8,Cell Ranger pipeline v7.1.0; Seurat v4.3.0–v5; Ingenuity Pathway Analysis (IPA),,,,,12,3,High
PMID:40394150,10.1038/s41416-025-03055-9,Mass spectrometric insights into the protein composition of human cutaneous neurofibromas: comparison of neurofibromas with the overlying skin.,2025,British journal of cancer,,collagen XV; collagen XVIII,,,Barocycler NEP 2320; Easy-nLC 1200; Q Exactive HF mass spectrometer; Thermo Xcalibur 4.1; Spectronaut Pulsar; BenchMark Ultra system; NanoZoomer S60 digital slide scanner; Pannoramic Midi FL slide scanner; R software version 4.0.0; lmerTest package version 3.1-2,,,,,12,10,High
PMID:41022755,10.1038/s41467-025-63619-4,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors.,2025,Nature communications,,βIII-tubulin; Human Nuclear Antigen,"pNF9511bc; ipNF03.3; ipn023λ; RHT92; 2V6.11; FiPS; NF1−/−−/− edited FiPS Ctrl1-SV4F-7, D12; 3PNF_SiPSsv_MM_11",GRDC24; NF-targeting capsid,,,,,,12,5,High
PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,2026,PloS one,,,icNF98.4c; icNF00.10a; icNF04.9a; i28cNF; i18cNF; i21cNF,hTERT and mCdk4; hTERT; mCdk4,nf-core sarek pipeline (v2.7.1); DeepVariant; nf-core rnaseq pipeline (v3.5),,,,,12,9,High
PMID:25535838,10.7554/eLife.05151,Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1.,2014,eLife,hGFAP-cre; Math1-cre; L7-cre; Nestin-creER,Calbindin; GABARα6; Tbr2; Calretinin; P27; β-gal,,,,,,Rotarod apparatus,,11,4,High
PMID:34257279,10.1038/s41467-021-24505-x,Neurofibromin regulates metabolic rate via neuronal mechanisms in Drosophila.,2021,Nature communications,Nf1 P1,nc82,,Nf1 RNAi; rl Sem; nSyb; R57C10; tsh-Gal4; Oct-TyrR-Gal4; PCB-Gal4,PhenoCapture 3.3; Fiji 2.0,,,,,11,4,High
PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,2022,Human mutation,,,,,Leiden Open Variation Database (LOVD); ClinVar NCBI; Human Gene Mutation Database (HGMD); Clinical Interpretation of Variants in Cancer (CIViC); Mastermind Genomic Search Engine; Alamut Visual version 2.15; gnomAD v2.1.1; UCSC LiftOver tool; alleleFrequencyApp; CanVar-UK cancer predisposition gene variant database,,,Manchester Criteria,,11,11,High
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,2023,Nature communications,,B-Actin; PTCH1,HSC1λ,,BWA-MEM v 0.7.12; GATK v3.6.0; Mutect V1.1.6; Strelka v1.0.13; STAR aligner (v.2.6.0); FusionCatcher v1.1.0; Seurat version 3.0; inferCNV (v.1.1.1),,,,,11,8,High
PMID:39321200,10.1158/1078-0432.CCR-24-1454,Multidimensional Immunotyping of Human NF1-Associated Peripheral Nerve Sheath Tumors Uncovers Tumor-Associated Macrophages as Key Drivers of Immune Evasion in the Tumor Microenvironment.,2024,Clinical cancer research : an official journal of the American Association for Cancer Research,,CD11c; CD19; CD163; CSF1R,,,nf-core/rnaseq (v3.11.2); salmon (v1.10.1); sva R package (v3.42.0); immunedeconv (v2.1.0); ggplot2 (v3.4.4); ggridges (v0.5.5); HALO imaging analysis software,,,,,11,9,High
PMID:41036607,10.1158/1535-7163.MCT-24-1053,Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,2026,Molecular cancer therapeutics,"Dhh::Cre, Nf1fl/fl, Pten",neurofibromin 1,,gRNA; Luciferase-IRES-GFP; PB7 transposase,Trimmomatic (v0.33); HISAT2 (v2.1.0); StringTie (v1.3.4d); DESeq2 (v1.42.0); GeneAnalytics(v),,Patient-derived xenograft (PDX) MPNST model,,,11,8,High
PMID:32396062,10.7554/eLife.55137,Tgfb3 collaborates with PP2A and notch signaling pathways to inhibit retina regeneration.,2020,eLife,,pSmad3; Zpr-1; Zn-5; HuC/D; PKC β1,,Tgfb3; Tgfb1b; tgfb3-EGFP; nCas9n-nanos3'UTR,CRISPRscan,,,,,10,1,High
PMID:33658640,10.1038/s41416-021-01270-8,Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours.,2021,British journal of cancer,Nf1-Arf flox/flox ;Postn-Cre,Ref-1,95.6; ipn02.3,Ref-1; STAT3,ImageJ (v1.48); HALO (Indica Labs); Aperio Image Analysis (Leica Biosystems),,RHT-92,,,10,6,High
PMID:37246765,10.1093/neuonc/noad097,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.,2023,Neuro-oncology,,"HLA-A,B,C; H-2; human nuclei",,,Cellpose; Xenosplit; maftools v2.10.0; CNVkit V2.0; DESeq2 package,3D microtissues,NF1-associated MPNST-PDX,,,10,6,High
PMID:24371224,10.1158/0008-5472.CAN-13-2062,Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis.,2014,Cancer research,Nf2 mice,c-Met; phosphorylated c-Met; mesothelin; phospho P-Met; MAPK,,Tp53; miR34a,,BioCoat Matrigel invasion chambers (Becton Dickinson),,,,9,5,High
PMID:24509877,10.1038/onc.2013.506,MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1.,2014,Oncogene,,MAF; DEPTOR,Normal human Schwann cells (NHSC); MPNST 88-14 cells; MPNST S462-TY cells,MAF; MAF ORF; Tet-On; AP-1 luciferase,,,,,,9,2,High
PMID:24882693,10.1016/j.jmb.2014.05.011,Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.,2014,Journal of molecular biology,,,Rosetta2(DE3) competent cells,Merlin isoform 1; Merlin(S518D) and Merlin(S518E) mutants; HiTrap Chelating Sepharose™ High Performance; Superdex 200 10/300 GL column,DYNAMIC software; Spectra Manager; Bindworks; MantidPlot,,,,,9,6,High
PMID:26904939,10.1016/j.celrep.2016.01.074,Insertional Mutagenesis Identifies a STAT3/Arid1b/β-catenin Pathway Driving Neurofibroma Initiation.,2016,Cell reports,Stat3(fl/fl);Nf1(fl/fl);DhhCre,P-Stat3 (Y705); P-Jak2; Jak2; P-β-catenin; GSK3β,,shRNAs; β-catenin ΔN90,,embryonic mouse spheres,,,,9,1,High
PMID:27999334,10.3390/genes7120133,Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,2016,Genes,,,,NF1 capture probes,NanoDrop 2000; Ion Torrent Personal Genome Machine—Ion Torrent PGM™; Torrent Suite software; Ingenuity Variant Analysis software; Integrative Genomics Viewer; Alamut Visual; AB3130 Genetic Analyzer; Sequencing Analysis software,,,,,9,9,High
PMID:28166733,10.1186/s12864-017-3519-7,A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma.,2017,BMC genomics,,tubulin; SUZ12,U87-MG,,Sci-kit Learn; python 3.5.1; Li-COR Image Studio Lite 5.0; R version 3.2.3; nf1_inactivation GitHub repository; GeneChip Human Transcriptome Array 2.0,,,,,9,8,High
PMID:29402968,10.1038/s41598-018-20894-0,Integrating Functional Analysis in the Next-Generation Sequencing Diagnostic Pipeline of RASopathies.,2018,Scientific reports,,DDK tag,,RASopathy gene panel; Luciferase reporter; ELK1; Dual luciferase reporter; Renilla luciferase; GFP fusion vector; cmlc1 probe,NextGENe software v.2.3.4.1,,,,,9,1,High
PMID:29715273,10.1371/journal.pone.0196726,Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation.,2018,PloS one,,CalbindinD-28K; phospho-Histone H3; phospho S518-Merlin; cyclophilin B,OLN93 mouse oligodendrocyte cell line; SC4-immortalized Nf2-/- primary Schwann cells; RT4-D6PT2 schwannoma cell line; TC620 human oligodendroglioma cell line,,XCELLigence Real Time Cell Analysis System,,,,,9,3,High
PMID:33442015,10.1038/s41591-020-01193-6,Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial.,2021,Nature medicine,,AXL; pAXL; pMEK1/2,,,Perseus (version 1.6.10.50); FlowJo Software (version 9.9.6); ImageJ (version 1.47); HALO Image Analysis Software (version 2.3),,,BPI-PI Scale; FragEL DNA Fragmentation Detection Kit (Sigma Aldrich #QIA21),,9,7,High
PMID:36316421,10.1038/s41598-022-21907-9,Non-invasive brain stimulation modulates GABAergic activity in neurofibromatosis 1.,2022,Scientific reports,,,,,SimNIBS 3.2; SPM8; jMRUI5.1; SPM12; Psychopy2; R version 1.2; MATLAB R2014a,,,NeuroConn DC-STIMULATOR MR; Vineland Adaptive Behaviour Scale—third edition,,9,7,High
PMID:36689660,10.1073/pnas.2208960120,Destabilizing NF1 variants act in a dominant negative manner through neurofibromin dimerization.,2023,Proceedings of the National Academy of Sciences of the United States of America,,HSP70; RASA1,NF1-null 293T cells,FLAG; HA; Tet-inducible; packaging; envelope,RELION,,,,,9,3,High
PMID:39129390,10.1002/1878-0261.13704,Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors.,2025,Molecular oncology,y [1] sc[*] v [1] sev [21]; P{y[+t7.7] v[+t1.8] = TKO.GS01796}attP40; P{ KK101909 }VIE‐260B,Drosophila neurofibromin; human neurofibromin,"Drosophila Schneider (S2R+) cells; dNF1‐KO; hTERT ipn02.3 2λ CRL‐3392; ipnNF09.4 (hTERT NF1 ipnNF09.4, RRID: CVCL_UI73)",dNf1,,,,,,9,7,High
PMID:40887659,10.1186/s40246-025-00803-z,RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity.,2025,Human genomics,,,,,RENOVO-NF1; Mutation Taster; HGMD; LOVD; PolyPhen-2; ESE Finder; GnomAD; 1000 Genomes; cutpointR,,,,,9,9,High
PMID:16835260,10.1093/hmg/ddl165,Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling.,2006,Human molecular genetics,,ColIA; Abl; c-abl; TGF-β,,1276P NF1 GRD; pac; c-abl siRNA; Scrambled siRNA,,,,,,8,1,High
PMID:18451155,10.1158/0008-5472.CAN-07-6867,Pten haploinsufficiency accelerates formation of high-grade astrocytomas.,2008,Cancer research,Mut3; Mut4,Ki67 antigen; glial fibrillary acidic protein; phosphorylated Akt; BrdUrd; doublecortin,,,,neurosphere cultures,,,,8,4,High
PMID:20554030,10.1016/j.jneuroim.2010.05.002,CXCL12 alone is insufficient for gliomagenesis in Nf1 mutant mice.,2010,Journal of neuroimmunology,"Nf1 flox/mut; GFAP-Cre, Nf1+/− GFAP CKO",Endoglin; p-PKA substrate; pS473-AKT; CXCR4,LN428 human glioblastoma multiforme (GBM) cell line,CXCL12; firefly luciferase-GFP fusion,,,,,,8,2,High
PMID:24386979,10.1186/1471-2407-14-6,"Modulation of Ras signaling alters the toxicity of hydroquinone, a benzene metabolite and component of cigarette smoke.",2014,BMC cancer,"Mx1-Cre, Nf1 flox/flox","Lineage markers (CD3e, CD11b, CD45R/B220, Ly6G/Ly6C, TER-119)",BY4743 background diploid yeast deletion strains; Y258 background haploid yeast MORF strain; MethoCult® M3434,StemSep,GraphPad Prism version 5.01; STATA 11,,,,,8,4,High
PMID:28126595,10.1016/j.ebiom.2017.01.020,Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target.,2017,EBioMedicine,,phospho-Merlin; HDAC1; PDLIM2,Human meningeal cells (HMC),PDLIM2 shRNA; λ-phosphatase,MaxQuant version 1.3.05; DAVID software,,,,,8,3,High
PMID:29787563,10.1371/journal.pone.0190001,Graph complexity analysis identifies an ETV5 tumor-specific network in human and murine low-grade glioma.,2018,PloS one,Nf1flox/null; GFAP-Cre; Nf1flox/R681*; GFAP-Cre; Nf1flox/null; Ptenflox/wt; GFAP-Cre; Nf1flox/null; Olig2-Cre,Etv5,Wild-type and Nf1-/- primary astrocytes,,ARACNe-AP algorithm; DESeq2 version 1.18.1,,,,,8,7,High
PMID:30571760,10.1371/journal.pone.0208835,Neurofibromin haploinsufficiency results in altered spermatogenesis in a mouse model of neurofibromatosis type 1.,2018,PloS one,Nf1Dsk9/+,p44/42 MAPK (ERK1/2); p44/42 MAPK phosphorylated at threonine 202 and tyrosine 204 (p-ERK1/2); phosphatidylinositol 3-kinase (PI3K),,,"InVivo 3.2.0 software; Image-Pro Plus software; Image J1.45s, version 1.44p; GraphPad 5 Prism software",,,,,8,8,High
PMID:32642734,10.1093/noajnl/vdz026,Whole exome sequencing reveals the maintained polyclonal nature from primary to metastatic malignant peripheral nerve sheath tumor in two patients with NF1.,2020,Neuro-oncology advances,C57BL6/J Nf1+/−;Trp53+/−,TRIM23,NPcis cell line,Trim23,Novoalign tool v3.02.06; PICARD tools v2.4.1; Genome Analysis Toolkit (GATK) v3.6-0; Mutect v1.1.4,,,,,8,6,High
PMID:33673681,10.3390/cancers13050999,Hybrid Minigene Assay: An Efficient Tool to Characterize mRNA Splicing Profiles of ,2021,Cancers,,,,Haloplex HS; SALSA MLPA P081/P082; Gentra Puregene; beta-globin; Lipofectamine 2000; TOPO TA,Human Splicing Finder (HSF) Version 2.4.1; Combined Annotation Dependent Depletion (CADD) v1.6,,,,,8,2,High
PMID:35393510,10.1038/s41418-022-00991-4,Tumor growth of neurofibromin-deficient cells is driven by decreased respiration and hampered by NAD,2022,Cell death and differentiation,cis Nf1+/−;P53+/−,,Nf1−/− MEFs; ipNF 04.4 cells,pBABE vectors,XF24 Extracellular Flux Analyzer; LC-MS/MS (Quattro Premier); FACSCanto II flow cytometer; FACSDiva software,,,,,8,7,High
PMID:36420221,10.1016/j.omtn.2022.10.026,Antisense oligonucleotides targeting exon 11 are able to partially rescue the NF2-related schwannomatosis phenotype ,2022,Molecular therapy. Nucleic acids,,,NF2 primary fibroblasts,PMOs; Gateway Gene Cloning system; FLAG Tag; Lipofectamine LTX,CLC-workbench; PredictProtein; GraphPad Prism software v7,,,,,8,4,High
PMID:36565307,10.1016/j.gim.2022.10.007,"COVID-19 in people with neurofibromatosis 1, neurofibromatosis 2, or schwannomatosis.",2023,Genetics in medicine : official journal of the American College of Medical Genetics,,,,,R v3.6.3; BSDA v1.2.0; gdata v2.18.0; ggplot2 v3.3.2,,,"International Classification of Diseases, 10th Revision (ICD-10); Systematized Nomenclature of Medicine (SNOMED); Logical Observation Identifiers Names and Codes (LOINC); Nebraska Lexicon",,8,4,High
PMID:37520682,10.1016/j.omtn.2023.06.018,Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1.,2023,Molecular therapy. Nucleic acids,NF1 R1947/+,,Schwann cells,NF1-targeting TALEN; Gentamicin; NF1 DLR; PBSB; UPF1,GraphPad Prism V9,,,,,8,5,High
PMID:37990867,10.1242/dmm.049861,Neurofibromin 1 mutations impair the function of human induced pluripotent stem cell-derived microglia.,2023,Disease models & mechanisms,,TRA-1-60; SSEA-4,CTL BJFF.6 hiPSCs,Hematopoietic differentiation factors,Karyostudio 1.3 software; Partek Flow software; Imaris software,hiMGL cells,,,,8,3,High
PMID:38201517,10.3390/cancers16010089,Synergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 Dendrimers.,2023,Cancers,,N-RAS; RAB5A; RAP1A,A549; MCF10A,,CompuSyn software Version 1.0; IBM SPSS Statistics software version 29.0.1.0; SPIN (Signal Processing in MR Version SVN Revision 1895),,,,,8,4,High
PMID:39409151,10.3390/ijms251910822,Proof of Concept for Genome Profiling of the Neurofibroma/Sarcoma Sequence in Neurofibromatosis Type 1.,2024,International journal of molecular sciences,,,,,Agilent Tapestation 4200; Varsome Clinical Software v.12.3.2; Plotly v4.9.3; CNVKit version 0.9.11; ggplot2 v3.5.1; GEPIA; Cluster Profiler v.4.0; UpSetR Version 1.4.0,,,,,8,8,High
PMID:41149489,10.3390/curroncol32100569,Small Extracellular Vesicles Derived from NF2-Associated Schwannoma Cells Modulate Tumor Progression and Immunity via HSP90.,2025,"Current oncology (Toronto, Ont.)",,HLA-DR; CD33; CD9; CD81; TOMM20,Primary Schwannoma Cells,,FlowJo software; Orbitrap Fusion Lumos mass spectrometer,,,,,8,5,High
PMID:22901811,10.1016/j.cell.2012.06.034,ERK inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities.,2012,Cell,Nf1 hGFAP CKO; Nf1 NcreER CKO,,,hGFAP-cre; Nf1 flox; Nf1 KO; Nestin-cre ER; R26 LacZR,,,,,,7,4,High
PMID:24824755,10.1371/journal.pone.0096733,BNIP3 regulates AT101 [(-)-gossypol] induced death in malignant peripheral nerve sheath tumor cells.,2014,PloS one,,BNIP3; BECLIN1,T265-2c,BNIP3; HIF-1α,Axio Vision Rel. 4.8 software; Graphpad Prism 6,,,,,7,3,High
PMID:25043298,10.1038/onc.2014.185,Oncogenic role of Merlin/NF2 in glioblastoma.,2015,Oncogene,,"Notch1; S518-Merlin; Na+,K+-ATPase",,Merlin siRNA; HA-Merlin; S518A HA-Merlin; IPA-3,,,,,,7,4,High
PMID:28398289,10.1038/sdata.2017.45,A high-throughput molecular data resource for cutaneous neurofibromas.,2017,Scientific data,,,,HumanOmni2.5-8,Dragen program; GATK pipeline; HudsonAlpha RNA-seq data analysis pipeline; TopHat v2.0; Cufflinks v0.9.3; Cutaneous NF Github repository,,,,,7,6,High
PMID:28465357,10.1101/gad.298703.117,Identification of hair shaft progenitors that create a niche for hair pigmentation.,2017,Genes & development,,P-cadherin; DCT; K14; LacZ; GFP/YFP; KIT,,,Prism7 (GraphPad),,,,,7,2,High
PMID:30274821,10.1016/j.ebiom.2018.09.042,Synergistic effect of Nutlin-3 combined with MG-132 on schwannoma cells through restoration of merlin and p53 tumour suppressors.,2018,EBioMedicine,,MDM2,Human Schwann cells (HSCs); RT4-D6P2T schwannoma cells,NF2 shRNA; P53 shRNA; P53,SPSS 17.0,,,,,7,4,High
PMID:30617350,10.1038/s41596-018-0105-7,"A cerebellopontine angle mouse model for the investigation of tumor biology, hearing, and neurological function in NF2-related vestibular schwannoma.",2019,Nature protocols,,,murine NF2 −/− Schwann cell line,GLuc,,,,DPOAE; ABR; hind-limb clasping test; ledge test; rotarod assay,,7,1,High
PMID:32869517,10.1002/mgg3.1400,Genome-wide association study of café-au-lait macule number in neurofibromatosis type 1.,2020,Molecular genetics & genomic medicine,,,,,SNP & Variation Suite v8.3.4; EMMAX; METAL; ComPaSS-GWAS; Haploview 4.2; GTEx,,,Wood's lamp,,7,7,High
PMID:33507822,10.1200/JCO.20.02220,NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibromas.,2021,Journal of clinical oncology : official journal of the American Society of Clinical Oncology,,,,,Phoenix WinNonlin (Version 8.1); NONMEM (version 7.2); Perl speaks NONMEM version 3.6.2; Pirana version 2.7.1,,,Numerical Rating Scale-11; Brief Pain Inventory Pain Interference subscale; Pediatric Quality of Life Inventory NF1 module,,7,6,High
PMID:33591953,10.1172/jci.insight.146351,Chromosome 8 gain is associated with high-grade transformation in MPNST.,2021,JCI insight,,COL4A; histone H3 (tri methyl K27),,CEP 8 (D8Z2); LSI MYC,Disambiguate v1.0; UPhyloplot2,,NF1-MPNST patient-derived xenografts,,,7,3,High
PMID:33978635,10.1093/noajnl/vdab020,Selumetinib normalizes Ras/MAPK signaling in clinically relevant neurofibromatosis type 1 minipig tissues in vivo.,2021,Neuro-oncology advances,NF1 R1947X minipig,Phospho-p44/42 ERK1/2; p44/42 ERK1/2; phosphor-p44/p42 MAPK (ERK1/2),,DUSP6; FOS,R Studio PKNCA package (version 0.9.3),,,,,7,5,High
PMID:34010628,10.1016/j.stem.2021.04.029,Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression.,2021,Cell stem cell,Nf1f/f;Trp53f/f;Nes-TK; Nf1f/f;Trp53f/f;CGD,CD16/32; Ter119,,,Seurat V3.0; STAR 2.4.2.8; GSVA package,,,,,7,5,High
PMID:34155781,10.1002/ajmg.a.62392,L-carnitine supplementation for muscle weakness and fatigue in children with neurofibromatosis type 1: A Phase 2a clinical trial.,2021,American journal of medical genetics. Part A,,,,,,,,MC-780MA Tanita Tokyo body composition analyzer; Citec hand-held dynamometer; Handwriting Speed Test; 6-minute-walk test; PedsQL Generic 4.0; PedsQL Neuromuscular 3.0; CBCL/6-18,,7,1,High
PMID:35673329,10.1093/texcom/tgac021,Neuroanatomical correlates of working memory performance in Neurofibromatosis 1.,2022,Cerebral cortex communications,,,,,SPM12 v7771; MATLAB vR2020b; MRIcroGL,,,n-back task; Corsi block task; Wechslers Intelligence Scale for Children-Fourth edition (WISC-IV); Vineland Adaptive Behavior Scale—third edition,,7,3,High
PMID:37770931,10.1186/s40478-023-01639-1,"Integration of single-nuclei RNA-sequencing, spatial transcriptomics and histochemistry defines the complex microenvironment of NF1-associated plexiform neurofibromas.",2023,Acta neuropathologica communications,,LAMA2; SLC22A3; PRRX1,,,Seurat 3.1.0; CellChatDB; Space Ranger; Seurat v4.0.1,,,,,7,4,High
PMID:38216587,10.1038/s41467-023-40408-5,Epigenetic reprogramming shapes the cellular landscape of schwannoma.,2024,Nature communications,,Pericentrin; γTubulin; Acetylated Tubulin,"Human Schwann Cells (HSC, ScienCell Research Laboratories #1700); Mouse Schwann Cells (MSC, ScienCell Research Laboratories #M1700-57)",,Signac; caret,,,,,7,2,High
PMID:38990917,10.1371/journal.pone.0305548,Optical coherence tomography of the macular ganglion cell layer in children with neurofibromatosis type 1 is a useful tool in the assessment for optic pathway gliomas.,2024,PloS one,,,,,,,,Cirrus HD-OCT; Teller acuity cards; Cardiff acuity cards; Lea cards; KM (Konstantin Moutakis) cards; Humphrey Field Analyzer perimetry; World Health Organization Categories of Childhood VI scale,,7,1,High
PMID:39858077,10.3390/cancers17020295,A Mixed Methods Study of Medication Adherence in Adults with Neurofibromatosis Type 1 (NF1) on a Clinical Trial of Selumetinib.,2025,Cancers,,,,,Aardex MEMS Adherence Software (ElectronReader 0.9.9),,,Life Events Checklist (LEC); PROMIS depression short form; PROMIS pain interference short form; PROMIS cognitive function short form; MEMS Cap; Barriers to Adherence Questionnaire,,7,2,High
PMID:40684195,10.1186/s40478-025-02075-z,Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1.,2025,Acta neuropathologica communications,,tomato; POSTN; TNC; PGP9.5; Aqp1,,,10x Genomics Cell Ranger 7.0.1; Seurat V3 package,,,,,7,2,High
PMID:18483311,10.1158/1535-7163.MCT-07-2335,Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors.,2008,Molecular cancer therapeutics,,phospho-S6K (T389); S6K1; Mib1,ST88-3; T265p21; DS-red STS26T cell line,,,,,,,6,4,High
PMID:18974932,10.1007/s11060-008-9721-3,A role for the p53 pathway in the pathology of meningiomas with NF2 loss.,2009,Journal of neuro-oncology,,,,D22S193; NF2 TET; D22S929; D22S268; D22S430; BstUI,,,,,,6,1,High
PMID:21199799,10.1158/0008-5472.CAN-10-2732,Dose-dependent effects of focal fractionated irradiation on secondary malignant neoplasms in Nf1 mutant mice.,2011,Cancer research,,phosphorylated ERK Thr202/Tyr204; phosphorylated Akt Ser473; phosphorylated S6 Ser235/236; γH2AX Ser139,Nf1-/- mouse embryo fibroblasts,,R 2.7.0,,,,,6,3,High
PMID:23071067,10.1158/0008-5472.CAN-12-1728,Genetically mediated Nf1 loss in mice promotes diverse radiation-induced tumors modeling second malignant neoplasms.,2012,Cancer research,,,,REPLI-g FFPE,Adobe Photoshop CS2; Peak Scanner software from Applied Biosystems; SDS3.0; COSMIC Database; Prizm v.4 (GraphPad),,,,,6,5,High
PMID:23175151,10.1038/bjc.2012.518,MicroRNA profiling of peripheral nerve sheath tumours identifies miR-29c as a tumour suppressor gene involved in tumour progression.,2013,British journal of cancer,,MMP2; MMP3,HT1080,Agilent Human miRNA Microarray V2; miR-29c,Feature extractionTM software,,,,,6,1,High
PMID:23432799,10.1186/1477-7525-11-21,"Development of the adult PedsQL™ neurofibromatosis type 1 module: initial feasibility, reliability and validity.",2013,Health and quality of life outcomes,,,,,SPSS 18; SAS 9.3,,,PedsQL™ Arthritis Module; PedsQL™ Cancer Module; PedsQL™ Cerebral Palsy Module; PedsQL™ Family Impact Module,,6,5,High
PMID:24559228,10.1186/1866-1955-6-4,Abnormal late visual responses and alpha oscillations in neurofibromatosis type 1: a link to visual and attention deficits.,2014,Journal of neurodevelopmental disorders,,,,,"MATLAB (R2008a, MathWorks, Natick, MA, USA); STIM 2 (Neuroscan, Charlotte, NC, USA); Scan 4.5 (Neuroscan); IBM SPSS Statistics, version 19",,,Wechsler Intelligence Scale for Children (WISC-III); Diamond Digital color monitor (Mitsubishi Electric Australia),,6,4,High
PMID:25549701,,Exome sequencing on malignant meningiomas identified mutations in neurofibromatosis type 2 (NF2) and meningioma 1 (MN1) genes.,2014,Discovery medicine,,,,Human All Exon; targeted region arrays,wANNOVAR web server; SeqMule; Codon Code Aligner; primer 3 (v. 0.4.0),,,,,6,4,High
PMID:26190969,10.3389/fncel.2015.00234,"In vivo synaptic transmission and morphology in mouse models of Tuberous sclerosis, Fragile X syndrome, Neurofibromatosis type 1, and Costello syndrome.",2015,Frontiers in cellular neuroscience,,,,Alexa Fluor 594-labeled dextrans,pCLAMP 9.2; Volocity 4.2; ImageJ 1.46; Igor 6.22A; NeuroMatic,,,,,6,5,High
PMID:26883872,10.1016/j.jprot.2016.02.004,3-D imaging mass spectrometry of protein distributions in mouse Neurofibromatosis 1 (NF1)-associated optic glioma.,2016,Journal of proteomics,,S100A10,,,Bruker AutoFlex III mass spectrometer; FlexImaging 4.0; Thermo LTQ Velos Orbitrap mass spectrometer; TagIdent; protein prospector MS-product,,,,,6,6,High
PMID:28525381,10.18632/oncotarget.17589,The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,2017,Oncotarget,Nf1flox/wt; Nf1flox/mut; Nf1flox/flox; Olig2-Cre; Nf1flox/mut; Olig2-Cre; Nf1flox/flox; Prom1-CreER; Nf1flox/mut; Prom1-CreER,,,,,,,,,6,6,High
PMID:30479396,10.1038/s41467-018-07452-y,NF1 heterozygosity fosters de novo tumorigenesis but impairs malignant transformation.,2018,Nature communications,PLP CreERT2; Nf1 f/−; ROSA-LacZ,K1; LUMICAN; CD28; CD69,,pan-T-cell isolation,,,,,,6,1,High
PMID:32457840,10.3389/fonc.2020.00687,"TGFβ Signaling Increases Net Acid Extrusion, Proliferation and Invasion in Panc-1 Pancreatic Cancer Cells: SMAD4 Dependence and Link to Merlin/NF2 Signaling.",2020,Frontiers in oncology,,NHE1,AsPC-1; HPDE H6c7,NHE1; Merlin,UN-SCAN-IT gel 6.1,,,,,6,2,High
PMID:34049498,10.1186/s11689-021-09364-3,Early differences in auditory processing relate to Autism Spectrum Disorder traits in infants with Neurofibromatosis Type I.,2021,Journal of neurodevelopmental disorders,,,,,,,,EGI 128-electrode Hydrocel Sensor Net; Mullen Scales of Early Learning (MSEL); Autism Observation Score for Infants (AOSI); Infant Behaviour Questionnaire-Revised (IBQ-R); MacArthur Bates Communicative Development Inventory (CDI); NIH consensus criteria,,6,2,High
PMID:34464388,10.1371/journal.pmed.1003734,Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional study.,2021,PLoS medicine,,,,,fastp v.0.2; BWA v.0.7.17; Samtools v.1.7; ichorCNA tool (Broad v.0.2.0); deepTools bamPEFragmentSize,,,RECIST 1.1,,6,5,High
PMID:34782607,10.1038/s41525-021-00258-w,Pathogenic neurofibromatosis type 1 (NF1) RNA splicing resolved by targeted RNAseq.,2021,NPJ genomic medicine,,,,PHA; IL-2,STAR mapper (Version 2.4.1d); Picard tools; QURNAs; Alamut v2.15 (Interactive Biosoftware),,,,,6,4,High
PMID:35087195,10.1038/s41380-021-01422-5,Altered canonical and striatal-frontal resting state functional connectivity in children with pathogenic variants in the Ras/mitogen-activated protein kinase pathway.,2022,Molecular psychiatry,,,,,melodic v3.15; fMRI Expert Analysis Tool (FEAT); Multiple Imputation by Chained Equations (MICE),,,Wechsler Intelligence Scale; A Developmental NEuroPSYchological Assessment (NEPSY-II); Tanner staging,,6,3,High
PMID:37140985,10.1172/JCI168227,Basement membrane proteins in extracellular matrix characterize NF1 neurofibroma development and response to MEK inhibitor.,2023,The Journal of clinical investigation,H7;Nf1mut,,hTERT ipNF05.5; E13.5 DRG neurosphere cells,,Cell Ranger 5.0.1; Seurat R package; Proteome Discoverer 2.4,,,,,6,6,High
PMID:37446790,10.3390/molecules28135128,Icariin Promotes Osteogenic Differentiation in a Cell Model with NF1 Gene Knockout by Activating the cAMP/PKA/CREB Pathway.,2023,"Molecules (Basel, Switzerland)",,phosphorylated PKA; PKA; phosphorylated CREB; CREB,,,DESeq2 (version 1.12.4); PRISM (version 8),,,,,6,2,High
PMID:37608248,10.1186/s11689-023-09492-y,Aberrant oscillatory activity in neurofibromatosis type 1: an EEG study of resting state and working memory.,2023,Journal of neurodevelopmental disorders,,,,,MATLAB (2019a); SPM12 (version 7771); EEGLAB (version 13.6.5b),,,Vineland Adaptive Behaviour Scale (VABS-III); adaptive auditory n-back task; non-adaptive visual n-back task,,6,3,High
PMID:38931352,10.3390/ph17060685,PET Imaging of Neurofibromatosis Type 1 with a Fluorine-18 Labeled Tryptophan Radiotracer.,2024,"Pharmaceuticals (Basel, Switzerland)","Trp53, Nf1, Suz12 triple mutant","indoleamine 2,3-dioxygenase; TDO2",,L-[18F]FETrp,Agilent ChemStation software (version C.01.07); VivoQuant software version 4.0,,,,,6,3,High
PMID:38945076,10.1016/j.redox.2024.103249,Selective nitration of Hsp90 acts as a metabolic switch promoting tumor cell proliferation.,2024,Redox biology,,nitrated Hsp90,"normal human Schwann cells (Cat. No. 1700, ScienCell Research Laboratories); Mouse merlin-null schwannoma cells",Mycoplasma detection primers; Hsp90β,XF96 Extracellular Flux Analyzer (Agilent Technologies),,,,,6,2,High
PMID:41602242,10.7759/cureus.100193,Perspectives of Patients and Providers on Chronic Pain Assessment in Neurofibromatosis Type 1 (NF1): A Qualitative Study.,2025,Cureus,,,,,ATLAS.ti (Version 9),,,Brief Pain Inventory Short Form (BPI-SF); Patient Health Questionnaire (PHQ); Structured Clinical Interview for DSM Self Report version (SCID-SR); Generalized Anxiety Disorder 7 Item version (GAD-7); PHQ-9,,6,1,High
PMID:8582272,10.1242/dev.121.11.3583,Neurofibromin-deficient fibroblasts fail to form perineurium in vitro.,1995,"Development (Cambridge, England)",C57BL/6J,,,NeoTkp; NF31a; NF31b; 2.5S NGF; rhGGF2,,,,,,6,1,High
PMID:21216928,10.1158/1535-7163.MCT-10-0654,Interpreting mammalian target of rapamycin and cell growth inhibition in a genetically engineered mouse model of Nf1-deficient astrocytes.,2011,Molecular cancer therapeutics,,"phospho-histone-H3 (Ser 10); Various (phospho-S6, phospho-4EBP1, phospho-STAT3, AKT, etc.)",K4622 grade II glioma cell line,,Gel-Pro Analyzer 4.0 software; R statistical package,,,,,5,4,High
PMID:24040940,10.1186/1479-5876-11-213,Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors.,2013,Journal of translational medicine,,ABCC1,NF02.2,,XenoBase version 3.5; Affymetrix Expression Console MAS 5.0; StepOne Software v2.3,,,,,5,4,High
PMID:24817309,10.1371/journal.pone.0097320,Nf2/Merlin controls spinal cord neural progenitor function in a Rac1/ErbB2-dependent manner.,2014,PloS one,,pErbB2,Nf2-deficient spinal cord neural progenitor cells,MSCV; Rac1 N17; PLKO,,,,,,5,2,High
PMID:25340526,10.1371/journal.pone.0107760,Nilotinib is more potent than imatinib for treating plexiform neurofibroma in vitro and in vivo.,2014,PloS one,,,PNF-derived Schwann cells,,Vevo 2100 micro-imaging system; Vevo software version 5.0.0; Chipster software; R bioconductor,,,,,5,5,High
PMID:25772366,10.1016/j.celrep.2015.02.041,Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties.,2015,Cell reports,,,TVZ NSCs,Abcg1,Affymetrix GeneChip Mouse Genome 430 2.0 Array; Partex Genomics Suite Version 6.6 beta,optic glioma neurospheres,,,,5,4,High
PMID:28029918,10.1056/NEJMoa1605943,Activity of Selumetinib in Neurofibromatosis Type 1-Related Plexiform Neurofibromas.,2016,The New England journal of medicine,DhhCre;Nf1fl/fl,,,,,,,volumetric magnetic resonance imaging analysis; Responsibility for Medication Questionnaire; Response Evaluation Criteria In Solid Tumors (RECIST); World Health Organization (WHO) criteria,,5,2,High
PMID:28256556,10.1038/srep43315,An inflammatory gene signature distinguishes neurofibroma Schwann cells and macrophages from cells in the normal peripheral nervous system.,2017,Scientific reports,,CSF1,,interferon alpha-2b,Affymetrix Mouse Gene 2.0 ST array; WebGestalt webserver,,,"mouse cytokine array (panel A, R&D system)",,5,2,High
PMID:28848060,10.1136/jmedgenet-2017-104519,Genetic Severity Score predicts clinical phenotype in NF2.,2017,Journal of medical genetics,,,,,SPSS V.23,,,UK NF2 Genetic Severity Score; 8-item NF2 disease-specific quality of life score; hearing grade score; Manchester NF2 diagnostic criteria,,5,5,High
PMID:29670214,10.1038/s41598-018-24310-5,Restoring functional neurofibromin by protein transduction.,2018,Scientific reports,,,Sf21 insect cells; E. coli DH10Multibac cells,NF1 siRNA; Control siRNA; Lipofectamine RNAiMAX,,,,,,5,1,High
PMID:29847659,10.1167/iovs.17-22588,Neurofibromin Deficiency Induces Endothelial Cell Proliferation and Retinal Neovascularization.,2018,Investigative ophthalmology & visual science,,phospho-Akt,human endothelial colony forming cells (ECFC); human microvascular endothelial cells (HMVEC); 293FT packaging cells,NF1 shRNA,,,,,,5,2,High
PMID:32098059,10.3390/genes11020226,Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1.,2020,Genes,,,,,PLIER; vcf2maf; MultiPLIER; metaVIPER; NF Data Portal,,,,,5,5,High
PMID:32438526,10.1002/lary.28671,Effects of Neurod1 Expression on Mouse and Human Schwannoma Cells.,2021,The Laryngoscope,Postn-cre;Nf2f/f,NeuroD1,Primary human vestibular schwannoma (VS) cell cultures,NeuroD1,,,,Noldus Cat-Walk XT system,,5,2,High
PMID:32642740,10.1093/noajnl/vdaa003,Quality of life in patients with neurofibromatosis type 1 and 2 in Canada.,2020,Neuro-oncology advances,,,,,R statistical software version 3.5.1,,,PROMIS pain interference short form 8a; PedsQL NF1 adult module; Ablon visibility index; House and Brackmann facial nerve scale,,5,3,High
PMID:32699356,10.1038/s41467-020-17382-3,Murine models of IDH-wild-type glioblastoma exhibit spatial segregation of tumor initiation and manifestation during evolution.,2020,Nature communications,,,,,Burrows–Wheeler Aligner; control-FREEC; RStudio; APE; MEGAX,,,,,5,5,High
PMID:33369425,10.1021/acs.jpcb.0c09742,Machine Learning of Allosteric Effects: The Analysis of Ligand-Induced Dynamics to Predict Functional Effects in TRAP1.,2021,The journal of physical chemistry. B,,,,,Schrödinger software suite release 2017–1; AMBER16; VMD (version 1.9.3); gromacs (version 4.6); MATLAB version 2019b,,,,,5,5,High
PMID:33934112,10.1038/s41419-021-03716-6,HIF1α-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia.,2021,Cell death & disease,,citrate synthetase,,psPAX; pMD2.G; UAS:eGFP-KRAS G12D,Ethovision 11,,,,,5,1,High
PMID:34011935,10.1038/s41419-021-03802-9,Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine.,2021,Cell death & disease,,MMP1; collagen I; S100 protein,Neurofibromatosis 1 fibroblasts,AHR,,,,,,5,2,High
PMID:37174087,10.3390/cancers15092621,Vinblastine/Methotrexate for Debilitating and Progressive Plexiform Neurofibroma in Children and Young Adults with Neurofibromatosis Type 1: A Phase 2 Study.,2023,Cancers,,,,,Stata 15,,,NIH Consensus Conference criteria; Lansky performance status; Karnofsky performance status; Response Evaluation in Neurofibromatosis and Schwannomatosis (REiNS),,5,3,High
PMID:37410426,10.1158/1078-0432.CCR-23-0749,"CDK4/6-MEK Inhibition in MPNSTs Causes Plasma Cell Infiltration, Sensitization to PD-L1 Blockade, and Tumor Regression.",2023,Clinical cancer research : an official journal of the American Association for Cancer Research,,phospho-RB1 S807/811; kappa light chain; SIAH,,Cas9 and sgRNAs targeting Nf1+Cdkn2a,FlowJo v10,,,,,5,3,High
PMID:38136356,10.3390/cancers15245811,Drug Responses in Plexiform Neurofibroma Type I (PNF1) Cell Lines Using High-Throughput Data and Combined Effectiveness and Potency.,2023,Cancers,,,ipNF05.5-MX; ipNF95.11b C/T; ipNF02.3 2λ; ipNF02.8,,Synapse,,,,,5,3,High
PMID:38175707,10.1172/jci.insight.168826,Unbalancing cAMP and Ras/MAPK pathways as a therapeutic strategy for cutaneous neurofibromas.,2024,JCI insight,,MPZ,NF1-/- iPSC-derived neural crest cells,PAM71,Salmon v1.8.0,neurofibromasphere model,,,,5,4,High
PMID:38481529,10.3389/fcell.2024.1359561,Generation of heterozygous and homozygous NF1 lines from human-induced pluripotent stem cells using CRISPR/Cas9 to investigate bone defects associated with neurofibromatosis type 1.,2024,Frontiers in cell and developmental biology,,,NF1-1 hiPSC line; NF1-2 hiPSC line; WT-1 hiPSC line; WT-2 hiPSC line,,CRISPOR software,,,,,5,3,High
PMID:39061138,10.3390/cancers16142498,A Fibroblast-Derived Secretome Stimulates the Growth and Invasiveness of 3D Plexiform Neurofibroma Spheroids.,2024,Cancers,,,ipNF95.11b C-RFP,,Volocity software 7.0.0; Nanoparticle Tracking Analysis software version 3.3 Dev Build 3.3.104; GraphPad Prism version 8.0.1,3D rBM overlay model,,,,5,4,High
PMID:39269317,10.1158/1078-0432.CCR-24-1750,MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor.,2024,Clinical cancer research : an official journal of the American Association for Cancer Research,,,M724; M5,Human Phospho-RTK Array; Guide RNA,Image Studio Lite software,,,,,5,3,High
PMID:39373898,10.1007/s12031-024-02271-x,Identification of Pathogenic Missense Mutations of NF1 Using Computational Approaches.,2024,Journal of molecular neuroscience : MN,,,,,PredictSNP2; iStable; Align GVGD; SNPeffect 4.0; iMutant 2.0,,,,,5,5,High
PMID:39472976,10.1186/s40478-024-01875-z,NF1 expression profiling in IDH-wildtype glioblastoma: genomic associations and survival outcomes.,2024,Acta neuropathologica communications,,podoplanin,GBM1 cell line; JHH-0879 cell line,,QuPath (v0.4.3); R (version 4.3.1),,,,,5,2,High
PMID:39824854,10.1038/s41598-025-85386-4,Comparison of 1D and 3D volume measurement techniques in NF2-associated vestibular schwannoma monitoring.,2025,Scientific reports,,,,,"iPlan Net software (Brainlab, Feldkirchen, Germany); Statistical Package for Social Studies (SPSS 10.0 for Windows, SPSS Inc.)",,,Hannover classification system; Koos classification system; RECIST guidelines,,5,4,High
PMID:40225167,10.1155/2023/9628049,Functional Assays Combined with Pre-mRNA-Splicing Analysis Improve Variant Classification and Diagnostics for Individuals with Neurofibromatosis Type 1 and Legius Syndrome.,2023,Human mutation,,,COS-7,H-RAS; SPRED1; RAF-RBD,"Alamut Visual Plus, version 1.5.1",,,,,5,1,High
PMID:41001593,10.1080/23723556.2025.2561292,Loss of Schwann cell's normal rhythmic core clock gene expression and gain of rhythmic expression of oncogenic driver genes in malignant NF1-associated peripheral nerve sheath tumor.,2025,Molecular & cellular oncology,,,BRGN; primary human Schwann cells (HSC),Custom gene panel,CLC Genomics Workbench 22; CosinorPy Python package,,,,,5,2,High
PMID:12057013,10.1186/1471-2164-3-13,Complex splicing pattern generates great diversity in human NF1 transcripts.,2002,BMC genomics,,,TOP-10F' cells,pCR2.1-TOPO,Splice Site Prediction by Neural Network (SSPNN); mfold computer program version 3.0,,,,,4,2,High
PMID:20195187,10.1097/MAO.0b013e3181d2777f,Merlin knockdown in human Schwann cells: clues to vestibular schwannoma tumorigenesis.,2010,"Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology",,ErbB2,"Human Schwann cells (HSC; ScienCell, Carlsbad, CA)",neurofibromin 2,"ABI Prism 7000 Sequence Detection System (Applied Biosystems, version 1.1 software)",,,,,4,3,High
PMID:21439418,10.1016/j.bone.2011.03.760,Primary osteopathy of vertebrae in a neurofibromatosis type 1 murine model.,2011,Bone,Nf1(flox/-);Col2.3Cre(+),,,,piXarray 100 DSR System; XCT Research SA + peripheral quantitative computed tomography (pQCT) scanner; MtestwR software,,,,,4,4,High
PMID:21949590,10.2478/v10134-010-0025-8,ALTERED CALCIUM CURRENTS AND AXONAL GROWTH IN Nf1 HAPLOINSUFFICIENT MICE.,2010,Translational neuroscience,,tau 1,,Lipofectamine,origin8.1; Nikon Elements software,,,,,4,2,High
PMID:24465906,10.1371/journal.pone.0086115,"Multiscale, converging defects of macro-porosity, microstructure and matrix mineralization impact long bone fragility in NF1.",2014,PloS one,Nf1Col1,panendothelial cell antigen,,,skyscan 1172; Labview 7.0,,,,,4,3,High
PMID:25043591,10.1002/jbmr.2316,Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx -/- mice.,2015,Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research,"TetOff-Osx-/-Nf1; Osx-/-Nf1flox/flox; Osx-tTA,tetO-cre;Nf1flox/flox",,Nf1flox/flox bone marrow stromal cells,,,,,,,4,4,High
PMID:28193237,10.1186/s12955-017-0607-y,Evaluation of quality of life in adults with neurofibromatosis 1 (NF1) using the Impact of NF1 on Quality Of Life (INF1-QOL) questionnaire.,2017,Health and quality of life outcomes,,,,,,,,Impact of NF1 on Quality Of Life (INF1-QOL) questionnaire; EuroQol (EQ 5D); Riccardi NF severity grade classification; NIH Consensus Development Conference 1987 diagnostic criteria,,4,3,High
PMID:28392281,10.1016/j.expneurol.2017.04.001,Human stem cell modeling in neurofibromatosis type 1 (NF1).,2018,Experimental neurology,,,tail-tip fibroblasts (TTFs),"reprogramming factors; OCT4, SOX2, MYC, KLF4, NANOG, LIN28",,NF1 patient-derived induced pluripotent stem cells (iPSCs),,,,4,1,High
PMID:30531922,10.1038/s41591-018-0263-8,The molecular landscape of glioma in patients with Neurofibromatosis 1.,2019,Nature medicine,,GZMB,U2OS,Human All Exon capture probes,netMHCpan-4.0,,,,,4,1,High
PMID:31053133,10.1186/s13023-019-1067-8,Burden of adult neurofibromatosis 1: development and validation of a burden assessment tool.,2019,Orphanet journal of rare diseases,,,,,SAS software Version 9.4,,,BoN (Burden of NF1) questionnaire; Dermatology Life Quality Index (DLQI); SF12,,4,2,High
PMID:32107864,10.1002/mgg3.1180,Expanding the Noonan spectrum/RASopathy NGS panel: Benefits of adding NF1 and SPRED1.,2020,Molecular genetics & genomic medicine,,,,DNA capture system,"bwa-mem v0.7.10; GATK, version 1.0.4705; VisCap",,,,,4,3,High
PMID:39093127,10.1158/1078-0432.CCR-24-0797,Early Detection of Malignant and Premalignant Peripheral Nerve Tumors Using Cell-Free DNA Fragmentomics.,2024,Clinical cancer research : an official journal of the American Association for Cancer Research,,,,xGen UDI-UMI Adapters; TruSight Oncology 500,ichorCNA; Python sklearn,,,,,4,2,High
PMID:39110684,10.1371/journal.pone.0308207,Electrical stimulation of Schwann cells on electrospun hyaluronic acid carbon nanotube fibers.,2024,PloS one,,,ipNF 95.11b; ipn 02.8,,ImageJ (v1.53a); NIH ImageJ (version 1.53a),,,,,4,3,High
PMID:39225289,10.1111/srt.70020,Comparing 3D imaging devices for the measurement of cutaneous neurofibromas in patients with Neurofibromatosis Type 1.,2024,Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI),,,,,IBM SPSS Statistics,,,Vectra H1; LifeViz Micro; Cherry Imaging,,4,4,High
PMID:39269317 | PMID:35789380,10.1158/1078-0432.CCR-24-1750 | 10.1158/2159-8290.CD-21-1671,MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor. | PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.,,,,,M1; M3; M4; M6,,,,,,,4,4,High
PMID:39669605,10.1016/j.gimo.2024.101816,Next-generation variant exon screening: Moving forward in routine genetic disease investigations.,2024,Genetics in medicine open,,,,IGT-T192V1 Plus panel,Burrows-Wheeler Aligner (bwa-0.7.15); Sambamba (v0.6.6); CASAVA v1.82,,,,,4,3,High
PMID:40063513,10.1158/1078-0432.CCR-24-3029,DLK1 Distinguishes Subsets of NF1-Associated Malignant Peripheral Nerve Sheath Tumors with Divergent Molecular Signatures.,2025,Clinical cancer research : an official journal of the American Association for Cancer Research,,,,,log-rank Mantel-Cox test; spatial transcriptomics profiling,,,Hematoxylin and eosin (H&E); immunohistochemical staining,,4,3,High
PMID:40304934,10.1186/s41687-025-00877-2,Development of patient reported outcome measures assessing tumor pain intensity and tumor pain interference for individuals with neurofibromatosis type 1 and plexiform neurofibromas: qualitative findings.,2025,Journal of patient-reported outcomes,,,,,,,,Numeric Rating Scale-11; PII; PAin INtensity Scale for plexiform neurofibromas (PAINS-pNF); Pain Interference Index for plexiform neurofibromas (PII-pNF),,4,2,High
PMID:40862755,10.3390/cells14161276,Fibroblasts Attenuate Anti-Tumor Drug Efficacy in Tumor Cells via Paracrine Interactions with Tumor Cells in 3D Plexiform Neurofibroma Cultures.,2025,Cells,,P-glycoprotein,,,Volocity software (Version 7.0.0); ImageJ 1.54g software,TAME chips,,,,4,2,High
PMID:41468561,10.1212/WNL.0000000000214480,NF1-Specific Growth Charts for Head Circumference Over the First 3 Years of Life.,2026,Neurology,,,,,LMSz; gamlssTools,,,Survey of Well-being of Young Children (SWYC); Centers for Disease Control (CDC) growth charts,,4,2,High
PMID:17924978,10.1111/j.1750-3639.2007.00105.x,Natural history of meningioma development in mice reveals: a synergy of Nf2 and p16(Ink4a) mutations.,2008,"Brain pathology (Zurich, Switzerland)",Nf2 flox2/flox2 ;p16 Ink4a*/*,PGDS,,Gd-DTPA,,,,,,3,1,High
PMID:20200958,10.1002/jbmr.42,Local low-dose lovastatin delivery improves the bone-healing defect caused by Nf1 loss of function in osteoblasts.,2010,Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research,Nf1(ob) (-/-); 2.3-kb α1(I) collagen-cre Nf1 flox/flox,,Nf1 flox/flox calvaria osteoblasts,,,,,,,3,3,High
PMID:21681782,10.1002/ajh.22035,Nf1 mutant mice with p19ARF gene loss develop accelerated hematopoietic disease resembling acute leukemia with a variable phenotype.,2011,American journal of hematology,Nf1 fcr,CD16/CD32,,,Prism 4.0,,,,,3,3,High
PMID:24595234,10.1371/journal.pone.0090853,In vivo functional analysis of the human NF2 tumor suppressor gene in Drosophila.,2014,PloS one,y w Mer4; 4/FM7; T80-Gal4 y w Mer4,,,apterous-Gal4,,,,,,3,2,High
PMID:24958239,10.1186/gb-2014-15-6-r80,SVA retrotransposon insertion-associated deletion represents a novel mutational mechanism underlying large genomic copy number changes with non-recurrent breakpoints.,2014,Genome biology,,,Epstein-Barr virus-transformed cell lines,NF1-area probes; GenomeWalker adaptors,,,,,,3,2,High
PMID:25003081,10.3389/fonc.2014.00147,An integrative analysis of meningioma tumors reveals the determinant genes and pathways of malignant transformation.,2014,Frontiers in oncology,,,,Human Mapping 100K Set; GeneChip Human Genome U133 Plus 2.0 Arrays,HaploReg v2,,,,,3,1,High
PMID:25026211,10.1016/j.ccr.2014.05.001,Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus.,2014,Cancer cell,,,Meso-33; FC-1801,Ultra Low Cluster Plates,,,,,,3,2,High
PMID:25329635,10.1371/journal.pgen.1004575,Genetic modifiers of neurofibromatosis type 1-associated café-au-lait macule count identified using multi-platform analysis.,2014,PLoS genetics,,,lymphoblastoid cell lines,,TRAP (Tiled Regression Analysis Package); GenomeStudio (v. 2010.2),,,,,3,3,High
PMID:28051113,10.1038/srep39348,"A comprehensive custom panel design for routine hereditary cancer testing: preserving control, improving diagnostics and revealing a complex variation landscape.",2017,Scientific reports,,,,,bam-readcount; regioneR; CLC Genomics Workbench v6,,,,,3,3,High
PMID:29438698,10.1016/j.ccell.2018.01.005,Programming of Schwann Cells by Lats1/2-TAZ/YAP Signaling Drives Malignant Peripheral Nerve Sheath Tumorigenesis.,2018,Cancer cell,,TAZ/YAP; TEAD1,,,MACS version 1.4.2,,,,,3,3,High
PMID:33082502,10.1038/s41598-020-74920-1,Image segmentation of plexiform neurofibromas from a deep neural network using multiple b-value diffusion data.,2020,Scientific reports,,,,,Analyze 12.0; MIM Encore 6.9.3,,,Magnetom Avanto,,3,3,High
PMID:33817379,10.1016/j.heliyon.2021.e06518,Clinical assessment of the use of topical liquid diclofenac following laser microporation of cutaneous neurofibromas in individuals with neurofibromatosis type 1.,2021,Heliyon,,,,,,,,P.L.E.A.S.E.® device; Dermlite DL3; NIH Consensus Development Conference NF1 diagnostic criteria,,3,3,High
PMID:33963966,10.1007/s10803-021-05043-3,Cognitive and Electrophysiological Correlates of Working Memory Impairments in Neurofibromatosis Type 1.,2022,Journal of autism and developmental disorders,,,,,,,,National Institute of Health diagnostic criteria for NF1; P300 event-related potential; WM nback task,,3,1,High
PMID:35244537,10.7554/eLife.74238,Detection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis using aneuploidy and mutation identification in plasma.,2022,eLife,,,,Klenow (exo-),Illumina CASAVA software (v1.8); RealSeqS,,,,,3,2,High
PMID:35735230,10.1093/database/baac045,Centralizing neurofibromatosis experimental tool knowledge with the NF Research Tools Database.,2022,Database : the journal of biological databases and curation,,,,,NF Research Tools Database; JSON-LD schema; Synapse collaborative science platform,,,,,3,3,High
PMID:35741605,10.3390/brainsci12060720,Integrated Drug Mining Reveals Actionable Strategies Inhibiting Plexiform Neurofibromas.,2022,Brain sciences,,,ipNF05.5 (mixed clone),,Mechanism Interrogation PlatE (MIPE 4.0) library; IDAPredict.2drug function package,,,,,3,3,High
PMID:36890585,10.1186/s40478-023-01525-w,Neurofibromatosis type 1-dependent alterations in mouse microglia function are not cell-intrinsic.,2023,Acta neuropathologica communications,,,,,Imaris × 64 version 9.6–9.9; IGOR Pro 6.37; Prism 7,,,,,3,3,High
PMID:37269078,10.1177/17407745231178839,Perspectives of adolescents with neurofibromatosis 1 and cutaneous neurofibromas: Implications for clinical trials.,2024,"Clinical trials (London, England)",,,,,REDCap,,,Children's Tumor Foundation NF Registry; 5-point Likert-type scales,,3,3,High
PMID:37378983,10.1001/jamanetworkopen.2023.20599,Effect of Mind-Body Skills Training on Quality of Life for Geographically Diverse Adults With Neurofibromatosis: A Fully Remote Randomized Clinical Trial.,2023,JAMA network open,,,,,,,,World Health Organization Quality of Life Brief Version (WHOQOL-BREF); Relaxation Response Resiliency Program for NF (3RP-NF); Health Enhancement Program for NF (HEP-NF),,3,2,High
PMID:38115252,10.1097/MD.0000000000036696,Identification of hub genes and drug candidates for NF2-related vestibular schwannoma by bioinformatics tools.,2023,Medicine,,,,,R 4.0.3; miRTarBase; connectivity map (CMap),,,,,3,3,High
PMID:38321701,10.1177/17407745231217279,Patient-reported measures of tinnitus for individuals with neurofibromatosis type 2-related schwannomatosis: Recommendations for clinical trials.,2024,"Clinical trials (London, England)",,,,,,,,Tinnitus Functional Index; Patient-Reported Outcomes Rating Acceptance Tool for Endpoints (PRO-RATE); Client Oriented Scale of Improvement-Tinnitus,,3,1,High
PMID:39415595,10.1242/dmm.050862,Generation of a zebrafish neurofibromatosis model via inducible knockout of nf2a/b.,2024,Disease models & mechanisms,Tg(U6x:nf2a/b-4sgRNA),,,nf2a/b-4sgRNA,CRISPResso2,,,,,3,3,High
PMID:39966622,10.1038/s41598-025-88589-x,The development of an artificial intelligence auto-segmentation tool for 3D volumetric analysis of vestibular schwannomas.,2025,Scientific reports,,,,,Simpleware ScanIP; DPP V1.0; Simpleware,,,,,3,3,High
PMID:40529476,10.1016/j.xjidi.2025.100380,Using Durometers to Quantify Stiffness as an Outcome Measure for Cutaneous Neurofibroma in Neurofibromatosis Type 1.,2025,JID innovations : skin science from molecules to population health,,,,,R 4.4.2 software,,,Rex Gauge durometer; Delfin SkinFibroMeter,,3,3,High
PMID:40723243,10.3390/cancers17142359,The Combination of HSP90 Inhibitors and Selumetinib Reinforces the Inhibitory Effects on Plexiform Neurofibromas.,2025,Cancers,DhhCre;Nf1f/f;Luciferase,,ipNF05.5 Mixed Clones,,WGCNA package v1.69,,,,,3,3,High
PMID:41444363,10.1038/s41598-025-32031-9,Focused ultrasound-mediated drug delivery of bevacizumab in treating NF2-related schwannomatosis in an animal model.,2025,Scientific reports,Postn-Cre; Nf2flox/flox,,,,SAS 9.4; ParaVision 6.0.1,,,,,3,3,High
PMID:41564118 | PMID:38907342,10.1371/journal.pone.0340183 | 10.1186/s40478-024-01821-z,"Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas. | snRNA-seq of human cutaneous neurofibromas before and after selumetinib treatment implicates role of altered Schwann cell states, inter-cellular signaling, and extracellular matrix in treatment response.",,,,,icNF97.2a; icNF97.2b; icNF98.4d,,,,,,,3,3,High
PMID:15240917,10.1155/S1110724304308107,Survival of Human Neurofibroma in Immunodeficient Mice and Initial Results of Therapy With Pirfenidone.,2004,Journal of biomedicine & biotechnology,,Gal α 1-3Gal,,,,,human neurofibroma xenografts,,,2,1,High
PMID:18242513,10.1016/j.ccr.2008.01.003,The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells.,2008,Cancer cell,Nf1/p53-/-,α4 integrin,,,,,,,,2,1,High
PMID:20049725,10.1002/emmm.200900027,Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene.,2009,EMBO molecular medicine,,,88-3,shSOX9,,,,,,2,1,High
PMID:20049725 | PMID:18483311,10.1002/emmm.200900027 | 10.1158/1535-7163.MCT-07-2335,Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene. | Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors.,,,,,S520; YST1,,,,,,,2,2,High
PMID:22384355,10.1534/g3.111.000687,The SPRED1 Variants Repository for Legius Syndrome.,2011,"G3 (Bethesda, Md.)",,,,,Mutalyzer 2.0; FusionCharts v3,,,,,2,2,High
PMID:24040940 | PMID:33032988,10.1186/1479-5876-11-213 | 10.1158/0008-5472.CAN-20-1365,Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors. | Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,,,,NF96.2; NF94.3,,,,,,,2,2,High
PMID:25851896,10.3988/jcn.2015.11.2.172,Preclinical assessment of the anticancer drug response of plexiform neurofibroma tissue using primary cultures.,2015,"Journal of clinical neurology (Seoul, Korea)",,,,,"ImageJ software (version 1.48; National Institutes of Health, Behesda, MD, USA)",primary cultures derived from plexiform neurofibromas,,,,2,2,High
PMID:25917366,10.1038/mp.2015.48,HCN channels are a novel therapeutic target for cognitive dysfunction in Neurofibromatosis type 1.,2015,Molecular psychiatry,9a−/9a− Nf1,,,biocytin,,,,,,2,1,High
PMID:27081657 | PMID:28725547,10.1002/acn3.288 | 10.1016/j.nicl.2017.06.032,A randomized placebo-controlled lovastatin trial for neurobehavioral function in neurofibromatosis I. | Spatial working memory in neurofibromatosis 1: Altered neural activity and functional connectivity.,,,,,,,FMRIB software library (FSL),,,Wechsler Abbreviated Scale of Intelligence (WASI),,2,1,High
PMID:29408605,10.1016/j.neuroscience.2018.01.054,Nf2 Mutation in Schwann Cells Delays Functional Neural Recovery Following Injury.,2018,Neuroscience,P0SchΔ39-121,,,,CatWalk XT,,,,,2,2,High
PMID:29958847,10.1016/j.neurad.2018.05.006,Radiomic biomarkers informative of cancerous transformation in neurofibromatosis-1 plexiform tumors.,2019,Journal of neuroradiology = Journal de neuroradiologie,,,,,Insight Toolkit; Slicer,,,,,2,2,High
PMID:33507258,10.1001/jamanetworkopen.2020.35479,Assessment of RAS Dependency for BRAF Alterations Using Cancer Genomic Databases.,2021,JAMA network open,,,,,GENIE (Genomics Evidence Neoplasia Information Exchange); TCGA (The Cancer Genome Atlas),,,,,2,2,High
PMID:34647023,10.1093/noajnl/vdab129,A genetic mouse model with postnatal ,2021,Neuro-oncology advances,NPcis (Stock #008191); Nf1 (#017640),,,,,,,,,2,2,High
PMID:37246765 | PMID:38000020,10.1093/neuonc/noad097 | 10.1126/sciadv.adg8876,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology. | CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,,,,,,,Trimmomatic v 0.39; GATK V4.2,,,,,2,2,High
PMID:38000020 | PMID:38127282,10.1126/sciadv.adg8876 | 10.1158/1078-0432.CCR-23-2548,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors. | Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,,,,JH-2-002; JH-2-103,,,,,,,2,2,High
PMID:38173515,10.1016/j.heliyon.2023.e23445,Development of a semi-automatic segmentation technique based on mean magnetic resonance imaging intensity thresholding for volumetric quantification of plexiform neurofibromas.,2024,Heliyon,,,,,"Matlab script (Version 9.9.0, Natick, MA); SSTMean",,,,,2,2,High
PMID:38621478,10.1016/j.bpsc.2024.04.003,Influences of RASopathies on Neuroanatomical Variation in Children.,2024,Biological psychiatry. Cognitive neuroscience and neuroimaging,,,,,FreeSurfer,,,Wechsler Intelligence Scales,,2,1,High
PMID:39881370,10.1186/s13065-024-01353-6,"Spectrophotometric and computational characterization of charge transfer complex of selumetinib with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone and its utilization in developing an innovative green and high throughput microwell assay for analysis of bulk form and pharmaceutical formulation.",2025,BMC chemistry,,,,,GAMESS software; Mutiwfn 3.7,,,,,2,2,High
PMID:40437318,10.1186/s41747-025-00594-x,Quantitative MRI of dorsal root ganglion alterations in neurofibromatosis type 1 patients with or without pain.,2025,European radiology experimental,,,,,3D Slicer,,,visual analogue scale,,2,1,High
PMID:41022755 | PMID:38000020 | PMID:33032988,10.1038/s41467-025-63619-4 | 10.1126/sciadv.adg8876 | 10.1158/0008-5472.CAN-20-1365,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors. | CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors. | Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,,,,,,,,JH-2-002; JH-2-031,,,2,2,High
PMID:15255999,10.1186/1476-4598-3-20,"Molecular profiling of malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1, based on large-scale real-time RT-PCR.",2004,Molecular cancer,,,,,Oligo 5.0 computer program,,,,,1,1,High
PMID:17924978 | PMID:38945076,10.1111/j.1750-3639.2007.00105.x | 10.1016/j.redox.2024.103249,Natural history of meningioma development in mice reveals: a synergy of Nf2 and p16(Ink4a) mutations. | Selective nitration of Hsp90 acts as a metabolic switch promoting tumor cell proliferation.,,,Nf2 flox2/flox2,,,,,,,,,1,1,High
PMID:18367665 | PMID:33658640 | PMID:33032988,10.1124/jpet.107.135830 | 10.1038/s41416-021-01270-8 | 10.1158/0008-5472.CAN-20-1365,Induction of apoptosis in neurofibromatosis type 1 malignant peripheral nerve sheath tumor cell lines by a combination of novel farnesyl transferase inhibitors and lovastatin. | Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours. | Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,,,,NF90-8,,,,,,,1,1,High
PMID:21111000 | PMID:38216587 | PMID:30617350 | PMID:30274821,10.1016/j.jneumeth.2010.10.021 | 10.1038/s41467-023-40408-5 | 10.1038/s41596-018-0105-7 | 10.1016/j.ebiom.2018.09.042,"A novel imaging-compatible sciatic nerve schwannoma model. | Epigenetic reprogramming shapes the cellular landscape of schwannoma. | A cerebellopontine angle mouse model for the investigation of tumor biology, hearing, and neurological function in NF2-related vestibular schwannoma. | Synergistic effect of Nutlin-3 combined with MG-132 on schwannoma cells through restoration of merlin and p53 tumour suppressors.",,,,,HEI-193,,,,,,,1,1,High
PMID:21216928 | PMID:26883872 | PMID:20551058,10.1158/1535-7163.MCT-10-0654 | 10.1016/j.jprot.2016.02.004 | 10.1158/0008-5472.CAN-09-3769,Interpreting mammalian target of rapamycin and cell growth inhibition in a genetically engineered mouse model of Nf1-deficient astrocytes. | 3-D imaging mass spectrometry of protein distributions in mouse Neurofibromatosis 1 (NF1)-associated optic glioma. | Cyclic AMP suppression is sufficient to induce gliomagenesis in a mouse model of neurofibromatosis-1.,,,Nf1 flox/flox; GFAP-Cre,,,,,,,,,1,1,High
PMID:21963652 | PMID:19191334 | PMID:23225063 | PMID:25772366,10.1016/j.expneurol.2011.09.005 | 10.1002/glia.20845 | 10.1002/ana.23793 | 10.1016/j.celrep.2015.02.041,PET imaging for attention deficit preclinical drug testing in neurofibromatosis-1 mice. | Microarray analyses reveal regional astrocyte heterogeneity with implications for neurofibromatosis type 1 (NF1)-regulated glial proliferation. | Dopamine deficiency underlies learning deficits in neurofibromatosis-1 mice. | Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties.,,,Nf1+/− GFAP CKO,,,,,,,,,1,1,High
PMID:23432799 | PMID:33442015,10.1186/1477-7525-11-21 | 10.1038/s41591-020-01193-6,"Development of the adult PedsQL™ neurofibromatosis type 1 module: initial feasibility, reliability and validity. | Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial.",,,,,,,,,,PedsQL™ NF1 Module,,1,1,High
PMID:23685747 | PMID:23535903,10.1038/ng.2641 | 10.1158/2159-8290.CD-13-0081,"Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis. | Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance.",,,,,,,GeneSpring GX v7.3.1,,,,,1,1,High
PMID:24375753 | PMID:20551058 | PMID:28525381,10.1002/ana.24093 | 10.1158/0008-5472.CAN-09-3769 | 10.18632/oncotarget.17589,Sex Is a major determinant of neuronal dysfunction in neurofibromatosis type 1. | Cyclic AMP suppression is sufficient to induce gliomagenesis in a mouse model of neurofibromatosis-1. | The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,,,Nf1flox/mut;GFAP-Cre,,,,,,,,,1,1,High
PMID:24509877 | PMID:18413802,10.1038/onc.2013.506 | 10.1158/1535-7163.MCT-07-0518,MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1. | Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells.,,,,,MPNST cell lines,,,,,,,1,1,High
PMID:24509877 | PMID:35393510 | PMID:16835260 | PMID:38000020,10.1038/onc.2013.506 | 10.1038/s41418-022-00991-4 | 10.1093/hmg/ddl165 | 10.1126/sciadv.adg8876,MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1. | Tumor growth of neurofibromin-deficient cells is driven by decreased respiration and hampered by NAD | Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling. | CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,,,,,,NF1-GRD,,,,,,1,1,High
PMID:24619350 | PMID:32642740,10.1007/s00415-014-7303-1 | 10.1093/noajnl/vdaa003,Longitudinal evaluation of quality of life in 288 patients with neurofibromatosis 2. | Quality of life in patients with neurofibromatosis type 1 and 2 in Canada.,,,,,,,,,,NFTI-QOL,,1,1,High
PMID:24681606 | PMID:23535903,10.18632/oncotarget.1609 | 10.1158/2159-8290.CD-13-0081,"Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity. | Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance.",,,,,,,CalcuSyn Version 2.1,,,,,1,1,High
PMID:24824755 | PMID:20049725 | PMID:32642733 | PMID:18483311,10.1371/journal.pone.0096733 | 10.1002/emmm.200900027 | 10.1093/noajnl/vdz061 | 10.1158/1535-7163.MCT-07-2335,BNIP3 regulates AT101 [(-)-gossypol] induced death in malignant peripheral nerve sheath tumor cells. | Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene. | KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors. | Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors.,,,,,90-8,,,,,,,1,1,High
PMID:26219339 | PMID:31527226,10.18632/oncotarget.4858 | 10.1158/1535-7163.MCT-19-0123,"A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas. | Ketotifen Modulates Mast Cell Chemotaxis to Kit-Ligand, but Does Not Impact Mast Cell Numbers, Degranulation, or Tumor Behavior in Neurofibromas of",,,,,,,GraphPad Prism 6.0,,,,,1,1,High
PMID:28256556 | PMID:26904939,10.1038/srep43315 | 10.1016/j.celrep.2016.01.074,An inflammatory gene signature distinguishes neurofibroma Schwann cells and macrophages from cells in the normal peripheral nervous system. | Insertional Mutagenesis Identifies a STAT3/Arid1b/β-catenin Pathway Driving Neurofibroma Initiation.,,,Nf1fl/fl;DhhCre,,,,,,,,,1,1,High
PMID:28589254,10.1007/s00259-017-3733-1,Characterisation of malignant peripheral nerve sheath tumours in neurofibromatosis-1 using heterogeneity analysis of ,2017,European journal of nuclear medicine and molecular imaging,,,,,MedCalc,,,,,1,1,High
PMID:29438698 | PMID:38216572,10.1016/j.ccell.2018.01.005 | 10.1038/s41467-024-44755-9,Programming of Schwann Cells by Lats1/2-TAZ/YAP Signaling Drives Malignant Peripheral Nerve Sheath Tumorigenesis. | Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.,,,,,SNF02.2,,,,,,,1,1,High
PMID:29715273 | PMID:24509877 | PMID:40684195,10.1371/journal.pone.0196726 | 10.1038/onc.2013.506 | 10.1186/s40478-025-02075-z,Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation. | MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1. | Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1.,,,,MBP,,,,,,,,1,1,High
PMID:29897904,10.1371/journal.pone.0197350,Traditional and systems biology based drug discovery for the rare tumor syndrome neurofibromatosis type 2.,2018,PloS one,,,,,www.synapse.org/SynodosNF2,,,,,1,1,High
PMID:29941005 | PMID:30055648 | PMID:38744290 | PMID:33767727,10.1186/s13023-018-0843-1 | 10.1186/s13104-018-3630-0 | 10.1016/j.crmeth.2024.100772 | 10.3389/fgene.2021.603195,Increased extracellular matrix deposition during chondrogenic differentiation of dental pulp stem cells from individuals with neurofibromatosis type 1: an in vitro 2D and 3D study. | Testing ATRA and MEK inhibitor PD0325901 effectiveness in a nude mouse model for human MPNST xenografts. | A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening. | Molecular Diagnosis of Neurofibromatosis by Multigene Panel Testing.,,,,CD34,,,,,,,,1,1,High
PMID:30055648 | PMID:33356508 | PMID:39996452,10.1186/s13104-018-3630-0 | 10.1177/0963689720964383 | 10.1111/cns.70287,Testing ATRA and MEK inhibitor PD0325901 effectiveness in a nude mouse model for human MPNST xenografts. | C6 Cell Injection into the Optic Nerve of Long-Evans Rats: A Short-Term Model of Optic Pathway Gliomas. | Cas9 Mouse Model of Skull Base Meningioma Driven by Combinational Gene Inactivation in Meningeal Cells.,,,,vimentin,,,,,,,,1,1,High
PMID:31527226 | PMID:24817309,10.1158/1535-7163.MCT-19-0123 | 10.1371/journal.pone.0097320,"Ketotifen Modulates Mast Cell Chemotaxis to Kit-Ligand, but Does Not Impact Mast Cell Numbers, Degranulation, or Tumor Behavior in Neurofibromas of | Nf2/Merlin controls spinal cord neural progenitor function in a Rac1/ErbB2-dependent manner.",,,,,,,GraphPad Prism 5.0,,,,,1,1,High
PMID:31836666 | PMID:36689660,10.1074/jbc.RA119.010934 | 10.1073/pnas.2208960120,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer. | Destabilizing NF1 variants act in a dominant negative manner through neurofibromin dimerization.,,,,,,NF1 isoform 2,,,,,,1,1,High
PMID:32457840 | PMID:20195187 | PMID:21072183 | PMID:31015291 | PMID:28126595 | PMID:29715273 | PMID:30274821 | PMID:39415595 | PMID:38945076 | PMID:24595234,10.3389/fonc.2020.00687 | 10.1097/MAO.0b013e3181d2777f | 10.1371/journal.pone.0013791 | 10.1126/scisignal.aau8749 | 10.1016/j.ebiom.2017.01.020 | 10.1371/journal.pone.0196726 | 10.1016/j.ebiom.2018.09.042 | 10.1242/dmm.050862 | 10.1016/j.redox.2024.103249 | 10.1371/journal.pone.0090853,"TGFβ Signaling Increases Net Acid Extrusion, Proliferation and Invasion in Panc-1 Pancreatic Cancer Cells: SMAD4 Dependence and Link to Merlin/NF2 Signaling. | Merlin knockdown in human Schwann cells: clues to vestibular schwannoma tumorigenesis. | p21-Activated kinases are required for transformation in a cell-based model of neurofibromatosis type 2. | Proximity biotinylation identifies a set of conformation-specific interactions between Merlin and cell junction proteins. | Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target. | Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation. | Synergistic effect of Nutlin-3 combined with MG-132 on schwannoma cells through restoration of merlin and p53 tumour suppressors. | Generation of a zebrafish neurofibromatosis model via inducible knockout of nf2a/b. | Selective nitration of Hsp90 acts as a metabolic switch promoting tumor cell proliferation. | In vivo functional analysis of the human NF2 tumor suppressor gene in Drosophila.",,,,Merlin,,,,,,,,1,1,High
PMID:32461556 | PMID:38481529 | PMID:39890807 | PMID:34646065 | PMID:37446790 | PMID:34011935 | PMID:29670214 | PMID:37140985 | PMID:36241865,10.1038/s41467-020-16432-0 | 10.3389/fcell.2024.1359561 | 10.1038/s41598-024-84493-y | 10.1155/2021/9386823 | 10.3390/molecules28135128 | 10.1038/s41419-021-03802-9 | 10.1038/s41598-018-24310-5 | 10.1172/JCI168227 | 10.1038/s12276-022-00850-9,Assessing the origin of high-grade serous ovarian cancer using CRISPR-modification of mouse organoids. | Generation of heterozygous and homozygous NF1 lines from human-induced pluripotent stem cells using CRISPR/Cas9 to investigate bone defects associated with neurofibromatosis type 1. | Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism. | Survival and | Icariin Promotes Osteogenic Differentiation in a Cell Model with NF1 Gene Knockout by Activating the cAMP/PKA/CREB Pathway. | Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine. | Restoring functional neurofibromin by protein transduction. | Basement membrane proteins in extracellular matrix characterize NF1 neurofibroma development and response to MEK inhibitor. | Transplanting neurofibromatosis-1 gene knockout neural stem cells improve functional recovery in rats with spinal cord injury by enhancing the mTORC2 pathway.,,,,,,Nf1,,,,,,1,1,High
PMID:32642734 | PMID:31462295 | PMID:39321200 | PMID:30479396 | PMID:38127282 | PMID:38216572 | PMID:37246765 | PMID:36598417,10.1093/noajnl/vdz026 | 10.1186/s40478-019-0792-5 | 10.1158/1078-0432.CCR-24-1454 | 10.1038/s41467-018-07452-y | 10.1158/1078-0432.CCR-23-2548 | 10.1038/s41467-024-44755-9 | 10.1093/neuonc/noad097 | 10.1158/2159-8290.CD-22-0786,Whole exome sequencing reveals the maintained polyclonal nature from primary to metastatic malignant peripheral nerve sheath tumor in two patients with NF1. | Telomere alterations in neurofibromatosis type 1-associated solid tumors. | Multidimensional Immunotyping of Human NF1-Associated Peripheral Nerve Sheath Tumors Uncovers Tumor-Associated Macrophages as Key Drivers of Immune Evasion in the Tumor Microenvironment. | NF1 heterozygosity fosters de novo tumorigenesis but impairs malignant transformation. | Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression. | Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance. | Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology. | Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,,,H3K27me3,,,,,,,,1,1,High
PMID:32642741,10.1093/noajnl/vdaa037,Effect of age and neurofibromatosis type 1 status on white matter integrity in the optic radiations.,2020,Neuro-oncology advances,,,,,FSL version 5.0.7,,,,,1,1,High
PMID:32699356 | PMID:18451155 | PMID:35589737 | PMID:19191334 | PMID:35945463 | PMID:20554030 | PMID:33356508 | PMID:25535838 | PMID:34930951 | PMID:25772366 | PMID:36241865 | PMID:20551058 | PMID:19144871,10.1038/s41467-020-17382-3 | 10.1158/0008-5472.CAN-07-6867 | 10.1038/s41467-022-30466-6 | 10.1002/glia.20845 | 10.1007/s00401-022-02478-5 | 10.1016/j.jneuroim.2010.05.002 | 10.1177/0963689720964383 | 10.7554/eLife.05151 | 10.1038/s41536-021-00195-3 | 10.1016/j.celrep.2015.02.041 | 10.1038/s12276-022-00850-9 | 10.1158/0008-5472.CAN-09-3769 | 10.3181/0809-RM-275,Murine models of IDH-wild-type glioblastoma exhibit spatial segregation of tumor initiation and manifestation during evolution. | Pten haploinsufficiency accelerates formation of high-grade astrocytomas. | Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1. | Microarray analyses reveal regional astrocyte heterogeneity with implications for neurofibromatosis type 1 (NF1)-regulated glial proliferation. | Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1. | CXCL12 alone is insufficient for gliomagenesis in Nf1 mutant mice. | C6 Cell Injection into the Optic Nerve of Long-Evans Rats: A Short-Term Model of Optic Pathway Gliomas. | Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1. | A bioinspired gelatin-hyaluronic acid-based hybrid interpenetrating network for the enhancement of retinal ganglion cells replacement therapy. | Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties. | Transplanting neurofibromatosis-1 gene knockout neural stem cells improve functional recovery in rats with spinal cord injury by enhancing the mTORC2 pathway. | Cyclic AMP suppression is sufficient to induce gliomagenesis in a mouse model of neurofibromatosis-1. | Identification of erythrocyte p55/MPP1 as a binding partner of NF2 tumor suppressor protein/Merlin.,,,,GFAP,,,,,,,,1,1,High
PMID:32781282 | PMID:21199799 | PMID:8582272 | PMID:21949590 | PMID:40590220 | PMID:36890585 | PMID:40684195 | PMID:23071067 | PMID:26190969 | PMID:21439418 | PMID:25772366 | PMID:29847659 | PMID:18242513 | PMID:28525381 | PMID:16835260 | PMID:18632543,10.1016/j.trsl.2020.08.001 | 10.1158/0008-5472.CAN-10-2732 | 10.1242/dev.121.11.3583 | 10.2478/v10134-010-0025-8 | 10.1172/JCI188932 | 10.1186/s40478-023-01525-w | 10.1186/s40478-025-02075-z | 10.1158/0008-5472.CAN-12-1728 | 10.3389/fncel.2015.00234 | 10.1016/j.bone.2011.03.760 | 10.1016/j.celrep.2015.02.041 | 10.1167/iovs.17-22588 | 10.1016/j.ccr.2008.01.003 | 10.18632/oncotarget.17589 | 10.1093/hmg/ddl165 | 10.1001/jama.300.3.287,"Nf1 heterozygous mice recapitulate the anthropometric and metabolic features of human neurofibromatosis type 1. | Dose-dependent effects of focal fractionated irradiation on secondary malignant neoplasms in Nf1 mutant mice. | Neurofibromin-deficient fibroblasts fail to form perineurium in vitro. | ALTERED CALCIUM CURRENTS AND AXONAL GROWTH IN Nf1 HAPLOINSUFFICIENT MICE. | A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice. | Neurofibromatosis type 1-dependent alterations in mouse microglia function are not cell-intrinsic. | Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1. | Genetically mediated Nf1 loss in mice promotes diverse radiation-induced tumors modeling second malignant neoplasms. | In vivo synaptic transmission and morphology in mouse models of Tuberous sclerosis, Fragile X syndrome, Neurofibromatosis type 1, and Costello syndrome. | Primary osteopathy of vertebrae in a neurofibromatosis type 1 murine model. | Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties. | Neurofibromin Deficiency Induces Endothelial Cell Proliferation and Retinal Neovascularization. | The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells. | The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation. | Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling. | Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial.",,,Nf1+/-,,,,,,,,,1,1,High
PMID:32781282 | PMID:29847659,10.1016/j.trsl.2020.08.001 | 10.1167/iovs.17-22588,Nf1 heterozygous mice recapitulate the anthropometric and metabolic features of human neurofibromatosis type 1. | Neurofibromin Deficiency Induces Endothelial Cell Proliferation and Retinal Neovascularization.,,,,,,,GraphPad Prism version 6.0h,,,,,1,1,High
PMID:32839340 | PMID:18242513,10.1073/pnas.2008391117 | 10.1016/j.ccr.2008.01.003,Brain-wide structural and functional disruption in mice with oligodendrocyte-specific | The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells.,,,Nf1 fl/+,,,,,,,,,1,1,High
PMID:32948135 | PMID:30274821 | PMID:33032988 | PMID:18413802,10.1186/s12885-020-07397-w | 10.1016/j.ebiom.2018.09.042 | 10.1158/0008-5472.CAN-20-1365 | 10.1158/1535-7163.MCT-07-0518,Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model. | Synergistic effect of Nutlin-3 combined with MG-132 on schwannoma cells through restoration of merlin and p53 tumour suppressors. | Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors. | Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells.,,,,cyclin D1,,,,,,,,1,1,High
PMID:32948135 | PMID:36241865,10.1186/s12885-020-07397-w | 10.1038/s12276-022-00850-9,Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model. | Transplanting neurofibromatosis-1 gene knockout neural stem cells improve functional recovery in rats with spinal cord injury by enhancing the mTORC2 pathway.,,,,bcl2,,,,,,,,1,1,High
PMID:33025139 | PMID:32369930 | PMID:28051113 | PMID:36598417,10.1007/s00401-020-02230-x | 10.3390/genes11050499 | 10.1038/srep39348 | 10.1158/2159-8290.CD-22-0786,"Epigenomic, genomic, and transcriptomic landscape of schwannomatosis. | Unmasking Intra-tumoral Heterogeneity and Clonal Evolution in NF1-MPNST. | A comprehensive custom panel design for routine hereditary cancer testing: preserving control, improving diagnostics and revealing a complex variation landscape. | Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.",,,,,,,BwaMem,,,,,1,1,High
PMID:33025139 | PMID:35945463 | PMID:36598417 | PMID:38216587,10.1007/s00401-020-02230-x | 10.1007/s00401-022-02478-5 | 10.1158/2159-8290.CD-22-0786 | 10.1038/s41467-023-40408-5,"Epigenomic, genomic, and transcriptomic landscape of schwannomatosis. | Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1. | Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA. | Epigenetic reprogramming shapes the cellular landscape of schwannoma.",,,,,,,minfi,,,,,1,1,High
PMID:33078583 | PMID:21681782 | PMID:21551250 | PMID:21726432,10.1002/jcsm.12632 | 10.1002/ajh.22035 | 10.1158/0008-5472.CAN-10-4577 | 10.1186/1741-7015-9-82,Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis. | Nf1 mutant mice with p19ARF gene loss develop accelerated hematopoietic disease resembling acute leukemia with a variable phenotype. | Susceptible stages in Schwann cells for NF1-associated plexiform neurofibroma development. | MIA is a potential biomarker for tumour load in neurofibromatosis type 1.,,,Nf1 flox,,,,,,,,,1,1,High
PMID:33085177 | PMID:38499890,10.1002/mgg3.1530 | 10.1186/s41687-024-00714-y,"The development of the PlexiQoL: A patient-reported outcome measure for adults with neurofibromatosis type 1-associated plexiform neurofibromas. | The PlexiQoL, a patient-reported outcome measure on quality of life in neurofibromatosis type 1-associated plexiform neurofibroma: translation, cultural adaptation and validation into the Dutch language for the Netherlands.",,,,,,,,,,PlexiQoL,,1,1,High
PMID:33273014 | PMID:28126595 | PMID:26219339 | PMID:36148553,10.1074/jbc.RA120.014960 | 10.1016/j.ebiom.2017.01.020 | 10.18632/oncotarget.4858 | 10.1093/brain/awac342,mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition. | Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target. | A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas. | Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma.,,,,,Ben-Men-1,,,,,,,1,1,High
PMID:33273014 | PMID:29715273 | PMID:30274821 | PMID:26219339 | PMID:24595234,10.1074/jbc.RA120.014960 | 10.1371/journal.pone.0196726 | 10.1016/j.ebiom.2018.09.042 | 10.18632/oncotarget.4858 | 10.1371/journal.pone.0090853,mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition. | Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation. | Synergistic effect of Nutlin-3 combined with MG-132 on schwannoma cells through restoration of merlin and p53 tumour suppressors. | A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas. | In vivo functional analysis of the human NF2 tumor suppressor gene in Drosophila.,,,,,,NF2,,,,,,1,1,High
PMID:33442015 | PMID:31527226 | PMID:33658640 | PMID:38127282,10.1038/s41591-020-01193-6 | 10.1158/1535-7163.MCT-19-0123 | 10.1038/s41416-021-01270-8 | 10.1158/1078-0432.CCR-23-2548,"Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial. | Ketotifen Modulates Mast Cell Chemotaxis to Kit-Ligand, but Does Not Impact Mast Cell Numbers, Degranulation, or Tumor Behavior in Neurofibromas of | Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours. | Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.",,,Nf1flox/flox;PostnCre,,,,,,,,,1,1,High
PMID:33767727,10.3389/fgene.2021.603195,Molecular Diagnosis of Neurofibromatosis by Multigene Panel Testing.,2021,Frontiers in genetics,,,,,Primer 3.0,,,,,1,1,High
PMID:33934112 | PMID:39415595,10.1038/s41419-021-03716-6 | 10.1242/dmm.050862,HIF1α-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia. | Generation of a zebrafish neurofibromatosis model via inducible knockout of nf2a/b.,,,,,,,CHOPCHOP,,,,,1,1,High
PMID:34257279 | PMID:29670214,10.1038/s41467-021-24505-x | 10.1038/s41598-018-24310-5,Neurofibromin regulates metabolic rate via neuronal mechanisms in Drosophila. | Restoring functional neurofibromin by protein transduction.,,,,,,Nf1-eGFP,,,,,,1,1,High
PMID:34935315 | PMID:24465906 | PMID:21726432,10.1117/1.JBO.26.12.125001 | 10.1371/journal.pone.0086115 | 10.1186/1741-7015-9-82,"Analysis of muscle tissue in vivo using fiber-optic autofluorescence and diffuse reflectance spectroscopy. | Multiscale, converging defects of macro-porosity, microstructure and matrix mineralization impact long bone fragility in NF1. | MIA is a potential biomarker for tumour load in neurofibromatosis type 1.",,,Nf1Prx1-/-,,,,,,,,,1,1,High
PMID:35393510 | PMID:35614131,10.1038/s41418-022-00991-4 | 10.1038/s41418-022-01020-0,Tumor growth of neurofibromin-deficient cells is driven by decreased respiration and hampered by NAD | The mitochondrial chaperone TRAP1 regulates F-ATP synthase channel formation.,,,,,,,Origin® 8,,,,,1,1,High
PMID:35614131 | PMID:35393510,10.1038/s41418-022-01020-0 | 10.1038/s41418-022-00991-4,The mitochondrial chaperone TRAP1 regulates F-ATP synthase channel formation. | Tumor growth of neurofibromin-deficient cells is driven by decreased respiration and hampered by NAD,,,,,sMPNST cells,,,,,,,1,1,High
PMID:35741605 | PMID:33934112 | PMID:33442015 | PMID:38136356,10.3390/brainsci12060720 | 10.1038/s41419-021-03716-6 | 10.1038/s41591-020-01193-6 | 10.3390/cancers15245811,Integrated Drug Mining Reveals Actionable Strategies Inhibiting Plexiform Neurofibromas. | HIF1α-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia. | Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial. | Drug Responses in Plexiform Neurofibroma Type I (PNF1) Cell Lines Using High-Throughput Data and Combined Effectiveness and Potency.,,,,,ipNF95.6,,,,,,,1,1,High
PMID:35741605 | PMID:39129390 | PMID:38136356 | PMID:40723243,10.3390/brainsci12060720 | 10.1002/1878-0261.13704 | 10.3390/cancers15245811 | 10.3390/cancers17142359,Integrated Drug Mining Reveals Actionable Strategies Inhibiting Plexiform Neurofibromas. | Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors. | Drug Responses in Plexiform Neurofibroma Type I (PNF1) Cell Lines Using High-Throughput Data and Combined Effectiveness and Potency. | The Combination of HSP90 Inhibitors and Selumetinib Reinforces the Inhibitory Effects on Plexiform Neurofibromas.,,,,,ipnNF95.11c,,,,,,,1,1,High
PMID:35741605 | PMID:39129390 | PMID:40862755 | PMID:36689660 | PMID:39061138 | PMID:40723243,10.3390/brainsci12060720 | 10.1002/1878-0261.13704 | 10.3390/cells14161276 | 10.1073/pnas.2208960120 | 10.3390/cancers16142498 | 10.3390/cancers17142359,Integrated Drug Mining Reveals Actionable Strategies Inhibiting Plexiform Neurofibromas. | Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors. | Fibroblasts Attenuate Anti-Tumor Drug Efficacy in Tumor Cells via Paracrine Interactions with Tumor Cells in 3D Plexiform Neurofibroma Cultures. | Destabilizing NF1 variants act in a dominant negative manner through neurofibromin dimerization. | A Fibroblast-Derived Secretome Stimulates the Growth and Invasiveness of 3D Plexiform Neurofibroma Spheroids. | The Combination of HSP90 Inhibitors and Selumetinib Reinforces the Inhibitory Effects on Plexiform Neurofibromas.,,,,,ipNF95.11bC,,,,,,,1,1,High
PMID:35741605 | PMID:40723243,10.3390/brainsci12060720 | 10.3390/cancers17142359,Integrated Drug Mining Reveals Actionable Strategies Inhibiting Plexiform Neurofibromas. | The Combination of HSP90 Inhibitors and Selumetinib Reinforces the Inhibitory Effects on Plexiform Neurofibromas.,,,,,ipNF05.5 (single clone),,,,,,,1,1,High
PMID:35945463 | PMID:33025139,10.1007/s00401-022-02478-5 | 10.1007/s00401-020-02230-x,"Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1. | Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.",,,,,,,Rtsne,,,,,1,1,High
PMID:35945463 | PMID:39093127,10.1007/s00401-022-02478-5 | 10.1158/1078-0432.CCR-24-0797,Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1. | Early Detection of Malignant and Premalignant Peripheral Nerve Tumors Using Cell-Free DNA Fragmentomics.,,,,,,,ComplexHeatmap,,,,,1,1,High
PMID:36316421 | PMID:33519543 | PMID:37608248,10.1038/s41598-022-21907-9 | 10.3389/fpsyt.2020.585700 | 10.1186/s11689-023-09492-y,Non-invasive brain stimulation modulates GABAergic activity in neurofibromatosis 1. | Autism Spectrum Disorder Symptom Profile Across the RASopathies. | Aberrant oscillatory activity in neurofibromatosis type 1: an EEG study of resting state and working memory.,,,,,,,SPSS version25,,,,,1,1,High
PMID:36322658 | PMID:37164978 | PMID:24681606 | PMID:23685747 | PMID:30055648 | PMID:41001593 | PMID:38203448 | PMID:32948135 | PMID:23535903,10.1126/sciadv.abo5442 | 10.1038/s41467-023-38432-6 | 10.18632/oncotarget.1609 | 10.1038/ng.2641 | 10.1186/s13104-018-3630-0 | 10.1080/23723556.2025.2561292 | 10.3390/ijms25010277 | 10.1186/s12885-020-07397-w | 10.1158/2159-8290.CD-13-0081,"Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy. | Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities. | Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity. | Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis. | Testing ATRA and MEK inhibitor PD0325901 effectiveness in a nude mouse model for human MPNST xenografts. | Loss of Schwann cell's normal rhythmic core clock gene expression and gain of rhythmic expression of oncogenic driver genes in malignant NF1-associated peripheral nerve sheath tumor. | FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells. | Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model. | Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance.",,,,,T265,,,,,,,1,1,High
PMID:36730269 | PMID:33273014 | PMID:37410426 | PMID:40723243,10.1371/journal.pone.0277305 | 10.1074/jbc.RA120.014960 | 10.1158/1078-0432.CCR-23-0749 | 10.3390/cancers17142359,"Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas. | mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition. | CDK4/6-MEK Inhibition in MPNSTs Causes Plasma Cell Infiltration, Sensitization to PD-L1 Blockade, and Tumor Regression. | The Combination of HSP90 Inhibitors and Selumetinib Reinforces the Inhibitory Effects on Plexiform Neurofibromas.",,,,,,,synergyfinder,,,,,1,1,High
PMID:36890585 | PMID:33442015,10.1186/s40478-023-01525-w | 10.1038/s41591-020-01193-6,Neurofibromatosis type 1-dependent alterations in mouse microglia function are not cell-intrinsic. | Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial.,,,,,,,MaxQuant version 1.6.10.43,,,,,1,1,High
PMID:36890585 | PMID:40684195 | PMID:19191334 | PMID:21439418 | PMID:34935315 | PMID:25772366 | PMID:29847659 | PMID:29787563 | PMID:28525381 | PMID:25535838 | PMID:20200958,10.1186/s40478-023-01525-w | 10.1186/s40478-025-02075-z | 10.1002/glia.20845 | 10.1016/j.bone.2011.03.760 | 10.1117/1.JBO.26.12.125001 | 10.1016/j.celrep.2015.02.041 | 10.1167/iovs.17-22588 | 10.1371/journal.pone.0190001 | 10.18632/oncotarget.17589 | 10.7554/eLife.05151 | 10.1002/jbmr.42,Neurofibromatosis type 1-dependent alterations in mouse microglia function are not cell-intrinsic. | Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1. | Microarray analyses reveal regional astrocyte heterogeneity with implications for neurofibromatosis type 1 (NF1)-regulated glial proliferation. | Primary osteopathy of vertebrae in a neurofibromatosis type 1 murine model. | Analysis of muscle tissue in vivo using fiber-optic autofluorescence and diffuse reflectance spectroscopy. | Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties. | Neurofibromin Deficiency Induces Endothelial Cell Proliferation and Retinal Neovascularization. | Graph complexity analysis identifies an ETV5 tumor-specific network in human and murine low-grade glioma. | The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation. | Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1. | Local low-dose lovastatin delivery improves the bone-healing defect caused by Nf1 loss of function in osteoblasts.,,,Nf1 flox/flox,,,,,,,,,1,1,High
PMID:37164978 | PMID:38136356,10.1038/s41467-023-38432-6 | 10.3390/cancers15245811,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities. | Drug Responses in Plexiform Neurofibroma Type I (PNF1) Cell Lines Using High-Throughput Data and Combined Effectiveness and Potency.,,,,,ipNF06.2A,,,,,,,1,1,High
PMID:37378983 | PMID:31462295 | PMID:33507822 | PMID:32572180,10.1001/jamanetworkopen.2023.20599 | 10.1186/s40478-019-0792-5 | 10.1200/JCO.20.02220 | 10.1038/s41436-020-0873-7,Effect of Mind-Body Skills Training on Quality of Life for Geographically Diverse Adults With Neurofibromatosis: A Fully Remote Randomized Clinical Trial. | Telomere alterations in neurofibromatosis type 1-associated solid tumors. | NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibromas. | Late morbidity and mortality in adult survivors of childhood glioma with neurofibromatosis type 1: report from the Childhood Cancer Survivor Study.,,,,,,,"SAS, version 9.4",,,,,1,1,High
PMID:37681415 | PMID:24375753,10.1172/jci.insight.168445 | 10.1002/ana.24093,Structural and functional analyses of a germline KRAS T50I mutation provide insights into Raf activation. | Sex Is a major determinant of neuronal dysfunction in neurofibromatosis type 1.,,,,p-ERK1/2,,,,,,,,1,1,High
PMID:38201517 | PMID:18367665 | PMID:18413802 | PMID:36689660,10.3390/cancers16010089 | 10.1124/jpet.107.135830 | 10.1158/1535-7163.MCT-07-0518 | 10.1073/pnas.2208960120,Synergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 Dendrimers. | Induction of apoptosis in neurofibromatosis type 1 malignant peripheral nerve sheath tumor cell lines by a combination of novel farnesyl transferase inhibitors and lovastatin. | Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells. | Destabilizing NF1 variants act in a dominant negative manner through neurofibromin dimerization.,,,,RAS,,,,,,,,1,1,High
PMID:38201517 | PMID:37164978 | PMID:24681606 | PMID:23685747 | PMID:41036607 | PMID:38203448 | PMID:23535903,10.3390/cancers16010089 | 10.1038/s41467-023-38432-6 | 10.18632/oncotarget.1609 | 10.1038/ng.2641 | 10.1158/1535-7163.MCT-24-1053 | 10.3390/ijms25010277 | 10.1158/2159-8290.CD-13-0081,"Synergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 Dendrimers. | Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities. | Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity. | Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis. | Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors. | FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells. | Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance.",,,,,S462TY,,,,,,,1,1,High
PMID:38201517 | PMID:41022755 | PMID:39269317 | PMID:18367665 | PMID:37246765 | PMID:33658640 | PMID:24824755 | PMID:39129390 | PMID:18413802 | PMID:24681606 | PMID:23685747 | PMID:20049725 | PMID:32642733 | PMID:18483311 | PMID:38127282 | PMID:38216572 | PMID:38203448 | PMID:23535903 | PMID:41036607 | PMID:33032988,10.3390/cancers16010089 | 10.1038/s41467-025-63619-4 | 10.1158/1078-0432.CCR-24-1750 | 10.1124/jpet.107.135830 | 10.1093/neuonc/noad097 | 10.1038/s41416-021-01270-8 | 10.1371/journal.pone.0096733 | 10.1002/1878-0261.13704 | 10.1158/1535-7163.MCT-07-0518 | 10.18632/oncotarget.1609 | 10.1038/ng.2641 | 10.1002/emmm.200900027 | 10.1093/noajnl/vdz061 | 10.1158/1535-7163.MCT-07-2335 | 10.1158/1078-0432.CCR-23-2548 | 10.1038/s41467-024-44755-9 | 10.3390/ijms25010277 | 10.1158/2159-8290.CD-13-0081 | 10.1158/1535-7163.MCT-24-1053 | 10.1158/0008-5472.CAN-20-1365,"Synergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 Dendrimers. | Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors. | MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor. | Induction of apoptosis in neurofibromatosis type 1 malignant peripheral nerve sheath tumor cell lines by a combination of novel farnesyl transferase inhibitors and lovastatin. | Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology. | Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours. | BNIP3 regulates AT101 [(-)-gossypol] induced death in malignant peripheral nerve sheath tumor cells. | Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors. | Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells. | Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity. | Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis. | Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene. | KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors. | Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors. | Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression. | Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance. | FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells. | Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance. | Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors. | Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.",,,,,ST88-14,,,,,,,1,1,High
PMID:38499890 | PMID:38811427,10.1186/s41687-024-00714-y | 10.1186/s41687-024-00732-w,"The PlexiQoL, a patient-reported outcome measure on quality of life in neurofibromatosis type 1-associated plexiform neurofibroma: translation, cultural adaptation and validation into the Dutch language for the Netherlands. | Quality of life in individuals with neurofibromatosis type 1 associated cutaneous neurofibromas: validation of the Dutch cNF-Skindex.",,,,,,,SPSS version 28.0,,,,,1,1,High
PMID:38502231 | PMID:34010628,10.1172/JCI176748 | 10.1016/j.stem.2021.04.029,STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy. | Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression.,,,cisNP,,,,,,,,,1,1,High
PMID:38502231 | PMID:35393510,10.1172/JCI176748 | 10.1038/s41418-022-00991-4,STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy. | Tumor growth of neurofibromin-deficient cells is driven by decreased respiration and hampered by NAD,,,,,cis MPNST cell line,,,,,,,1,1,High
PMID:38811427,10.1186/s41687-024-00732-w,Quality of life in individuals with neurofibromatosis type 1 associated cutaneous neurofibromas: validation of the Dutch cNF-Skindex.,2024,Journal of patient-reported outcomes,,,,,,,,cNF-Skindex,,1,1,High
PMID:39129390 | PMID:40862755 | PMID:39061138 | PMID:33658640,10.1002/1878-0261.13704 | 10.3390/cells14161276 | 10.3390/cancers16142498 | 10.1038/s41416-021-01270-8,Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors. | Fibroblasts Attenuate Anti-Tumor Drug Efficacy in Tumor Cells via Paracrine Interactions with Tumor Cells in 3D Plexiform Neurofibroma Cultures. | A Fibroblast-Derived Secretome Stimulates the Growth and Invasiveness of 3D Plexiform Neurofibroma Spheroids. | Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours.,,,,,"ipNF05.5 (hTERT NF1 ipNF05.5, RRID: CVCL_UI71)",,,,,,,1,1,High
PMID:39269317 | PMID:23175151 | PMID:29438698 | PMID:40025578 | PMID:36322658 | PMID:35511749 | PMID:32642733 | PMID:38216572,10.1158/1078-0432.CCR-24-1750 | 10.1038/bjc.2012.518 | 10.1016/j.ccell.2018.01.005 | 10.1186/s40478-025-01965-6 | 10.1126/sciadv.abo5442 | 10.1158/1535-7163.MCT-21-0947 | 10.1093/noajnl/vdz061 | 10.1038/s41467-024-44755-9,MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor. | MicroRNA profiling of peripheral nerve sheath tumours identifies miR-29c as a tumour suppressor gene involved in tumour progression. | Programming of Schwann Cells by Lats1/2-TAZ/YAP Signaling Drives Malignant Peripheral Nerve Sheath Tumorigenesis. | Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment. | Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy. | A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors. | KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors. | Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.,,,,,SNF96.2,,,,,,,1,1,High
PMID:40394150 | PMID:32699356 | PMID:32948135 | PMID:32642734 | PMID:35589737 | PMID:19191334 | PMID:32461556 | PMID:29715273 | PMID:34040258 | PMID:35945463 | PMID:29941005 | PMID:29438698 | PMID:24681606 | PMID:30055648 | PMID:33032988 | PMID:26904939 | PMID:40684195 | PMID:32642733 | PMID:36148553 | PMID:33356508 | PMID:37246765 | PMID:24371224 | PMID:25535838 | PMID:33591953 | PMID:38945076 | PMID:34930951 | PMID:39996452 | PMID:21216928,10.1038/s41416-025-03055-9 | 10.1038/s41467-020-17382-3 | 10.1186/s12885-020-07397-w | 10.1093/noajnl/vdz026 | 10.1038/s41467-022-30466-6 | 10.1002/glia.20845 | 10.1038/s41467-020-16432-0 | 10.1371/journal.pone.0196726 | 10.1038/s41586-021-03580-6 | 10.1007/s00401-022-02478-5 | 10.1186/s13023-018-0843-1 | 10.1016/j.ccell.2018.01.005 | 10.18632/oncotarget.1609 | 10.1186/s13104-018-3630-0 | 10.1158/0008-5472.CAN-20-1365 | 10.1016/j.celrep.2016.01.074 | 10.1186/s40478-025-02075-z | 10.1093/noajnl/vdz061 | 10.1093/brain/awac342 | 10.1177/0963689720964383 | 10.1093/neuonc/noad097 | 10.1158/0008-5472.CAN-13-2062 | 10.7554/eLife.05151 | 10.1172/jci.insight.146351 | 10.1016/j.redox.2024.103249 | 10.1038/s41536-021-00195-3 | 10.1111/cns.70287 | 10.1158/1535-7163.MCT-10-0654,Mass spectrometric insights into the protein composition of human cutaneous neurofibromas: comparison of neurofibromas with the overlying skin. | Murine models of IDH-wild-type glioblastoma exhibit spatial segregation of tumor initiation and manifestation during evolution. | Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model. | Whole exome sequencing reveals the maintained polyclonal nature from primary to metastatic malignant peripheral nerve sheath tumor in two patients with NF1. | Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1. | Microarray analyses reveal regional astrocyte heterogeneity with implications for neurofibromatosis type 1 (NF1)-regulated glial proliferation. | Assessing the origin of high-grade serous ovarian cancer using CRISPR-modification of mouse organoids. | Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation. | NF1 mutation drives neuronal activity-dependent initiation of optic glioma. | Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1. | Increased extracellular matrix deposition during chondrogenic differentiation of dental pulp stem cells from individuals with neurofibromatosis type 1: an in vitro 2D and 3D study. | Programming of Schwann Cells by Lats1/2-TAZ/YAP Signaling Drives Malignant Peripheral Nerve Sheath Tumorigenesis. | Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity. | Testing ATRA and MEK inhibitor PD0325901 effectiveness in a nude mouse model for human MPNST xenografts. | Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors. | Insertional Mutagenesis Identifies a STAT3/Arid1b/β-catenin Pathway Driving Neurofibroma Initiation. | Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1. | KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors. | Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma. | C6 Cell Injection into the Optic Nerve of Long-Evans Rats: A Short-Term Model of Optic Pathway Gliomas. | Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology. | Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis. | Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1. | Chromosome 8 gain is associated with high-grade transformation in MPNST. | Selective nitration of Hsp90 acts as a metabolic switch promoting tumor cell proliferation. | A bioinspired gelatin-hyaluronic acid-based hybrid interpenetrating network for the enhancement of retinal ganglion cells replacement therapy. | Cas9 Mouse Model of Skull Base Meningioma Driven by Combinational Gene Inactivation in Meningeal Cells. | Interpreting mammalian target of rapamycin and cell growth inhibition in a genetically engineered mouse model of Nf1-deficient astrocytes.,,,,Ki67,,,,,,,,1,1,High
PMID:40737523,10.2196/71728,Clinician Perspectives of a Magnetic Resonance Imaging-Based 3D Volumetric Analysis Tool for Neurofibromatosis Type 2-Related Schwannomatosis: Qualitative Pilot Study.,2025,JMIR human factors,,,,,,,,Likert scale questionnaire,,1,1,High
PMID:41001593 | PMID:32948135,10.1080/23723556.2025.2561292 | 10.1186/s12885-020-07397-w,Loss of Schwann cell's normal rhythmic core clock gene expression and gain of rhythmic expression of oncogenic driver genes in malignant NF1-associated peripheral nerve sheath tumor. | Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model.,,,,,NSF1,,,,,,,1,1,High
PMID:41022755 | PMID:24932921 | PMID:33436083 | PMID:33934112 | PMID:29670214 | PMID:25043591 | PMID:20200958,10.1038/s41467-025-63619-4 | 10.1002/jbmr.2298 | 10.1186/s13072-020-00380-6 | 10.1038/s41419-021-03716-6 | 10.1038/s41598-018-24310-5 | 10.1002/jbmr.2316 | 10.1002/jbmr.42,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors. | Neurofibromin deficiency-associated transcriptional dysregulation suggests a novel therapy for tibial pseudoarthrosis in NF1. | Distinctive epigenomic alterations in NF1-deficient cutaneous and plexiform neurofibromas drive differential MKK/p38 signaling. | HIF1α-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia. | Restoring functional neurofibromin by protein transduction. | Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx -/- mice. | Local low-dose lovastatin delivery improves the bone-healing defect caused by Nf1 loss of function in osteoblasts.,,,,phospho-ERK1/2,,,,,,,,1,1,High
PMID:41022755 | PMID:26904939,10.1038/s41467-025-63619-4 | 10.1016/j.celrep.2016.01.074,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors. | Insertional Mutagenesis Identifies a STAT3/Arid1b/β-catenin Pathway Driving Neurofibroma Initiation.,,,,,,,,neurofibromaspheres,,,,1,1,High
PMID:41022755 | PMID:28166733 | PMID:38714355 | PMID:39472976 | PMID:41564118 | PMID:30479396 | PMID:39129390 | PMID:34257279 | PMID:34011935 | PMID:25535838,10.1038/s41467-025-63619-4 | 10.1186/s12864-017-3519-7 | 10.1158/1535-7163.MCT-23-0510 | 10.1186/s40478-024-01875-z | 10.1371/journal.pone.0340183 | 10.1038/s41467-018-07452-y | 10.1002/1878-0261.13704 | 10.1038/s41467-021-24505-x | 10.1038/s41419-021-03802-9 | 10.7554/eLife.05151,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors. | A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma. | MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma. | NF1 expression profiling in IDH-wildtype glioblastoma: genomic associations and survival outcomes. | Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas. | NF1 heterozygosity fosters de novo tumorigenesis but impairs malignant transformation. | Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors. | Neurofibromin regulates metabolic rate via neuronal mechanisms in Drosophila. | Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine. | Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1.,,,,NF1,,,,,,,,1,1,High
PMID:41022755 | PMID:32383545 | PMID:33658640 | PMID:38502231 | PMID:23328114 | PMID:37164978 | PMID:24681606 | PMID:23685747 | PMID:30055648 | PMID:20049725 | PMID:32642733 | PMID:18483311 | PMID:38127282 | PMID:41001593 | PMID:32948135 | PMID:37410426 | PMID:23535903 | PMID:35511749,10.1038/s41467-025-63619-4 | 10.15252/embr.201949117 | 10.1038/s41416-021-01270-8 | 10.1172/JCI176748 | 10.18632/oncotarget.793 | 10.1038/s41467-023-38432-6 | 10.18632/oncotarget.1609 | 10.1038/ng.2641 | 10.1186/s13104-018-3630-0 | 10.1002/emmm.200900027 | 10.1093/noajnl/vdz061 | 10.1158/1535-7163.MCT-07-2335 | 10.1158/1078-0432.CCR-23-2548 | 10.1080/23723556.2025.2561292 | 10.1186/s12885-020-07397-w | 10.1158/1078-0432.CCR-23-0749 | 10.1158/2159-8290.CD-13-0081 | 10.1158/1535-7163.MCT-21-0947,"Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors. | Hexokinase 2 displacement from mitochondria-associated membranes prompts Ca | Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours. | STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy. | Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition. | Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities. | Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity. | Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis. | Testing ATRA and MEK inhibitor PD0325901 effectiveness in a nude mouse model for human MPNST xenografts. | Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene. | KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors. | Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors. | Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression. | Loss of Schwann cell's normal rhythmic core clock gene expression and gain of rhythmic expression of oncogenic driver genes in malignant NF1-associated peripheral nerve sheath tumor. | Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model. | CDK4/6-MEK Inhibition in MPNSTs Causes Plasma Cell Infiltration, Sensitization to PD-L1 Blockade, and Tumor Regression. | Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance. | A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.",,,,,S462,,,,,,,1,1,High
PMID:41022755 | PMID:38175707 | PMID:41444363 | PMID:38216572 | PMID:37246765 | PMID:39110684 | PMID:34646065,10.1038/s41467-025-63619-4 | 10.1172/jci.insight.168826 | 10.1038/s41598-025-32031-9 | 10.1038/s41467-024-44755-9 | 10.1093/neuonc/noad097 | 10.1371/journal.pone.0308207 | 10.1155/2021/9386823,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors. | Unbalancing cAMP and Ras/MAPK pathways as a therapeutic strategy for cutaneous neurofibromas. | Focused ultrasound-mediated drug delivery of bevacizumab in treating NF2-related schwannomatosis in an animal model. | Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance. | Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology. | Electrical stimulation of Schwann cells on electrospun hyaluronic acid carbon nanotube fibers. | Survival and,,,,S100B,,,,,,,,1,1,High
PMID:41022755 | PMID:38714355,10.1038/s41467-025-63619-4 | 10.1158/1535-7163.MCT-23-0510,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors. | MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.,,,,,LN229,,,,,,,1,1,High
PMID:41022755 | PMID:40590220 | PMID:21072183 | PMID:29670214 | PMID:37681415 | PMID:25043591 | PMID:20200958 | PMID:24375753,10.1038/s41467-025-63619-4 | 10.1172/JCI188932 | 10.1371/journal.pone.0013791 | 10.1038/s41598-018-24310-5 | 10.1172/jci.insight.168445 | 10.1002/jbmr.2316 | 10.1002/jbmr.42 | 10.1002/ana.24093,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors. | A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice. | p21-Activated kinases are required for transformation in a cell-based model of neurofibromatosis type 2. | Restoring functional neurofibromin by protein transduction. | Structural and functional analyses of a germline KRAS T50I mutation provide insights into Raf activation. | Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx -/- mice. | Local low-dose lovastatin delivery improves the bone-healing defect caused by Nf1 loss of function in osteoblasts. | Sex Is a major determinant of neuronal dysfunction in neurofibromatosis type 1.,,,,ERK1/2,,,,,,,,1,1,High
PMID:41444363 | PMID:24817309,10.1038/s41598-025-32031-9 | 10.1371/journal.pone.0097320,Focused ultrasound-mediated drug delivery of bevacizumab in treating NF2-related schwannomatosis in an animal model. | Nf2/Merlin controls spinal cord neural progenitor function in a Rac1/ErbB2-dependent manner.,,,Nf2flox/flox,,,,,,,,,1,1,High
PMID:41564118 | PMID:39669605,10.1371/journal.pone.0340183 | 10.1016/j.gimo.2024.101816,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas. | Next-generation variant exon screening: Moving forward in routine genetic disease investigations.,,,,,,,Genome Analysis Toolkit (GATK),,,,,1,1,High
PMID:41591566 | PMID:33591953 | PMID:38216587,10.1007/s00401-026-02979-7 | 10.1172/jci.insight.146351 | 10.1038/s41467-023-40408-5,FAP expression as a marker of malignant transformation enabling in vivo characterization in peripheral nerve sheath tumors: a multimodal and translational study. | Chromosome 8 gain is associated with high-grade transformation in MPNST. | Epigenetic reprogramming shapes the cellular landscape of schwannoma.,,,,,,,Seurat,,,,,1,1,High
PMID:41598414,10.3390/jcm15020475,Dermoscopy-Guided High-Frequency Ultrasound Imaging of Subcentimeter Cutaneous and Subcutaneous Neurofibromas in Patients with Neurofibromatosis Type 1.,2026,Journal of clinical medicine,,,,,,,,Dermus SkinScanner,,1,1,High
PMID:27956228,10.1053/j.gastro.2016.12.002,Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice.,2017,Gastroenterology,,HMGA2; CK19,p53−/− mouse embryonic liver progenitor cells; 293fs cells,Cas9/sgRNA; Myc; SB10 transposase,FastQC (version 0.11.2); Bowtie (version 1.0.0); BWA version 0.7.5; SAMtools (version 0.1.19); VarScan2 (version 2.3); STAR (version 2.3.0e); DESeq (version 1.18.0),,,,,14,7,Medium
PMID:23535903,10.1158/2159-8290.CD-13-0081,"Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance.",2013,Cancer discovery,,activated β-catenin; GSK3B; AXIN1; CCND1,,GSK3B; AXIN1; CTNNB1; TNKS; RSPO2; CTNNB1 S33Y,pheatmap package,,,,,11,1,Medium
PMID:27081657,10.1002/acn3.288,A randomized placebo-controlled lovastatin trial for neurobehavioral function in neurofibromatosis I.,2016,Annals of clinical and translational neurology,,,,,,,,Brief Visuospatial Memory Test – Revised (BVMT); Letter‐Number Sequencing task (LNS); Digit Cancellation; Hopkins Verbal Learning Test (HVLT); WISC‐III Object Assembly; Achenbach Child Behavior Checklist (CBCL); Young Adult Self Report (YASR); Neuropsychological Assessment Battery (NAB) Mazes; Delis–Kaplan Executive Function Scale (D‐KEFS) verbal fluency; Behavior Rating Inventory of Executive Function (BRIEF),,10,0,Medium
PMID:19191334,10.1002/glia.20845,Microarray analyses reveal regional astrocyte heterogeneity with implications for neurofibromatosis type 1 (NF1)-regulated glial proliferation.,2009,Glia,,AQP4; LHX2; FOXG1; FOXP2; HOXB3; GLAST; NF1GRP-D,,,Gel-Pro Analyzer 4.0; GraphPad Prism 4.0,,,,,9,3,Medium
PMID:21072183,10.1371/journal.pone.0013791,p21-Activated kinases are required for transformation in a cell-based model of neurofibromatosis type 2.,2010,PloS one,,Pak2; phospho-MEK1 (Ser298); phospho-Erk1/2 (Thr202/Tyr204); phospho-Akt (Thr308); phospho-Pak1–3 (Ser141),NIH-3T3; φNX packaging cell line,GST-PID; Gst-PID L107F,,,,,,9,3,Medium
PMID:18413802,10.1158/1535-7163.MCT-07-0518,Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells.,2008,Molecular cancer therapeutics,,MPM-2; B-Raf; phospho-Rb,LS141; DDLS,Ras Binding Domain; B-Raf; C-Raf,,,,,,8,0,Medium
PMID:18632543,10.1001/jama.300.3.287,Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial.,2008,JAMA,,,,,SPSS 12.0,,,Rey complex figure test; cancellation test; prism adaptation task; Stroop color word test; Wechsler Intelligence Scale for Children–Revised; Beery developmental test of visual-motor integration; judgment of line orientation task,,8,1,Medium
PMID:25377441,10.1111/pme.12620,Development and validation of the English Pain Interference Index and Pain Interference Index-Parent report.,2015,"Pain medicine (Malden, Mass.)",,,,,,,,Pain Interference Index (PII); Pain Interference Index-Parent report (PII-P); Modified Brief Pain Inventory (MBPI); Faces Pain Scale-Revised (FPS-R); Pain Rating Scale (PRS); Pain Rating Scale-Parent version (PRS-P); NF Disease Severity Scale; NF1 Disease Complications Scale,,8,2,Medium
PMID:30542164,10.1038/s41586-018-0774-y,Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome.,2018,Nature,,IL6 receptor; TNFα; IL3,U937; Raji; Eμ-ALL; Human CD19scFv-CD28–4–1BB-CD3ζ CAR-T cells (PM-CAR1003),,R version 3.5.1,,,,,8,1,Medium
PMID:32369930,10.3390/genes11050499,Unmasking Intra-tumoral Heterogeneity and Clonal Evolution in NF1-MPNST.,2020,Genes,,,,,Pindel; GenVisR; SIFT; Polyphen; ClonEvol; Partek Flow; gplots; PantherDB,,,,,8,8,Medium
PMID:32461556,10.1038/s41467-020-16432-0,Assessing the origin of high-grade serous ovarian cancer using CRISPR-modification of mouse organoids.,2020,Nature communications,,PAX8; Ac-alpha-Tubulin; γH2A.X,,Trp53; Brca1; Pten,,oviductal organoids; OSE organoids,,,,8,0,Medium
PMID:20551058,10.1158/0008-5472.CAN-09-3769,Cyclic AMP suppression is sufficient to induce gliomagenesis in a mouse model of neurofibromatosis-1.,2010,Cancer research,,PDE4A; LCA; phosphorylated protein kinase A substrate,Daoy,PDE4A1; PDE4A1-H229Q; firefly luciferase-eGFP fusion,,,,,,7,0,Medium
PMID:36241865,10.1038/s12276-022-00850-9,Transplanting neurofibromatosis-1 gene knockout neural stem cells improve functional recovery in rats with spinal cord injury by enhancing the mTORC2 pathway.,2022,Experimental & molecular medicine,,NF-200; P-mTOR; Rictor; myelin basic protein,Neural stem cells,Rictor; TUNEL,,,,,,7,2,Medium
PMID:40217315,10.1186/s13073-025-01462-4,A single-cell atlas of Schwannoma across genetic backgrounds and anatomic locations.,2025,Genome medicine,,CD44; HLA Class I ABC; MHC Class II,,,Smart-seq2; scdDblFinder; scran; QuPath,,,,,7,5,Medium
PMID:19144871,10.3181/0809-RM-275,Identification of erythrocyte p55/MPP1 as a binding partner of NF2 tumor suppressor protein/Merlin.,2009,"Experimental biology and medicine (Maywood, N.J.)",,p55/MPP1; NF-H; Caspr,DH5α bacteria,MBP fusion; His-p55,,,,,,6,0,Medium
PMID:23685747,10.1038/ng.2641,Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis.,2013,Nature genetics,,FOXR2,,SB11; T2/Onc15; EGFR; FOXR2; HPRT,,,,,,6,0,Medium
PMID:27458360,10.3389/fnhum.2016.00334,COMT Val(158)Met Polymorphism Is Associated with Verbal Working Memory in Neurofibromatosis Type 1.,2016,Frontiers in human neuroscience,,,,COMT val158met probe,Stratagene Mx3005 – MxPro QPCR-Software,,,Wechsler Adult and Children Intelligence Scales; Brazilian Wechsler Intelligence Scales (WAIS-III or WISC-III); School Achievement Test; Brazilian Criterion for Economic Classification (CCEB),,6,1,Medium
PMID:28735371,10.1007/s10897-017-0128-1,Identifying Symptoms of Distress in Youth Living with Neurofibromatosis Type 1 (NF1).,2018,Journal of genetic counseling,,,,,,,,Distress Thermometer (DT); Children's Depression Inventory (CDI-S); Children's Depression Inventory Parent Version (CDI-P); Lansky Score; Karnofsky Score; Distress Thermometer Acceptability and Feasibility Scales,,6,1,Medium
PMID:32187457,10.1056/NEJMoa1912735,Selumetinib in Children with Inoperable Plexiform Neurofibromas.,2020,The New England journal of medicine,,,,,,,,"Numerical Rating Scale (NRS-11); Pediatric Quality of Life Inventory (PedsQL) Generic Core Scales; Global Impression of Change scale; Patient-Reported Outcomes Measurement Information System (PROMIS) Mobility short form; Patient-Reported Outcomes Measurement Information System (PROMIS) Upper Extremity short form; NCI Common Terminology Criteria for Adverse Events, version 4.0",,6,0,Medium
PMID:32419643,10.1177/1533033820919759,Long Noncoding RNA WT1-AS Inhibit Cell Malignancy via miR-494-3p in Glioma.,2020,Technology in cancer research & treatment,,Ago2,M059J; U118; A172,WT1-AS,SPSS version 19.0,,,,,6,1,Medium
PMID:32642733,10.1093/noajnl/vdz061,KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors.,2020,Neuro-oncology advances,,KIF11; KIF15,CCD-1112Sk,KIF15/KIF23 siRNA; RGS2; ispinesib,,,,,,6,0,Medium
PMID:34065204,10.3390/ijms22105367,RABL6A Regulates Schwann Cell Senescence in an RB1-Dependent Manner.,2021,International journal of molecular sciences,,p-RB1-S807/811; RB1,Primary human Schwann cells (NHSC),RABL6A shRNA; RB1 shRNA; β-Galactosidase,,,,,,6,2,Medium
PMID:37681415,10.1172/jci.insight.168445,Structural and functional analyses of a germline KRAS T50I mutation provide insights into Raf activation.,2023,JCI insight,,EGFP,MOLM-13; 293T lenti-X cells,pCW57.1; KRAS WT; KRAS G12D,,,,,,6,0,Medium
PMID:21963652,10.1016/j.expneurol.2011.09.005,PET imaging for attention deficit preclinical drug testing in neurofibromatosis-1 mice.,2011,Experimental neurology,,p-MAPK; total MAPK,,WC-10,Beta Imager 2000Z Digital Beta Imaging System; Siemens Focus F220,,,,,5,4,Medium
PMID:24375753,10.1002/ana.24093,Sex Is a major determinant of neuronal dysfunction in neurofibromatosis type 1.,2014,Annals of neurology,,,,,,,,Ras activation assay (Millipore); cAMP assay (New East Biosciences); TUNEL assay (Roche Diagnostics); dopamine assay (Rocky Mountain Diagnostics); virtual optokinetic system (VOS),,5,0,Medium
PMID:32948135,10.1186/s12885-020-07397-w,Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model.,2020,BMC cancer,,p21; bcl6,B8 fibroblasts,PSME3,MATLAB® version R2007a,,,,,5,1,Medium
PMID:41591566,10.1007/s00401-026-02979-7,FAP expression as a marker of malignant transformation enabling in vivo characterization in peripheral nerve sheath tumors: a multimodal and translational study.,2026,Acta neuropathologica,,FAP,,LNTH-1363S,GEOquery; Biobase,,,H-score,,5,2,Medium
PMID:32572180,10.1038/s41436-020-0873-7,Late morbidity and mortality in adult survivors of childhood glioma with neurofibromatosis type 1: report from the Childhood Cancer Survivor Study.,2020,Genetics in medicine : official journal of the American College of Medical Genetics,,,,,R version 3.5.0,,,"Behavior Problem Index (BPI); CCSS Neurocognitive Questionnaire; Common Terminology Criteria for Adverse Events, version 4.0 (CTCAE v4.0)",,4,1,Medium
PMID:33519543,10.3389/fpsyt.2020.585700,Autism Spectrum Disorder Symptom Profile Across the RASopathies.,2020,Frontiers in psychiatry,,,,,,,,"Autism Diagnostic Interview Revised (ADI-R); Autism Diagnostic Observation Schedule-2 (ADOS-2); Wechsler Abbreviated Scale of Intelligence-II (WASI-II); Conners Parent Rating Scale (3rd edition, short form)",,4,0,Medium
PMID:34630515,10.3389/fgene.2021.721045,Assessment of Mosaicism and Detection of Cryptic Alleles in CRISPR/Cas9-Engineered Neurofibromatosis Type 1 and ,2021,Frontiers in genetics,,,LLC-PK1 ATCC CL-101,PrimeSTAR GXL,CRISPOR; JMP Pro 15.0.0,,,,,4,2,Medium
PMID:35945463,10.1007/s00401-022-02478-5,Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1.,2022,Acta neuropathologica,,synaptophysin; histone H3 K27M mutant protein; histone H3 lysine 27 trimethylation,,,UCSF500 NGS Panel,,,,,4,1,Medium
PMID:18670322,10.1097/MLG.0b013e318177e20b,Vestibular schwannoma quantitative polymerase chain reaction expression of estrogen and progesterone receptors.,2008,The Laryngoscope,,,,oligo-dT,"DNA Engine Peltier Thermal cycler (PTC-200); ABI Prism 7,000 Sequence Detection System",,,,,3,2,Medium
PMID:21726432,10.1186/1741-7015-9-82,MIA is a potential biomarker for tumour load in neurofibromatosis type 1.,2011,BMC medicine,,MIA,,,AxioVision 4.1 software; analySIS 5.0 software,,,,,3,2,Medium
PMID:24753394,10.1002/pbc.25041,Phase II trial of pirfenidone in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas.,2014,Pediatric blood & cancer,,,,,,,,NCI Common Terminology Criteria for Adverse Events (CTCAE) version 3; Impact of Pediatric Illness (IPI) Scale; STIR MRI,,3,1,Medium
PMID:27021207,10.1002/ajmg.a.37623,Acceptance and commitment therapy in youth with neurofibromatosis type 1 (NF1) and chronic pain and their parents: A pilot study of feasibility and preliminary efficacy.,2016,American journal of medical genetics. Part A,,,,,,,,Impact of Pediatric Illness Scale; Pain Management Inventory; Post-Treatment Questionnaire,,3,2,Medium
PMID:28725547,10.1016/j.nicl.2017.06.032,Spatial working memory in neurofibromatosis 1: Altered neural activity and functional connectivity.,2017,NeuroImage. Clinical,,,,,SPSS software v. 21,,,"Wechsler Adult Intelligence Scale, Version 4 (WAIS-IV); University of Maryland Letter–Number Sequencing (LNS) task",,3,1,Medium
PMID:31527226,10.1158/1535-7163.MCT-19-0123,"Ketotifen Modulates Mast Cell Chemotaxis to Kit-Ligand, but Does Not Impact Mast Cell Numbers, Degranulation, or Tumor Behavior in Neurofibromas of ",2019,Molecular cancer therapeutics,,,,Kit Ligand,Agilent 1200 HPLC; ABI 3200 MS/MS,,,,,3,2,Medium
PMID:33273014 | PMID:26219339,10.1074/jbc.RA120.014960 | 10.18632/oncotarget.4858,mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition. | A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.,,,,p70S6K; S6; NDRG1,,,,,,,,3,1,Medium
PMID:33356508,10.1177/0963689720964383,C6 Cell Injection into the Optic Nerve of Long-Evans Rats: A Short-Term Model of Optic Pathway Gliomas.,2020,Cell transplantation,,β-tubulin III,C6 cells,,MATLAB software,,,,,3,1,Medium
PMID:34106871,10.1109/JBHI.2021.3087735,DINs: Deep Interactive Networks for Neurofibroma Segmentation in Neurofibromatosis Type 1 on Whole-Body MRI.,2022,IEEE journal of biomedical and health informatics,,,,,DINs (Deep Interactive Networks); 3DQI software; MEDx software,,,,,3,3,Medium
PMID:18367665,10.1124/jpet.107.135830,Induction of apoptosis in neurofibromatosis type 1 malignant peripheral nerve sheath tumor cell lines by a combination of novel farnesyl transferase inhibitors and lovastatin.,2008,The Journal of pharmacology and experimental therapeutics,,Phospho-Rb Ser 780,Primary normal rat Schwann cells,,,,,,,2,1,Medium
PMID:18636037,10.1097/MAO.0b013e31817f7398,The ErbB inhibitors trastuzumab and erlotinib inhibit growth of vestibular schwannoma xenografts in nude mice: a preliminary study.,2008,"Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology",,,,,Image J software,,vestibular schwannoma xenografts,,,2,1,Medium
PMID:24932921,10.1002/jbmr.2298,Neurofibromin deficiency-associated transcriptional dysregulation suggests a novel therapy for tibial pseudoarthrosis in NF1.,2014,Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research,,,,Human Exome; pcDNA3.1,,,,,,2,0,Medium
PMID:24980480,10.1186/1479-7364-8-10,Novel age-dependent targets in vestibular schwannomas.,2014,Human genomics,,,,Human Universal Reference RNA,Bioconductor limma package,,,,,2,1,Medium
PMID:25012216,10.1186/s40478-014-0082-1,A neuronal function of the tumor suppressor protein merlin.,2014,Acta neuropathologica communications,,,,,,,,nerve conduction velocity; electrophysiological measurements,,2,0,Medium
PMID:28831766,10.1007/s12104-017-9768-1,NMR resonance assignments of the EVH1 domain of neurofibromin's recruitment factor Spred1.,2017,Biomolecular NMR assignments,,,BL21(DE3) Star,Spred1(EVH1),,,,,,2,0,Medium
PMID:29438698 | PMID:36148553,10.1016/j.ccell.2018.01.005 | 10.1093/brain/awac342,Programming of Schwann Cells by Lats1/2-TAZ/YAP Signaling Drives Malignant Peripheral Nerve Sheath Tumorigenesis. | Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma.,,,,TAZ; YAP,,,,,,,,2,2,Medium
PMID:32642740 | PMID:38811427,10.1093/noajnl/vdaa003 | 10.1186/s41687-024-00732-w,Quality of life in patients with neurofibromatosis type 1 and 2 in Canada. | Quality of life in individuals with neurofibromatosis type 1 associated cutaneous neurofibromas: validation of the Dutch cNF-Skindex.,,,,,,,,,,EQ-5D-5L; SF-36,,2,0,Medium
PMID:32839340,10.1073/pnas.2008391117,Brain-wide structural and functional disruption in mice with oligodendrocyte-specific ,2020,Proceedings of the National Academy of Sciences of the United States of America,,,,,ExplorDTI; Advanced Normalization Tools (ANTs),,,,,2,2,Medium
PMID:33085177,10.1002/mgg3.1530,The development of the PlexiQoL: A patient-reported outcome measure for adults with neurofibromatosis type 1-associated plexiform neurofibromas.,2020,Molecular genetics & genomic medicine,,,,,,,,Nottingham Health Profile; Short Form-36,,2,0,Medium
PMID:34377779,10.1212/NXG.0000000000000616,Impact of MEK Inhibitor Therapy on Neurocognitive Functioning in NF1.,2021,Neurology. Genetics,,,,,,,,Cogstate; Behavior Rating Inventory of Executive Function,,2,0,Medium
PMID:35723774,10.1007/s10072-022-06203-8,A randomized controlled trial of remote microphone listening devices to treat auditory deficits in children with neurofibromatosis type 1.,2022,Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology,,,,,,,,CNC-word test; LIFE-R Questionnaire,,2,0,Medium
PMID:36322658 | PMID:36148553,10.1126/sciadv.abo5442 | 10.1093/brain/awac342,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy. | Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma.,,,,ALDH1A1,,ALDH1A1,,,,,,2,0,Medium
PMID:39996452,10.1111/cns.70287,Cas9 Mouse Model of Skull Base Meningioma Driven by Combinational Gene Inactivation in Meningeal Cells.,2025,CNS neuroscience & therapeutics,,EMA,,Cre and gRNAs,,,,,,2,0,Medium
PMID:40352015,10.7759/cureus.82033,Development of a Machine Learning Algorithm for the Prediction of WHO Grade 1 Meningioma Recurrence.,2025,Cureus,,,,,Python version 3.10,,,Ki-67/MIB-1 index,,2,1,Medium
PMID:41411243,10.1371/journal.pgen.1011976,PERADIGM: Phenotype embedding similarity-based rare disease gene mapping.,2025,PLoS genetics,,,,,PERADIGM; Word2Vec,,,,,2,2,Medium
PMID:18451155 | PMID:36322658 | PMID:40684195 | PMID:23328114 | PMID:36241865,10.1158/0008-5472.CAN-07-6867 | 10.1126/sciadv.abo5442 | 10.1186/s40478-025-02075-z | 10.18632/oncotarget.793 | 10.1038/s12276-022-00850-9,Pten haploinsufficiency accelerates formation of high-grade astrocytomas. | Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy. | Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1. | Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition. | Transplanting neurofibromatosis-1 gene knockout neural stem cells improve functional recovery in rats with spinal cord injury by enhancing the mTORC2 pathway.,,,,nestin,,,,,,,,1,1,Medium
PMID:18670322 | PMID:21726432,10.1097/MLG.0b013e318177e20b | 10.1186/1741-7015-9-82,Vestibular schwannoma quantitative polymerase chain reaction expression of estrogen and progesterone receptors. | MIA is a potential biomarker for tumour load in neurofibromatosis type 1.,,,,,,PCR master mix,,,,,,1,0,Medium
PMID:20195187 | PMID:28166733 | PMID:25043298,10.1097/MAO.0b013e3181d2777f | 10.1186/s12864-017-3519-7 | 10.1038/onc.2014.185,Merlin knockdown in human Schwann cells: clues to vestibular schwannoma tumorigenesis. | A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma. | Oncogenic role of Merlin/NF2 in glioblastoma.,,,,EGFR,,,,,,,,1,1,Medium
PMID:20195187 | PMID:33032988,10.1097/MAO.0b013e3181d2777f | 10.1158/0008-5472.CAN-20-1365,Merlin knockdown in human Schwann cells: clues to vestibular schwannoma tumorigenesis. | Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,,,,,non-targeting control,,,,,,1,0,Medium
PMID:20200958 | PMID:21949590,10.1002/jbmr.42 | 10.2478/v10134-010-0025-8,Local low-dose lovastatin delivery improves the bone-healing defect caused by Nf1 loss of function in osteoblasts. | ALTERED CALCIUM CURRENTS AND AXONAL GROWTH IN Nf1 HAPLOINSUFFICIENT MICE.,,,,,,eGFP,,,,,,1,0,Medium
PMID:21072183 | PMID:34011935,10.1371/journal.pone.0013791 | 10.1038/s41419-021-03802-9,p21-Activated kinases are required for transformation in a cell-based model of neurofibromatosis type 2. | Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine.,,,,Mek1/2,,,,,,,,1,1,Medium
PMID:21111000,10.1016/j.jneumeth.2010.10.021,A novel imaging-compatible sciatic nerve schwannoma model.,2011,Journal of neuroscience methods,,,,Fluc and mCherry,,,,,,1,0,Medium
PMID:22961690 | PMID:23432799,10.1002/pbc.24281 | 10.1186/1477-7525-11-21,"Phase I trial and pharmacokinetic study of sorafenib in children with neurofibromatosis type I and plexiform neurofibromas. | Development of the adult PedsQL™ neurofibromatosis type 1 module: initial feasibility, reliability and validity.",,,,,,,,,,PedsQL 4.0 Generic Core Scales,,1,0,Medium
PMID:23175151 | PMID:34010628 | PMID:28256556 | PMID:23535903,10.1038/bjc.2012.518 | 10.1016/j.stem.2021.04.029 | 10.1038/srep43315 | 10.1158/2159-8290.CD-13-0081,"MicroRNA profiling of peripheral nerve sheath tumours identifies miR-29c as a tumour suppressor gene involved in tumour progression. | Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression. | An inflammatory gene signature distinguishes neurofibroma Schwann cells and macrophages from cells in the normal peripheral nervous system. | Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance.",,,,,,,limma package,,,,,1,1,Medium
PMID:24040940 | PMID:25851896 | PMID:30479396 | PMID:24681606 | PMID:40025578 | PMID:30055648 | PMID:18636037 | PMID:38744290 | PMID:36148553 | PMID:33356508 | PMID:41001593 | PMID:33591953 | PMID:36598417 | PMID:21111000 | PMID:33767727 | PMID:15255999 | PMID:15240917 | PMID:19144871,10.1186/1479-5876-11-213 | 10.3988/jcn.2015.11.2.172 | 10.1038/s41467-018-07452-y | 10.18632/oncotarget.1609 | 10.1186/s40478-025-01965-6 | 10.1186/s13104-018-3630-0 | 10.1097/MAO.0b013e31817f7398 | 10.1016/j.crmeth.2024.100772 | 10.1093/brain/awac342 | 10.1177/0963689720964383 | 10.1080/23723556.2025.2561292 | 10.1172/jci.insight.146351 | 10.1158/2159-8290.CD-22-0786 | 10.1016/j.jneumeth.2010.10.021 | 10.3389/fgene.2021.603195 | 10.1186/1476-4598-3-20 | 10.1155/S1110724304308107 | 10.3181/0809-RM-275,"Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors. | Preclinical assessment of the anticancer drug response of plexiform neurofibroma tissue using primary cultures. | NF1 heterozygosity fosters de novo tumorigenesis but impairs malignant transformation. | Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity. | Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment. | Testing ATRA and MEK inhibitor PD0325901 effectiveness in a nude mouse model for human MPNST xenografts. | The ErbB inhibitors trastuzumab and erlotinib inhibit growth of vestibular schwannoma xenografts in nude mice: a preliminary study. | A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening. | Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma. | C6 Cell Injection into the Optic Nerve of Long-Evans Rats: A Short-Term Model of Optic Pathway Gliomas. | Loss of Schwann cell's normal rhythmic core clock gene expression and gain of rhythmic expression of oncogenic driver genes in malignant NF1-associated peripheral nerve sheath tumor. | Chromosome 8 gain is associated with high-grade transformation in MPNST. | Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA. | A novel imaging-compatible sciatic nerve schwannoma model. | Molecular Diagnosis of Neurofibromatosis by Multigene Panel Testing. | Molecular profiling of malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1, based on large-scale real-time RT-PCR. | Survival of Human Neurofibroma in Immunodeficient Mice and Initial Results of Therapy With Pirfenidone. | Identification of erythrocyte p55/MPP1 as a binding partner of NF2 tumor suppressor protein/Merlin.",,,,S100,,,,,,,,1,1,Medium
PMID:24509877 | PMID:21551250 | PMID:34040258 | PMID:40025578 | PMID:26904939 | PMID:40684195 | PMID:20049725,10.1038/onc.2013.506 | 10.1158/0008-5472.CAN-10-4577 | 10.1038/s41586-021-03580-6 | 10.1186/s40478-025-01965-6 | 10.1016/j.celrep.2016.01.074 | 10.1186/s40478-025-02075-z | 10.1002/emmm.200900027,MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1. | Susceptible stages in Schwann cells for NF1-associated plexiform neurofibroma development. | NF1 mutation drives neuronal activity-dependent initiation of optic glioma. | Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment. | Insertional Mutagenesis Identifies a STAT3/Arid1b/β-catenin Pathway Driving Neurofibroma Initiation. | Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1. | Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene.,,,,S100β,,,,,,,,1,1,Medium
PMID:25917366 | PMID:24375753,10.1038/mp.2015.48 | 10.1002/ana.24093,HCN channels are a novel therapeutic target for cognitive dysfunction in Neurofibromatosis type 1. | Sex Is a major determinant of neuronal dysfunction in neurofibromatosis type 1.,,,,,,,,,,Morris water maze,,1,0,Medium
PMID:25917366 | PMID:32839340,10.1038/mp.2015.48 | 10.1073/pnas.2008391117,HCN channels are a novel therapeutic target for cognitive dysfunction in Neurofibromatosis type 1. | Brain-wide structural and functional disruption in mice with oligodendrocyte-specific,,,,,,,,,,Rotarod,,1,0,Medium
PMID:26219339 | PMID:18483311,10.18632/oncotarget.4858 | 10.1158/1535-7163.MCT-07-2335,A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas. | Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors.,,,,phospho-Akt (S473),,,,,,,,1,1,Medium
PMID:27458360 | PMID:30192842,10.3389/fnhum.2016.00334 | 10.1371/journal.pone.0203520,COMT Val(158)Met Polymorphism Is Associated with Verbal Working Memory in Neurofibromatosis Type 1. | Use of machine learning to predict cognitive performance based on brain metabolism in Neurofibromatosis type 1.,,,,,,,,,,Corsi block-tapping task,,1,0,Medium
PMID:28051113 | PMID:36420221,10.1038/srep39348 | 10.1016/j.omtn.2022.10.026,"A comprehensive custom panel design for routine hereditary cancer testing: preserving control, improving diagnostics and revealing a complex variation landscape. | Antisense oligonucleotides targeting exon 11 are able to partially rescue the NF2-related schwannomatosis phenotype",,,,,,I2HCP panel,,,,,,1,0,Medium
PMID:28398289 | PMID:36598417,10.1038/sdata.2017.45 | 10.1158/2159-8290.CD-22-0786,A high-throughput molecular data resource for cutaneous neurofibromas. | Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,,,,,,VarDict,,,,,1,1,Medium
PMID:28465357 | PMID:29438698,10.1101/gad.298703.117 | 10.1016/j.ccell.2018.01.005,Identification of hair shaft progenitors that create a niche for hair pigmentation. | Programming of Schwann Cells by Lats1/2-TAZ/YAP Signaling Drives Malignant Peripheral Nerve Sheath Tumorigenesis.,,,,Krox20,,,,,,,,1,1,Medium
PMID:28725547 | PMID:27081657,10.1016/j.nicl.2017.06.032 | 10.1002/acn3.288,Spatial working memory in neurofibromatosis 1: Altered neural activity and functional connectivity. | A randomized placebo-controlled lovastatin trial for neurobehavioral function in neurofibromatosis I.,,,,,,,,,,Spatial capacity working memory (SCAP) task,,1,0,Medium
PMID:29715273 | PMID:26219339,10.1371/journal.pone.0196726 | 10.18632/oncotarget.4858,Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation. | A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.,,,,NF2,,,,,,,,1,1,Medium
PMID:29715273 | PMID:32438526,10.1371/journal.pone.0196726 | 10.1002/lary.28671,Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation. | Effects of Neurod1 Expression on Mouse and Human Schwannoma Cells.,,,,,,empty vector,,,,,,1,0,Medium
PMID:29941005 | PMID:25851896,10.1186/s13023-018-0843-1 | 10.3988/jcn.2015.11.2.172,Increased extracellular matrix deposition during chondrogenic differentiation of dental pulp stem cells from individuals with neurofibromatosis type 1: an in vitro 2D and 3D study. | Preclinical assessment of the anticancer drug response of plexiform neurofibroma tissue using primary cultures.,,,,CD90,,,,,,,,1,0,Medium
PMID:30479396 | PMID:30531922 | PMID:34040258 | PMID:39321200,10.1038/s41467-018-07452-y | 10.1038/s41591-018-0263-8 | 10.1038/s41586-021-03580-6 | 10.1158/1078-0432.CCR-24-1454,NF1 heterozygosity fosters de novo tumorigenesis but impairs malignant transformation. | The molecular landscape of glioma in patients with Neurofibromatosis 1. | NF1 mutation drives neuronal activity-dependent initiation of optic glioma. | Multidimensional Immunotyping of Human NF1-Associated Peripheral Nerve Sheath Tumors Uncovers Tumor-Associated Macrophages as Key Drivers of Immune Evasion in the Tumor Microenvironment.,,,,CD8,,,,,,,,1,1,Medium
PMID:30479396 | PMID:38502231 | PMID:33356508 | PMID:39321200,10.1038/s41467-018-07452-y | 10.1172/JCI176748 | 10.1177/0963689720964383 | 10.1158/1078-0432.CCR-24-1454,NF1 heterozygosity fosters de novo tumorigenesis but impairs malignant transformation. | STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy. | C6 Cell Injection into the Optic Nerve of Long-Evans Rats: A Short-Term Model of Optic Pathway Gliomas. | Multidimensional Immunotyping of Human NF1-Associated Peripheral Nerve Sheath Tumors Uncovers Tumor-Associated Macrophages as Key Drivers of Immune Evasion in the Tumor Microenvironment.,,,,FoxP3,,,,,,,,1,1,Medium
PMID:30479396 | PMID:38502231 | PMID:40025578,10.1038/s41467-018-07452-y | 10.1172/JCI176748 | 10.1186/s40478-025-01965-6,NF1 heterozygosity fosters de novo tumorigenesis but impairs malignant transformation. | STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy. | Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment.,,,,CD4,,,,,,,,1,1,Medium
PMID:30531922 | PMID:38216587,10.1038/s41591-018-0263-8 | 10.1038/s41467-023-40408-5,The molecular landscape of glioma in patients with Neurofibromatosis 1. | Epigenetic reprogramming shapes the cellular landscape of schwannoma.,,,,CD68,,,,,,,,1,1,Medium
PMID:30542164 | PMID:30479396 | PMID:38502231 | PMID:30531922 | PMID:36322658 | PMID:38216587 | PMID:39321200 | PMID:37410426,10.1038/s41586-018-0774-y | 10.1038/s41467-018-07452-y | 10.1172/JCI176748 | 10.1038/s41591-018-0263-8 | 10.1126/sciadv.abo5442 | 10.1038/s41467-023-40408-5 | 10.1158/1078-0432.CCR-24-1454 | 10.1158/1078-0432.CCR-23-0749,"Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome. | NF1 heterozygosity fosters de novo tumorigenesis but impairs malignant transformation. | STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy. | The molecular landscape of glioma in patients with Neurofibromatosis 1. | Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy. | Epigenetic reprogramming shapes the cellular landscape of schwannoma. | Multidimensional Immunotyping of Human NF1-Associated Peripheral Nerve Sheath Tumors Uncovers Tumor-Associated Macrophages as Key Drivers of Immune Evasion in the Tumor Microenvironment. | CDK4/6-MEK Inhibition in MPNSTs Causes Plasma Cell Infiltration, Sensitization to PD-L1 Blockade, and Tumor Regression.",,,,CD3,,,,,,,,1,1,Medium
PMID:31462295 | PMID:30531922 | PMID:35945463,10.1186/s40478-019-0792-5 | 10.1038/s41591-018-0263-8 | 10.1007/s00401-022-02478-5,Telomere alterations in neurofibromatosis type 1-associated solid tumors. | The molecular landscape of glioma in patients with Neurofibromatosis 1. | Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1.,,,,ATRX,,,,,,,,1,0,Medium
PMID:31545171 | PMID:35589737 | PMID:20200958 | PMID:19191334 | PMID:28392281 | PMID:25772366 | PMID:23685747 | PMID:17924978 | PMID:38127282 | PMID:25043591,10.7554/eLife.48983 | 10.1038/s41467-022-30466-6 | 10.1002/jbmr.42 | 10.1002/glia.20845 | 10.1016/j.expneurol.2017.04.001 | 10.1016/j.celrep.2015.02.041 | 10.1038/ng.2641 | 10.1111/j.1750-3639.2007.00105.x | 10.1158/1078-0432.CCR-23-2548 | 10.1002/jbmr.2316,Optical dopamine monitoring with dLight1 reveals mesolimbic phenotypes in a mouse model of neurofibromatosis type 1. | Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1. | Local low-dose lovastatin delivery improves the bone-healing defect caused by Nf1 loss of function in osteoblasts. | Microarray analyses reveal regional astrocyte heterogeneity with implications for neurofibromatosis type 1 (NF1)-regulated glial proliferation. | Human stem cell modeling in neurofibromatosis type 1 (NF1). | Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties. | Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis. | Natural history of meningioma development in mice reveals: a synergy of Nf2 and p16(Ink4a) mutations. | Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression. | Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx -/- mice.,,,,,,Cre,,,,,,1,0,Medium
PMID:31836666 | PMID:37681415 | PMID:36689660,10.1074/jbc.RA119.010934 | 10.1172/jci.insight.168445 | 10.1073/pnas.2208960120,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer. | Structural and functional analyses of a germline KRAS T50I mutation provide insights into Raf activation. | Destabilizing NF1 variants act in a dominant negative manner through neurofibromin dimerization.,,,,KRAS,,,,,,,,1,1,Medium
PMID:32187457 | PMID:40304934,10.1056/NEJMoa1912735 | 10.1186/s41687-025-00877-2,Selumetinib in Children with Inoperable Plexiform Neurofibromas. | Development of patient reported outcome measures assessing tumor pain intensity and tumor pain interference for individuals with neurofibromatosis type 1 and plexiform neurofibromas: qualitative findings.,,,,,,,,,,Pain Interference Index,,1,0,Medium
PMID:32369930 | PMID:35332608,10.3390/genes11050499 | 10.1002/humu.24370,Unmasking Intra-tumoral Heterogeneity and Clonal Evolution in NF1-MPNST. | Re-evaluation of missense variant classifications in NF2.,,,,,,,COSMIC,,,,,1,1,Medium
PMID:32369930 | PMID:36598417,10.3390/genes11050499 | 10.1158/2159-8290.CD-22-0786,Unmasking Intra-tumoral Heterogeneity and Clonal Evolution in NF1-MPNST. | Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,,,,,,manta,,,,,1,1,Medium
PMID:32369930 | PMID:40887659,10.3390/genes11050499 | 10.1186/s40246-025-00803-z,Unmasking Intra-tumoral Heterogeneity and Clonal Evolution in NF1-MPNST. | RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity.,,,,,,,ClinVar,,,,,1,1,Medium
PMID:32383545 | PMID:23175151,10.15252/embr.201949117 | 10.1038/bjc.2012.518,Hexokinase 2 displacement from mitochondria-associated membranes prompts Ca | MicroRNA profiling of peripheral nerve sheath tumours identifies miR-29c as a tumour suppressor gene involved in tumour progression.,,,,MMP9,,,,,,,,1,0,Medium
PMID:32572180 | PMID:28735371,10.1038/s41436-020-0873-7 | 10.1007/s10897-017-0128-1,Late morbidity and mortality in adult survivors of childhood glioma with neurofibromatosis type 1: report from the Childhood Cancer Survivor Study. | Identifying Symptoms of Distress in Youth Living with Neurofibromatosis Type 1 (NF1).,,,,,,,,,,Brief Symptom Inventory 18 (BSI-18),,1,0,Medium
PMID:32642734 | PMID:19191334 | PMID:25772366,10.1093/noajnl/vdz026 | 10.1002/glia.20845 | 10.1016/j.celrep.2015.02.041,Whole exome sequencing reveals the maintained polyclonal nature from primary to metastatic malignant peripheral nerve sheath tumor in two patients with NF1. | Microarray analyses reveal regional astrocyte heterogeneity with implications for neurofibromatosis type 1 (NF1)-regulated glial proliferation. | Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties.,,,,,,LacZ,,,,,,1,0,Medium
PMID:32642734 | PMID:32369930,10.1093/noajnl/vdz026 | 10.3390/genes11050499,Whole exome sequencing reveals the maintained polyclonal nature from primary to metastatic malignant peripheral nerve sheath tumor in two patients with NF1. | Unmasking Intra-tumoral Heterogeneity and Clonal Evolution in NF1-MPNST.,,,,,,,SciClone,,,,,1,1,Medium
PMID:32642734 | PMID:32461556 | PMID:38502231 | PMID:24509877 | PMID:36322658 | PMID:34040258 | PMID:35511749 | PMID:26904939 | PMID:36241865 | PMID:24817309,10.1093/noajnl/vdz026 | 10.1038/s41467-020-16432-0 | 10.1172/JCI176748 | 10.1038/onc.2013.506 | 10.1126/sciadv.abo5442 | 10.1038/s41586-021-03580-6 | 10.1158/1535-7163.MCT-21-0947 | 10.1016/j.celrep.2016.01.074 | 10.1038/s12276-022-00850-9 | 10.1371/journal.pone.0097320,Whole exome sequencing reveals the maintained polyclonal nature from primary to metastatic malignant peripheral nerve sheath tumor in two patients with NF1. | Assessing the origin of high-grade serous ovarian cancer using CRISPR-modification of mouse organoids. | STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy. | MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1. | Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy. | NF1 mutation drives neuronal activity-dependent initiation of optic glioma. | A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors. | Insertional Mutagenesis Identifies a STAT3/Arid1b/β-catenin Pathway Driving Neurofibroma Initiation. | Transplanting neurofibromatosis-1 gene knockout neural stem cells improve functional recovery in rats with spinal cord injury by enhancing the mTORC2 pathway. | Nf2/Merlin controls spinal cord neural progenitor function in a Rac1/ErbB2-dependent manner.,,,,Cleaved-caspase 3,,,,,,,,1,1,Medium
PMID:32699356 | PMID:18451155,10.1038/s41467-020-17382-3 | 10.1158/0008-5472.CAN-07-6867,Murine models of IDH-wild-type glioblastoma exhibit spatial segregation of tumor initiation and manifestation during evolution. | Pten haploinsufficiency accelerates formation of high-grade astrocytomas.,,,,Pten,,,,,,,,1,1,Medium
PMID:32699356 | PMID:24509877 | PMID:25535838,10.1038/s41467-020-17382-3 | 10.1038/onc.2013.506 | 10.7554/eLife.05151,Murine models of IDH-wild-type glioblastoma exhibit spatial segregation of tumor initiation and manifestation during evolution. | MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1. | Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1.,,,,p-S6,,,,,,,,1,1,Medium
PMID:32699356 | PMID:32948135 | PMID:32461556 | PMID:35945463 | PMID:30274821 | PMID:30055648 | PMID:24371224,10.1038/s41467-020-17382-3 | 10.1186/s12885-020-07397-w | 10.1038/s41467-020-16432-0 | 10.1007/s00401-022-02478-5 | 10.1016/j.ebiom.2018.09.042 | 10.1186/s13104-018-3630-0 | 10.1158/0008-5472.CAN-13-2062,Murine models of IDH-wild-type glioblastoma exhibit spatial segregation of tumor initiation and manifestation during evolution. | Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model. | Assessing the origin of high-grade serous ovarian cancer using CRISPR-modification of mouse organoids. | Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1. | Synergistic effect of Nutlin-3 combined with MG-132 on schwannoma cells through restoration of merlin and p53 tumour suppressors. | Testing ATRA and MEK inhibitor PD0325901 effectiveness in a nude mouse model for human MPNST xenografts. | Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis.,,,,p53,,,,,,,,1,1,Medium
PMID:32699356 | PMID:36730269 | PMID:41564118 | PMID:41149489 | PMID:27956228 | PMID:24509877 | PMID:24681606 | PMID:28166733 | PMID:40684195 | PMID:38216572 | PMID:37246765 | PMID:24371224 | PMID:25535838,10.1038/s41467-020-17382-3 | 10.1371/journal.pone.0277305 | 10.1371/journal.pone.0340183 | 10.3390/curroncol32100569 | 10.1053/j.gastro.2016.12.002 | 10.1038/onc.2013.506 | 10.18632/oncotarget.1609 | 10.1186/s12864-017-3519-7 | 10.1186/s40478-025-02075-z | 10.1038/s41467-024-44755-9 | 10.1093/neuonc/noad097 | 10.1158/0008-5472.CAN-13-2062 | 10.7554/eLife.05151,Murine models of IDH-wild-type glioblastoma exhibit spatial segregation of tumor initiation and manifestation during evolution. | Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas. | Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas. | Small Extracellular Vesicles Derived from NF2-Associated Schwannoma Cells Modulate Tumor Progression and Immunity via HSP90. | Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice. | MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1. | Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity. | A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma. | Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1. | Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance. | Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology. | Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis. | Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1.,,,,p-Erk,,,,,,,,1,1,Medium
PMID:32733557,10.1155/2020/5976465,"Gene Expression, Network Analysis, and Drug Discovery of Neurofibromatosis Type 2-Associated Vestibular Schwannomas Based on Bioinformatics Analysis.",2020,Journal of oncology,,,,,GPL17586 Platform [HTA-2_0] Affymetrix Human Transcriptome Array 2.0,,,,,1,1,Medium
PMID:32733557 | PMID:27458360,10.1155/2020/5976465 | 10.3389/fnhum.2016.00334,"Gene Expression, Network Analysis, and Drug Discovery of Neurofibromatosis Type 2-Associated Vestibular Schwannomas Based on Bioinformatics Analysis. | COMT Val(158)Met Polymorphism Is Associated with Verbal Working Memory in Neurofibromatosis Type 1.",,,,,,,SPSS 20.0,,,,,1,1,Medium
PMID:33025139 | PMID:32098059 | PMID:37410426,10.1007/s00401-020-02230-x | 10.3390/genes11020226 | 10.1158/1078-0432.CCR-23-0749,"Epigenomic, genomic, and transcriptomic landscape of schwannomatosis. | Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1. | CDK4/6-MEK Inhibition in MPNSTs Causes Plasma Cell Infiltration, Sensitization to PD-L1 Blockade, and Tumor Regression.",,,,,,,CIBERSORT,,,,,1,1,Medium
PMID:33273014 | PMID:20195187,10.1074/jbc.RA120.014960 | 10.1097/MAO.0b013e3181d2777f,mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition. | Merlin knockdown in human Schwann cells: clues to vestibular schwannoma tumorigenesis.,,,,ERBB3,,,,,,,,1,1,Medium
PMID:33273014 | PMID:38216572 | PMID:19144871,10.1074/jbc.RA120.014960 | 10.1038/s41467-024-44755-9 | 10.3181/0809-RM-275,mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition. | Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance. | Identification of erythrocyte p55/MPP1 as a binding partner of NF2 tumor suppressor protein/Merlin.,,,,NF2/merlin,,,,,,,,1,1,Medium
PMID:33442015 | PMID:29847659 | PMID:41444363 | PMID:34010628 | PMID:18483311 | PMID:38127282,10.1038/s41591-020-01193-6 | 10.1167/iovs.17-22588 | 10.1038/s41598-025-32031-9 | 10.1016/j.stem.2021.04.029 | 10.1158/1535-7163.MCT-07-2335 | 10.1158/1078-0432.CCR-23-2548,Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial. | Neurofibromin Deficiency Induces Endothelial Cell Proliferation and Retinal Neovascularization. | Focused ultrasound-mediated drug delivery of bevacizumab in treating NF2-related schwannomatosis in an animal model. | Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression. | Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors. | Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,,,CD31,,,,,,,,1,1,Medium
PMID:33442015 | PMID:36730269 | PMID:41149489 | PMID:38216572 | PMID:24371224 | PMID:32419643,10.1038/s41591-020-01193-6 | 10.1371/journal.pone.0277305 | 10.3390/curroncol32100569 | 10.1038/s41467-024-44755-9 | 10.1158/0008-5472.CAN-13-2062 | 10.1177/1533033820919759,Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial. | Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas. | Small Extracellular Vesicles Derived from NF2-Associated Schwannoma Cells Modulate Tumor Progression and Immunity via HSP90. | Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance. | Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis. | Long Noncoding RNA WT1-AS Inhibit Cell Malignancy via miR-494-3p in Glioma.,,,,pAKT,,,,,,,,1,1,Medium
PMID:33442015 | PMID:40304934,10.1038/s41591-020-01193-6 | 10.1186/s41687-025-00877-2,Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial. | Development of patient reported outcome measures assessing tumor pain intensity and tumor pain interference for individuals with neurofibromatosis type 1 and plexiform neurofibromas: qualitative findings.,,,,,,,,,,NRS-11,,1,0,Medium
PMID:33507258 | PMID:39472976 | PMID:41564118,10.1001/jamanetworkopen.2020.35479 | 10.1186/s40478-024-01875-z | 10.1371/journal.pone.0340183,Assessment of RAS Dependency for BRAF Alterations Using Cancer Genomic Databases. | NF1 expression profiling in IDH-wildtype glioblastoma: genomic associations and survival outcomes. | Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,,,,,,cBioPortal,,,,,1,1,Medium
PMID:33658640 | PMID:26904939,10.1038/s41416-021-01270-8 | 10.1016/j.celrep.2016.01.074,Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours. | Insertional Mutagenesis Identifies a STAT3/Arid1b/β-catenin Pathway Driving Neurofibroma Initiation.,,,,p-STAT3,,,,,,,,1,0,Medium
PMID:33934112 | PMID:35393510 | PMID:33658640 | PMID:24824755,10.1038/s41419-021-03716-6 | 10.1038/s41418-022-00991-4 | 10.1038/s41416-021-01270-8 | 10.1371/journal.pone.0096733,HIF1α-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia. | Tumor growth of neurofibromin-deficient cells is driven by decreased respiration and hampered by NAD | Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours. | BNIP3 regulates AT101 [(-)-gossypol] induced death in malignant peripheral nerve sheath tumor cells.,,,,HIF1α,,,,,,,,1,0,Medium
PMID:34011935 | PMID:18413802,10.1038/s41419-021-03802-9 | 10.1158/1535-7163.MCT-07-0518,Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine. | Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells.,,,,phospho-MEK1/2,,,,,,,,1,1,Medium
PMID:34040258 | PMID:30274821 | PMID:35511749 | PMID:38216572 | PMID:18367665,10.1038/s41586-021-03580-6 | 10.1016/j.ebiom.2018.09.042 | 10.1158/1535-7163.MCT-21-0947 | 10.1038/s41467-024-44755-9 | 10.1124/jpet.107.135830,NF1 mutation drives neuronal activity-dependent initiation of optic glioma. | Synergistic effect of Nutlin-3 combined with MG-132 on schwannoma cells through restoration of merlin and p53 tumour suppressors. | A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors. | Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance. | Induction of apoptosis in neurofibromatosis type 1 malignant peripheral nerve sheath tumor cell lines by a combination of novel farnesyl transferase inhibitors and lovastatin.,,,,caspase-3,,,,,,,,1,1,Medium
PMID:34040258 | PMID:34930951,10.1038/s41586-021-03580-6 | 10.1038/s41536-021-00195-3,NF1 mutation drives neuronal activity-dependent initiation of optic glioma. | A bioinspired gelatin-hyaluronic acid-based hybrid interpenetrating network for the enhancement of retinal ganglion cells replacement therapy.,,,,BRN3A,,,,,,,,1,0,Medium
PMID:34040258 | PMID:40684195,10.1038/s41586-021-03580-6 | 10.1186/s40478-025-02075-z,NF1 mutation drives neuronal activity-dependent initiation of optic glioma. | Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1.,,,,PDGFRα,,,,,,,,1,1,Medium
PMID:34377779 | PMID:31558455,10.1212/NXG.0000000000000616 | 10.1136/bmjopen-2019-030601,Impact of MEK Inhibitor Therapy on Neurocognitive Functioning in NF1. | Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study.,,,,,,,,,,BRIEF,,1,0,Medium
PMID:34415582 | PMID:32396062,10.1002/glia.24075 | 10.7554/eLife.55137,Notch signaling via Hey1 and Id2b regulates Müller glia's regenerative response to retinal injury. | Tgfb3 collaborates with PP2A and notch signaling pathways to inhibit retina regeneration.,,,,glutamine synthetase,,,,,,,,1,0,Medium
PMID:34646065,10.1155/2021/9386823,Survival and ,2021,Sarcoma,,,,,SPSS 25,,,,,1,1,Medium
PMID:34930951 | PMID:23328114,10.1038/s41536-021-00195-3 | 10.18632/oncotarget.793,A bioinspired gelatin-hyaluronic acid-based hybrid interpenetrating network for the enhancement of retinal ganglion cells replacement therapy. | Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition.,,,,Caspase9,,,,,,,,1,1,Medium
PMID:35614131 | PMID:33934112,10.1038/s41418-022-01020-0 | 10.1038/s41419-021-03716-6,The mitochondrial chaperone TRAP1 regulates F-ATP synthase channel formation. | HIF1α-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia.,,,,TRAP1,,,,,,,,1,0,Medium
PMID:35741605 | PMID:33025139 | PMID:38216572,10.3390/brainsci12060720 | 10.1007/s00401-020-02230-x | 10.1038/s41467-024-44755-9,"Integrated Drug Mining Reveals Actionable Strategies Inhibiting Plexiform Neurofibromas. | Epigenomic, genomic, and transcriptomic landscape of schwannomatosis. | Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.",,,,,,,ConsensusClusterPlus,,,,,1,1,Medium
PMID:35789380 | PMID:26219339 | PMID:23685747 | PMID:41023593 | PMID:25772366,10.1158/2159-8290.CD-21-1671 | 10.18632/oncotarget.4858 | 10.1038/ng.2641 | 10.1186/s10020-025-01353-9 | 10.1016/j.celrep.2015.02.041,PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry. | A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas. | Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis. | Selective inhibition of BRAF and CRAF sensitizes NF1-deficient malignant peripheral nerve sheath tumors to MEK inhibitors. | Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties.,,,,,,shRNA,,,,,,1,0,Medium
PMID:35945463 | PMID:34065204 | PMID:30055648,10.1007/s00401-022-02478-5 | 10.3390/ijms22105367 | 10.1186/s13104-018-3630-0,Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1. | RABL6A Regulates Schwann Cell Senescence in an RB1-Dependent Manner. | Testing ATRA and MEK inhibitor PD0325901 effectiveness in a nude mouse model for human MPNST xenografts.,,,,p16,,,,,,,,1,1,Medium
PMID:36316421 | PMID:35673329,10.1038/s41598-022-21907-9 | 10.1093/texcom/tgac021,Non-invasive brain stimulation modulates GABAergic activity in neurofibromatosis 1. | Neuroanatomical correlates of working memory performance in Neurofibromatosis 1.,,,,,,,,,,Conners 3 rating scale,,1,0,Medium
PMID:36322658 | PMID:33591953,10.1126/sciadv.abo5442 | 10.1172/jci.insight.146351,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy. | Chromosome 8 gain is associated with high-grade transformation in MPNST.,,,,,,,inferCNV,,,,,1,1,Medium
PMID:36322658 | PMID:38907342,10.1126/sciadv.abo5442 | 10.1186/s40478-024-01821-z,"Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy. | snRNA-seq of human cutaneous neurofibromas before and after selumetinib treatment implicates role of altered Schwann cell states, inter-cellular signaling, and extracellular matrix in treatment response.",,,,,,,CellChat,,,,,1,1,Medium
PMID:36322658 | PMID:41591566,10.1126/sciadv.abo5442 | 10.1007/s00401-026-02979-7,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy. | FAP expression as a marker of malignant transformation enabling in vivo characterization in peripheral nerve sheath tumors: a multimodal and translational study.,,,,,,,Slingshot,,,,,1,1,Medium
PMID:36420221 | PMID:29670214,10.1016/j.omtn.2022.10.026 | 10.1038/s41598-018-24310-5,Antisense oligonucleotides targeting exon 11 are able to partially rescue the NF2-related schwannomatosis phenotype | Restoring functional neurofibromin by protein transduction.,,,,,,Endo-Porter,,,,,,1,0,Medium
PMID:36730269 | PMID:41149489 | PMID:33273014 | PMID:29847659 | PMID:20554030 | PMID:26219339 | PMID:21072183 | PMID:18483311 | PMID:38216572 | PMID:24371224 | PMID:32419643,10.1371/journal.pone.0277305 | 10.3390/curroncol32100569 | 10.1074/jbc.RA120.014960 | 10.1167/iovs.17-22588 | 10.1016/j.jneuroim.2010.05.002 | 10.18632/oncotarget.4858 | 10.1371/journal.pone.0013791 | 10.1158/1535-7163.MCT-07-2335 | 10.1038/s41467-024-44755-9 | 10.1158/0008-5472.CAN-13-2062 | 10.1177/1533033820919759,Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas. | Small Extracellular Vesicles Derived from NF2-Associated Schwannoma Cells Modulate Tumor Progression and Immunity via HSP90. | mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition. | Neurofibromin Deficiency Induces Endothelial Cell Proliferation and Retinal Neovascularization. | CXCL12 alone is insufficient for gliomagenesis in Nf1 mutant mice. | A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas. | p21-Activated kinases are required for transformation in a cell-based model of neurofibromatosis type 2. | Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors. | Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance. | Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis. | Long Noncoding RNA WT1-AS Inhibit Cell Malignancy via miR-494-3p in Glioma.,,,,AKT,,,,,,,,1,1,Medium
PMID:37174087 | PMID:28029918,10.3390/cancers15092621 | 10.1056/NEJMoa1605943,Vinblastine/Methotrexate for Debilitating and Progressive Plexiform Neurofibroma in Children and Young Adults with Neurofibromatosis Type 1: A Phase 2 Study. | Activity of Selumetinib in Neurofibromatosis Type 1-Related Plexiform Neurofibromas.,,,,,,,,,,National Cancer Institute Common Terminology Criteria for Adverse Events version 4.0,,1,0,Medium
PMID:37246765 | PMID:33591953,10.1093/neuonc/noad097 | 10.1172/jci.insight.146351,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology. | Chromosome 8 gain is associated with high-grade transformation in MPNST.,,,,,,,Variant Effect Predictor (VEP),,,,,1,1,Medium
PMID:37770931 | PMID:33591953 | PMID:38216587,10.1186/s40478-023-01639-1 | 10.1172/jci.insight.146351 | 10.1038/s41467-023-40408-5,"Integration of single-nuclei RNA-sequencing, spatial transcriptomics and histochemistry defines the complex microenvironment of NF1-associated plexiform neurofibromas. | Chromosome 8 gain is associated with high-grade transformation in MPNST. | Epigenetic reprogramming shapes the cellular landscape of schwannoma.",,,,,,,CellRanger,,,,,1,1,Medium
PMID:38115252 | PMID:35741605 | PMID:28166733,10.1097/MD.0000000000036696 | 10.3390/brainsci12060720 | 10.1186/s12864-017-3519-7,Identification of hub genes and drug candidates for NF2-related vestibular schwannoma by bioinformatics tools. | Integrated Drug Mining Reveals Actionable Strategies Inhibiting Plexiform Neurofibromas. | A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma.,,,,,,,WGCNA,,,,,1,1,Medium
PMID:38201517 | PMID:33442015 | PMID:32383545 | PMID:23175151 | PMID:37446790 | PMID:32461556 | PMID:33273014 | PMID:38502231 | PMID:39129390 | PMID:28126595 | PMID:23535903 | PMID:24681606 | PMID:34065204 | PMID:23685747 | PMID:26219339 | PMID:38714355 | PMID:36148553 | PMID:38203448 | PMID:24824755 | PMID:29847659 | PMID:29670214 | PMID:25043298 | PMID:36241865,10.3390/cancers16010089 | 10.1038/s41591-020-01193-6 | 10.15252/embr.201949117 | 10.1038/bjc.2012.518 | 10.3390/molecules28135128 | 10.1038/s41467-020-16432-0 | 10.1074/jbc.RA120.014960 | 10.1172/JCI176748 | 10.1002/1878-0261.13704 | 10.1016/j.ebiom.2017.01.020 | 10.1158/2159-8290.CD-13-0081 | 10.18632/oncotarget.1609 | 10.3390/ijms22105367 | 10.1038/ng.2641 | 10.18632/oncotarget.4858 | 10.1158/1535-7163.MCT-23-0510 | 10.1093/brain/awac342 | 10.3390/ijms25010277 | 10.1371/journal.pone.0096733 | 10.1167/iovs.17-22588 | 10.1038/s41598-018-24310-5 | 10.1038/onc.2014.185 | 10.1038/s12276-022-00850-9,"Synergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 Dendrimers. | Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial. | Hexokinase 2 displacement from mitochondria-associated membranes prompts Ca | MicroRNA profiling of peripheral nerve sheath tumours identifies miR-29c as a tumour suppressor gene involved in tumour progression. | Icariin Promotes Osteogenic Differentiation in a Cell Model with NF1 Gene Knockout by Activating the cAMP/PKA/CREB Pathway. | Assessing the origin of high-grade serous ovarian cancer using CRISPR-modification of mouse organoids. | mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition. | STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy. | Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors. | Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target. | Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance. | Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity. | RABL6A Regulates Schwann Cell Senescence in an RB1-Dependent Manner. | Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis. | A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas. | MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma. | Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma. | FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells. | BNIP3 regulates AT101 [(-)-gossypol] induced death in malignant peripheral nerve sheath tumor cells. | Neurofibromin Deficiency Induces Endothelial Cell Proliferation and Retinal Neovascularization. | Restoring functional neurofibromin by protein transduction. | Oncogenic role of Merlin/NF2 in glioblastoma. | Transplanting neurofibromatosis-1 gene knockout neural stem cells improve functional recovery in rats with spinal cord injury by enhancing the mTORC2 pathway.",,,,GAPDH,,,,,,,,1,0,Medium
PMID:38216123 | PMID:24681606,10.1016/j.molmet.2024.101876 | 10.18632/oncotarget.1609,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer. | Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity.,,,,pAKT S473,,,,,,,,1,1,Medium
PMID:38216123 | PMID:38481529 | PMID:37446790 | PMID:39890807 | PMID:29438698 | PMID:29847659 | PMID:36241865,10.1016/j.molmet.2024.101876 | 10.3389/fcell.2024.1359561 | 10.3390/molecules28135128 | 10.1038/s41598-024-84493-y | 10.1016/j.ccell.2018.01.005 | 10.1167/iovs.17-22588 | 10.1038/s12276-022-00850-9,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer. | Generation of heterozygous and homozygous NF1 lines from human-induced pluripotent stem cells using CRISPR/Cas9 to investigate bone defects associated with neurofibromatosis type 1. | Icariin Promotes Osteogenic Differentiation in a Cell Model with NF1 Gene Knockout by Activating the cAMP/PKA/CREB Pathway. | Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism. | Programming of Schwann Cells by Lats1/2-TAZ/YAP Signaling Drives Malignant Peripheral Nerve Sheath Tumorigenesis. | Neurofibromin Deficiency Induces Endothelial Cell Proliferation and Retinal Neovascularization. | Transplanting neurofibromatosis-1 gene knockout neural stem cells improve functional recovery in rats with spinal cord injury by enhancing the mTORC2 pathway.,,,,neurofibromin,,,,,,,,1,1,Medium
PMID:38216572 | PMID:27956228 | PMID:35789380 | PMID:39415595,10.1038/s41467-024-44755-9 | 10.1053/j.gastro.2016.12.002 | 10.1158/2159-8290.CD-21-1671 | 10.1242/dmm.050862,Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance. | Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice. | PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry. | Generation of a zebrafish neurofibromatosis model via inducible knockout of nf2a/b.,,,,,,sgRNA,,,,,,1,0,Medium
PMID:38499890,10.1186/s41687-024-00714-y,"The PlexiQoL, a patient-reported outcome measure on quality of life in neurofibromatosis type 1-associated plexiform neurofibroma: translation, cultural adaptation and validation into the Dutch language for the Netherlands.",2024,Journal of patient-reported outcomes,,,,,,,,Nottingham Health Profile (NHP),,1,0,Medium
PMID:38502231 | PMID:38714355 | PMID:33658640,10.1172/JCI176748 | 10.1158/1535-7163.MCT-23-0510 | 10.1038/s41416-021-01270-8,STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy. | MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma. | Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours.,,,,cleaved PARP,,,,,,,,1,1,Medium
PMID:38502231 | PMID:40025578 | PMID:39321200 | PMID:37410426,10.1172/JCI176748 | 10.1186/s40478-025-01965-6 | 10.1158/1078-0432.CCR-24-1454 | 10.1158/1078-0432.CCR-23-0749,"STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy. | Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment. | Multidimensional Immunotyping of Human NF1-Associated Peripheral Nerve Sheath Tumors Uncovers Tumor-Associated Macrophages as Key Drivers of Immune Evasion in the Tumor Microenvironment. | CDK4/6-MEK Inhibition in MPNSTs Causes Plasma Cell Infiltration, Sensitization to PD-L1 Blockade, and Tumor Regression.",,,,PD-L1,,,,,,,,1,1,Medium
PMID:38603731,10.1371/journal.pone.0302017,Raman difference spectroscopy and U-Net convolutional neural network for molecular analysis of cutaneous neurofibroma.,2024,PloS one,,,,,Ventana-785-Raman spectrometer,,,,,1,1,Medium
PMID:38744290 | PMID:32098059,10.1016/j.crmeth.2024.100772 | 10.3390/genes11020226,A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening. | Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1.,,,,,,,MCP-Counter,,,,,1,1,Medium
PMID:38907342 | PMID:37770931 | PMID:35589737 | PMID:35945463 | PMID:38216587 | PMID:29438698 | PMID:38744290 | PMID:38216572 | PMID:36598417 | PMID:39415595,10.1186/s40478-024-01821-z | 10.1186/s40478-023-01639-1 | 10.1038/s41467-022-30466-6 | 10.1007/s00401-022-02478-5 | 10.1038/s41467-023-40408-5 | 10.1016/j.ccell.2018.01.005 | 10.1016/j.crmeth.2024.100772 | 10.1038/s41467-024-44755-9 | 10.1158/2159-8290.CD-22-0786 | 10.1242/dmm.050862,"snRNA-seq of human cutaneous neurofibromas before and after selumetinib treatment implicates role of altered Schwann cell states, inter-cellular signaling, and extracellular matrix in treatment response. | Integration of single-nuclei RNA-sequencing, spatial transcriptomics and histochemistry defines the complex microenvironment of NF1-associated plexiform neurofibromas. | Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1. | Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1. | Epigenetic reprogramming shapes the cellular landscape of schwannoma. | Programming of Schwann Cells by Lats1/2-TAZ/YAP Signaling Drives Malignant Peripheral Nerve Sheath Tumorigenesis. | A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening. | Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance. | Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA. | Generation of a zebrafish neurofibromatosis model via inducible knockout of nf2a/b.",,,,SOX10,,,,,,,,1,1,Medium
PMID:38931352 | PMID:34011935,10.3390/ph17060685 | 10.1038/s41419-021-03802-9,PET Imaging of Neurofibromatosis Type 1 with a Fluorine-18 Labeled Tryptophan Radiotracer. | Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine.,,,,AHR,,,,,,,,1,0,Medium
PMID:39129390 | PMID:33658640 | PMID:25043298,10.1002/1878-0261.13704 | 10.1038/s41416-021-01270-8 | 10.1038/onc.2014.185,Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors. | Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours. | Oncogenic role of Merlin/NF2 in glioblastoma.,,,,PARP,,,,,,,,1,1,Medium
PMID:39269317 | PMID:34415582 | PMID:34630515 | PMID:37164978 | PMID:32642733 | PMID:39129390 | PMID:39890807 | PMID:41036607 | PMID:41023593,10.1158/1078-0432.CCR-24-1750 | 10.1002/glia.24075 | 10.3389/fgene.2021.721045 | 10.1038/s41467-023-38432-6 | 10.1093/noajnl/vdz061 | 10.1002/1878-0261.13704 | 10.1038/s41598-024-84493-y | 10.1158/1535-7163.MCT-24-1053 | 10.1186/s10020-025-01353-9,MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor. | Notch signaling via Hey1 and Id2b regulates Müller glia's regenerative response to retinal injury. | Assessment of Mosaicism and Detection of Cryptic Alleles in CRISPR/Cas9-Engineered Neurofibromatosis Type 1 and | Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities. | KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors. | Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors. | Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism. | Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors. | Selective inhibition of BRAF and CRAF sensitizes NF1-deficient malignant peripheral nerve sheath tumors to MEK inhibitors.,,,,,,Cas9,,,,,,1,0,Medium
PMID:39269317 | PMID:39129390 | PMID:35393510,10.1158/1078-0432.CCR-24-1750 | 10.1002/1878-0261.13704 | 10.1038/s41418-022-00991-4,MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor. | Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors. | Tumor growth of neurofibromin-deficient cells is driven by decreased respiration and hampered by NAD,,,,,,CRISPR-Cas9,,,,,,1,0,Medium
PMID:40191916 | PMID:39373898,10.1093/g3journal/jkaf067 | 10.1007/s12031-024-02271-x,"The draft genome of the Wisconsin Miniature SwineTM, a valuable biomedical research tool. | Identification of Pathogenic Missense Mutations of NF1 Using Computational Approaches.",,,,,,,AlphaFold 3,,,,,1,1,Medium
PMID:40217315 | PMID:30479396 | PMID:29941005 | PMID:34010628 | PMID:40684195 | PMID:33356508 | PMID:34930951,10.1186/s13073-025-01462-4 | 10.1038/s41467-018-07452-y | 10.1186/s13023-018-0843-1 | 10.1016/j.stem.2021.04.029 | 10.1186/s40478-025-02075-z | 10.1177/0963689720964383 | 10.1038/s41536-021-00195-3,A single-cell atlas of Schwannoma across genetic backgrounds and anatomic locations. | NF1 heterozygosity fosters de novo tumorigenesis but impairs malignant transformation. | Increased extracellular matrix deposition during chondrogenic differentiation of dental pulp stem cells from individuals with neurofibromatosis type 1: an in vitro 2D and 3D study. | Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression. | Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1. | C6 Cell Injection into the Optic Nerve of Long-Evans Rats: A Short-Term Model of Optic Pathway Gliomas. | A bioinspired gelatin-hyaluronic acid-based hybrid interpenetrating network for the enhancement of retinal ganglion cells replacement therapy.,,,,CD45,,,,,,,,1,1,Medium
PMID:40590220 | PMID:31545171 | PMID:21072183 | PMID:39129390 | PMID:24509877 | PMID:20049725 | PMID:25043591,10.1172/JCI188932 | 10.7554/eLife.48983 | 10.1371/journal.pone.0013791 | 10.1002/1878-0261.13704 | 10.1038/onc.2013.506 | 10.1002/emmm.200900027 | 10.1002/jbmr.2316,A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice. | Optical dopamine monitoring with dLight1 reveals mesolimbic phenotypes in a mouse model of neurofibromatosis type 1. | p21-Activated kinases are required for transformation in a cell-based model of neurofibromatosis type 2. | Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors. | MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1. | Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene. | Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx -/- mice.,,,,,,GFP,,,,,,1,0,Medium
PMID:40684195 | PMID:38744290,10.1186/s40478-025-02075-z | 10.1016/j.crmeth.2024.100772,Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1. | A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening.,,,,cKIT,,,,,,,,1,1,Medium
PMID:40887659 | PMID:27999334,10.1186/s40246-025-00803-z | 10.3390/genes7120133,RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity. | Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,,,,,,,Human Splicing Finder,,,,,1,1,Medium
PMID:41022755 | PMID:31836666 | PMID:40225167 | PMID:36689660,10.1038/s41467-025-63619-4 | 10.1074/jbc.RA119.010934 | 10.1155/2023/9628049 | 10.1073/pnas.2208960120,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors. | Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer. | Functional Assays Combined with Pre-mRNA-Splicing Analysis Improve Variant Classification and Diagnostics for Individuals with Neurofibromatosis Type 1 and Legius Syndrome. | Destabilizing NF1 variants act in a dominant negative manner through neurofibromin dimerization.,,,,HA,,,,,,,,1,0,Medium
PMID:41022755 | PMID:38744290,10.1038/s41467-025-63619-4 | 10.1016/j.crmeth.2024.100772,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors. | A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening.,,,,NGFR,,,,,,,,1,0,Medium
PMID:41411243 | PMID:32869517,10.1371/journal.pgen.1011976 | 10.1002/mgg3.1400,PERADIGM: Phenotype embedding similarity-based rare disease gene mapping. | Genome-wide association study of café-au-lait macule number in neurofibromatosis type 1.,,,,,,,PLINK,,,,,1,1,Medium
PMID:34415582,10.1002/glia.24075,Notch signaling via Hey1 and Id2b regulates Müller glia's regenerative response to retinal injury.,2021,Glia,,,,dll4; dlb; hey1; id2b; dll4-gRNAs; n3-gRNAs; n3,,,,,,7,0,Low
PMID:34930951,10.1038/s41536-021-00195-3,A bioinspired gelatin-hyaluronic acid-based hybrid interpenetrating network for the enhancement of retinal ganglion cells replacement therapy.,2021,NPJ Regenerative medicine,,Thy1.1; Cmyc; Oct4; STEM121,human retinal ganglion cells (hRGC),,,,,,,5,0,Low
PMID:35118381,10.1093/noajnl/vdab184,Neutrophil depletion enhanced the ,2022,Neuro-oncology advances,,Ly6G,GL261; GL261-luc,luciferase,,,,,,4,0,Low
PMID:33934112 | PMID:32457840,10.1038/s41419-021-03716-6 | 10.3389/fonc.2020.00687,"HIF1α-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia. | TGFβ Signaling Increases Net Acid Extrusion, Proliferation and Invasion in Panc-1 Pancreatic Cancer Cells: SMAD4 Dependence and Link to Merlin/NF2 Signaling.",,,,,MiaPaCa-2; PANC1; BxPc3,,,,,,,3,0,Low
PMID:20554030 | PMID:20551058,10.1016/j.jneuroim.2010.05.002 | 10.1158/0008-5472.CAN-09-3769,CXCL12 alone is insufficient for gliomagenesis in Nf1 mutant mice. | Cyclic AMP suppression is sufficient to induce gliomagenesis in a mouse model of neurofibromatosis-1.,,,,CXCL12; phosphorylated CXCR4,,,,,,,,2,0,Low
PMID:21963652 | PMID:24375753,10.1016/j.expneurol.2011.09.005 | 10.1002/ana.24093,PET imaging for attention deficit preclinical drug testing in neurofibromatosis-1 mice. | Sex Is a major determinant of neuronal dysfunction in neurofibromatosis type 1.,,,,DARPP32; p-DARPP32,,,,,,,,2,0,Low
PMID:23535903 | PMID:24681606,10.1158/2159-8290.CD-13-0081 | 10.18632/oncotarget.1609,"Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance. | Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity.",,,,,iHSC1λ; iHSC2λ,,,,,,,2,0,Low
PMID:37990867 | PMID:24371224,10.1242/dmm.049861 | 10.1158/0008-5472.CAN-13-2062,Neurofibromin 1 mutations impair the function of human induced pluripotent stem cell-derived microglia. | Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis.,,,,OCT3/4; NANOG,,,,,,,,2,0,Low
PMID:18242513 | PMID:38175707,10.1016/j.ccr.2008.01.003 | 10.1172/jci.insight.168826,The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells. | Unbalancing cAMP and Ras/MAPK pathways as a therapeutic strategy for cutaneous neurofibromas.,,,,p75,,,,,,,,1,0,Low
PMID:18451155 | PMID:20554030 | PMID:23685747 | PMID:36241865 | PMID:20551058,10.1158/0008-5472.CAN-07-6867 | 10.1016/j.jneuroim.2010.05.002 | 10.1038/ng.2641 | 10.1038/s12276-022-00850-9 | 10.1158/0008-5472.CAN-09-3769,Pten haploinsufficiency accelerates formation of high-grade astrocytomas. | CXCL12 alone is insufficient for gliomagenesis in Nf1 mutant mice. | Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis. | Transplanting neurofibromatosis-1 gene knockout neural stem cells improve functional recovery in rats with spinal cord injury by enhancing the mTORC2 pathway. | Cyclic AMP suppression is sufficient to induce gliomagenesis in a mouse model of neurofibromatosis-1.,,,,CNPase,,,,,,,,1,0,Low
PMID:18451155 | PMID:36241865,10.1158/0008-5472.CAN-07-6867 | 10.1038/s12276-022-00850-9,Pten haploinsufficiency accelerates formation of high-grade astrocytomas. | Transplanting neurofibromatosis-1 gene knockout neural stem cells improve functional recovery in rats with spinal cord injury by enhancing the mTORC2 pathway.,,,,β3-tubulin,,,,,,,,1,0,Low
PMID:19191334 | PMID:25772366,10.1002/glia.20845 | 10.1016/j.celrep.2015.02.041,Microarray analyses reveal regional astrocyte heterogeneity with implications for neurofibromatosis type 1 (NF1)-regulated glial proliferation. | Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties.,,,,O4,,,,,,,,1,0,Low
PMID:19191334 | PMID:32642733 | PMID:38203448 | PMID:21216928,10.1002/glia.20845 | 10.1093/noajnl/vdz061 | 10.3390/ijms25010277 | 10.1158/1535-7163.MCT-10-0654,Microarray analyses reveal regional astrocyte heterogeneity with implications for neurofibromatosis type 1 (NF1)-regulated glial proliferation. | KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors. | FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells. | Interpreting mammalian target of rapamycin and cell growth inhibition in a genetically engineered mouse model of Nf1-deficient astrocytes.,,,,α-tubulin,,,,,,,,1,0,Low
PMID:19191334 | PMID:37164978,10.1002/glia.20845 | 10.1038/s41467-023-38432-6,Microarray analyses reveal regional astrocyte heterogeneity with implications for neurofibromatosis type 1 (NF1)-regulated glial proliferation. | Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,,,APC,,,,,,,,1,0,Low
PMID:20195187 | PMID:30055648 | PMID:36420221 | PMID:33658640,10.1097/MAO.0b013e3181d2777f | 10.1186/s13104-018-3630-0 | 10.1016/j.omtn.2022.10.026 | 10.1038/s41416-021-01270-8,Merlin knockdown in human Schwann cells: clues to vestibular schwannoma tumorigenesis. | Testing ATRA and MEK inhibitor PD0325901 effectiveness in a nude mouse model for human MPNST xenografts. | Antisense oligonucleotides targeting exon 11 are able to partially rescue the NF2-related schwannomatosis phenotype | Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours.,,,,actin,,,,,,,,1,0,Low
PMID:21072183 | PMID:36689660,10.1371/journal.pone.0013791 | 10.1073/pnas.2208960120,p21-Activated kinases are required for transformation in a cell-based model of neurofibromatosis type 2. | Destabilizing NF1 variants act in a dominant negative manner through neurofibromin dimerization.,,,,GST,,,,,,,,1,0,Low
PMID:21551250,10.1158/0008-5472.CAN-10-4577,Susceptible stages in Schwann cells for NF1-associated plexiform neurofibroma development.,2011,Cancer research,,GAP43,,,,,,,,1,0,Low
PMID:22961690,10.1002/pbc.24281,Phase I trial and pharmacokinetic study of sorafenib in children with neurofibromatosis type I and plexiform neurofibromas.,2013,Pediatric blood & cancer,,,,,,,,HPLC/MS/MS method,,1,0,Low
PMID:23535903 | PMID:26904939,10.1158/2159-8290.CD-13-0081 | 10.1016/j.celrep.2016.01.074,"Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance. | Insertional Mutagenesis Identifies a STAT3/Arid1b/β-catenin Pathway Driving Neurofibroma Initiation.",,,,β-catenin,,,,,,,,1,0,Low
PMID:23685747 | PMID:40025578,10.1038/ng.2641 | 10.1186/s40478-025-01965-6,Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis. | Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment.,,,,,K562,,,,,,,1,0,Low
PMID:23685747 | PMID:41036607,10.1038/ng.2641 | 10.1158/1535-7163.MCT-24-1053,Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis. | Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,,,,,iHSCs,,,,,,,1,0,Low
PMID:24509877 | PMID:25535838,10.1038/onc.2013.506 | 10.7554/eLife.05151,MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1. | Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1.,,,,BLBP,,,,,,,,1,0,Low
PMID:24681606,10.18632/oncotarget.1609,Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity.,2014,Oncotarget,,p-4EBP,,,,,,,,1,0,Low
PMID:25535838 | PMID:36241865,10.7554/eLife.05151 | 10.1038/s12276-022-00850-9,Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1. | Transplanting neurofibromatosis-1 gene knockout neural stem cells improve functional recovery in rats with spinal cord injury by enhancing the mTORC2 pathway.,,,,MAP2,,,,,,,,1,0,Low
PMID:26219339 | PMID:21072183,10.18632/oncotarget.4858 | 10.1371/journal.pone.0013791,A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas. | p21-Activated kinases are required for transformation in a cell-based model of neurofibromatosis type 2.,,,,PAK1,,,,,,,,1,0,Low
PMID:26904939 | PMID:33658640,10.1016/j.celrep.2016.01.074 | 10.1038/s41416-021-01270-8,Insertional Mutagenesis Identifies a STAT3/Arid1b/β-catenin Pathway Driving Neurofibroma Initiation. | Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours.,,,,Stat3,,,,,,,,1,0,Low
PMID:27956228 | PMID:24371224,10.1053/j.gastro.2016.12.002 | 10.1158/0008-5472.CAN-13-2062,Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice. | Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis.,,,,beta-Catenin,,,,,,,,1,0,Low
PMID:27956228 | PMID:24509877 | PMID:20049725 | PMID:32396062,10.1053/j.gastro.2016.12.002 | 10.1038/onc.2013.506 | 10.1002/emmm.200900027 | 10.7554/eLife.55137,Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice. | MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1. | Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene. | Tgfb3 collaborates with PP2A and notch signaling pathways to inhibit retina regeneration.,,,,SOX9,,,,,,,,1,0,Low
PMID:28392281 | PMID:34065204,10.1016/j.expneurol.2017.04.001 | 10.3390/ijms22105367,Human stem cell modeling in neurofibromatosis type 1 (NF1). | RABL6A Regulates Schwann Cell Senescence in an RB1-Dependent Manner.,,,,,mouse embryonic fibroblasts (MEFs),,,,,,,1,0,Low
PMID:30479396 | PMID:37410426,10.1038/s41467-018-07452-y | 10.1158/1078-0432.CCR-23-0749,"NF1 heterozygosity fosters de novo tumorigenesis but impairs malignant transformation. | CDK4/6-MEK Inhibition in MPNSTs Causes Plasma Cell Infiltration, Sensitization to PD-L1 Blockade, and Tumor Regression.",,,,B220,,,,,,,,1,0,Low
PMID:30542164 | PMID:32383545,10.1038/s41586-018-0774-y | 10.15252/embr.201949117,Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome. | Hexokinase 2 displacement from mitochondria-associated membranes prompts Ca,,,,,CT26,,,,,,,1,0,Low
PMID:30542164 | PMID:38907342 | PMID:41149489 | PMID:36890585 | PMID:28256556,10.1038/s41586-018-0774-y | 10.1186/s40478-024-01821-z | 10.3390/curroncol32100569 | 10.1186/s40478-023-01525-w | 10.1038/srep43315,"Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome. | snRNA-seq of human cutaneous neurofibromas before and after selumetinib treatment implicates role of altered Schwann cell states, inter-cellular signaling, and extracellular matrix in treatment response. | Small Extracellular Vesicles Derived from NF2-Associated Schwannoma Cells Modulate Tumor Progression and Immunity via HSP90. | Neurofibromatosis type 1-dependent alterations in mouse microglia function are not cell-intrinsic. | An inflammatory gene signature distinguishes neurofibroma Schwann cells and macrophages from cells in the normal peripheral nervous system.",,,,CD11b,,,,,,,,1,0,Low
PMID:31015291 | PMID:40684195,10.1126/scisignal.aau8749 | 10.1186/s40478-025-02075-z,Proximity biotinylation identifies a set of conformation-specific interactions between Merlin and cell junction proteins. | Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1.,,,,RFP,,,,,,,,1,0,Low
PMID:31836666 | PMID:40225167,10.1074/jbc.RA119.010934 | 10.1155/2023/9628049,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer. | Functional Assays Combined with Pre-mRNA-Splicing Analysis Improve Variant Classification and Diagnostics for Individuals with Neurofibromatosis Type 1 and Legius Syndrome.,,,,V5,,,,,,,,1,0,Low
PMID:32383545 | PMID:37446790,10.15252/embr.201949117 | 10.3390/molecules28135128,Hexokinase 2 displacement from mitochondria-associated membranes prompts Ca | Icariin Promotes Osteogenic Differentiation in a Cell Model with NF1 Gene Knockout by Activating the cAMP/PKA/CREB Pathway.,,,,,C2C12 cells,,,,,,,1,0,Low
PMID:32419643 | PMID:33934112,10.1177/1533033820919759 | 10.1038/s41419-021-03716-6,Long Noncoding RNA WT1-AS Inhibit Cell Malignancy via miR-494-3p in Glioma. | HIF1α-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia.,,,,,U87,,,,,,,1,0,Low
PMID:32419643 | PMID:33934112 | PMID:25043298,10.1177/1533033820919759 | 10.1038/s41419-021-03716-6 | 10.1038/onc.2014.185,Long Noncoding RNA WT1-AS Inhibit Cell Malignancy via miR-494-3p in Glioma. | HIF1α-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia. | Oncogenic role of Merlin/NF2 in glioblastoma.,,,,,U251,,,,,,,1,0,Low
PMID:32461556 | PMID:24371224,10.1038/s41467-020-16432-0 | 10.1158/0008-5472.CAN-13-2062,Assessing the origin of high-grade serous ovarian cancer using CRISPR-modification of mouse organoids. | Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis.,,,,Cytokeratin-8,,,,,,,,1,0,Low
PMID:32642733 | PMID:35511749,10.1093/noajnl/vdz061 | 10.1158/1535-7163.MCT-21-0947,KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors. | A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.,,,,,HS-Sch-2,,,,,,,1,0,Low
PMID:32699356 | PMID:18451155 | PMID:29715273 | PMID:35945463 | PMID:20554030 | PMID:20551058,10.1038/s41467-020-17382-3 | 10.1158/0008-5472.CAN-07-6867 | 10.1371/journal.pone.0196726 | 10.1007/s00401-022-02478-5 | 10.1016/j.jneuroim.2010.05.002 | 10.1158/0008-5472.CAN-09-3769,Murine models of IDH-wild-type glioblastoma exhibit spatial segregation of tumor initiation and manifestation during evolution. | Pten haploinsufficiency accelerates formation of high-grade astrocytomas. | Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation. | Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1. | CXCL12 alone is insufficient for gliomagenesis in Nf1 mutant mice. | Cyclic AMP suppression is sufficient to induce gliomagenesis in a mouse model of neurofibromatosis-1.,,,,Olig2,,,,,,,,1,0,Low
PMID:32699356 | PMID:36322658 | PMID:29438698 | PMID:18636037 | PMID:18242513 | PMID:32396062 | PMID:25535838,10.1038/s41467-020-17382-3 | 10.1126/sciadv.abo5442 | 10.1016/j.ccell.2018.01.005 | 10.1097/MAO.0b013e31817f7398 | 10.1016/j.ccr.2008.01.003 | 10.7554/eLife.55137 | 10.7554/eLife.05151,Murine models of IDH-wild-type glioblastoma exhibit spatial segregation of tumor initiation and manifestation during evolution. | Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy. | Programming of Schwann Cells by Lats1/2-TAZ/YAP Signaling Drives Malignant Peripheral Nerve Sheath Tumorigenesis. | The ErbB inhibitors trastuzumab and erlotinib inhibit growth of vestibular schwannoma xenografts in nude mice: a preliminary study. | The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells. | Tgfb3 collaborates with PP2A and notch signaling pathways to inhibit retina regeneration. | Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1.,,,,BrdU,,,,,,,,1,0,Low
PMID:33078583 | PMID:38201517 | PMID:41022755 | PMID:18451155 | PMID:32438526 | PMID:32457840 | PMID:24509877 | PMID:34040258 | PMID:33436083 | PMID:34011935 | PMID:41036607 | PMID:21072183 | PMID:26904939 | PMID:33934112 | PMID:20049725 | PMID:24371224 | PMID:23328114 | PMID:30274821 | PMID:32419643,10.1002/jcsm.12632 | 10.3390/cancers16010089 | 10.1038/s41467-025-63619-4 | 10.1158/0008-5472.CAN-07-6867 | 10.1002/lary.28671 | 10.3389/fonc.2020.00687 | 10.1038/onc.2013.506 | 10.1038/s41586-021-03580-6 | 10.1186/s13072-020-00380-6 | 10.1038/s41419-021-03802-9 | 10.1158/1535-7163.MCT-24-1053 | 10.1371/journal.pone.0013791 | 10.1016/j.celrep.2016.01.074 | 10.1038/s41419-021-03716-6 | 10.1002/emmm.200900027 | 10.1158/0008-5472.CAN-13-2062 | 10.18632/oncotarget.793 | 10.1016/j.ebiom.2018.09.042 | 10.1177/1533033820919759,"Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis. | Synergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 Dendrimers. | Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors. | Pten haploinsufficiency accelerates formation of high-grade astrocytomas. | Effects of Neurod1 Expression on Mouse and Human Schwannoma Cells. | TGFβ Signaling Increases Net Acid Extrusion, Proliferation and Invasion in Panc-1 Pancreatic Cancer Cells: SMAD4 Dependence and Link to Merlin/NF2 Signaling. | MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1. | NF1 mutation drives neuronal activity-dependent initiation of optic glioma. | Distinctive epigenomic alterations in NF1-deficient cutaneous and plexiform neurofibromas drive differential MKK/p38 signaling. | Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine. | Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors. | p21-Activated kinases are required for transformation in a cell-based model of neurofibromatosis type 2. | Insertional Mutagenesis Identifies a STAT3/Arid1b/β-catenin Pathway Driving Neurofibroma Initiation. | HIF1α-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia. | Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene. | Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis. | Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition. | Synergistic effect of Nutlin-3 combined with MG-132 on schwannoma cells through restoration of merlin and p53 tumour suppressors. | Long Noncoding RNA WT1-AS Inhibit Cell Malignancy via miR-494-3p in Glioma.",,,,β-actin,,,,,,,,1,0,Low
PMID:33078583 | PMID:38216123 | PMID:39129390 | PMID:34257279 | PMID:18367665,10.1002/jcsm.12632 | 10.1016/j.molmet.2024.101876 | 10.1002/1878-0261.13704 | 10.1038/s41467-021-24505-x | 10.1124/jpet.107.135830,Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis. | NF1 deficiency drives metabolic reprogramming in ER+ breast cancer. | Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors. | Neurofibromin regulates metabolic rate via neuronal mechanisms in Drosophila. | Induction of apoptosis in neurofibromatosis type 1 malignant peripheral nerve sheath tumor cell lines by a combination of novel farnesyl transferase inhibitors and lovastatin.,,,,β-tubulin,,,,,,,,1,0,Low
PMID:33442015 | PMID:26904939,10.1038/s41591-020-01193-6 | 10.1016/j.celrep.2016.01.074,Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial. | Insertional Mutagenesis Identifies a STAT3/Arid1b/β-catenin Pathway Driving Neurofibroma Initiation.,,,,pGSK-3β,,,,,,,,1,0,Low
PMID:33673681 | PMID:30531922,10.3390/cancers13050999 | 10.1038/s41591-018-0263-8,Hybrid Minigene Assay: An Efficient Tool to Characterize mRNA Splicing Profiles of | The molecular landscape of glioma in patients with Neurofibromatosis 1.,,,,,HEK293 cells,,,,,,,1,0,Low
PMID:34065204 | PMID:37410426,10.3390/ijms22105367 | 10.1158/1078-0432.CCR-23-0749,"RABL6A Regulates Schwann Cell Senescence in an RB1-Dependent Manner. | CDK4/6-MEK Inhibition in MPNSTs Causes Plasma Cell Infiltration, Sensitization to PD-L1 Blockade, and Tumor Regression.",,,,RABL6A,,,,,,,,1,0,Low
PMID:34415582 | PMID:20551058,10.1002/glia.24075 | 10.1158/0008-5472.CAN-09-3769,Notch signaling via Hey1 and Id2b regulates Müller glia's regenerative response to retinal injury. | Cyclic AMP suppression is sufficient to induce gliomagenesis in a mouse model of neurofibromatosis-1.,,,,mCherry,,,,,,,,1,0,Low
PMID:34415582 | PMID:41022755 | PMID:40590220 | PMID:31545171 | PMID:31015291 | PMID:32461556 | PMID:29715273 | PMID:36890585 | PMID:34257279,10.1002/glia.24075 | 10.1038/s41467-025-63619-4 | 10.1172/JCI188932 | 10.7554/eLife.48983 | 10.1126/scisignal.aau8749 | 10.1038/s41467-020-16432-0 | 10.1371/journal.pone.0196726 | 10.1186/s40478-023-01525-w | 10.1038/s41467-021-24505-x,Notch signaling via Hey1 and Id2b regulates Müller glia's regenerative response to retinal injury. | Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors. | A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice. | Optical dopamine monitoring with dLight1 reveals mesolimbic phenotypes in a mouse model of neurofibromatosis type 1. | Proximity biotinylation identifies a set of conformation-specific interactions between Merlin and cell junction proteins. | Assessing the origin of high-grade serous ovarian cancer using CRISPR-modification of mouse organoids. | Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation. | Neurofibromatosis type 1-dependent alterations in mouse microglia function are not cell-intrinsic. | Neurofibromin regulates metabolic rate via neuronal mechanisms in Drosophila.,,,,GFP,,,,,,,,1,0,Low
PMID:35589737 | PMID:23328114 | PMID:25772366,10.1038/s41467-022-30466-6 | 10.18632/oncotarget.793 | 10.1016/j.celrep.2015.02.041,Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1. | Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition. | Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties.,,,,Tuj-1,,,,,,,,1,0,Low
PMID:35589737 | PMID:34930951,10.1038/s41467-022-30466-6 | 10.1038/s41536-021-00195-3,Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1. | A bioinspired gelatin-hyaluronic acid-based hybrid interpenetrating network for the enhancement of retinal ganglion cells replacement therapy.,,,,Rbpms,,,,,,,,1,0,Low
PMID:36322658 | PMID:33934112 | PMID:38203448,10.1126/sciadv.abo5442 | 10.1038/s41419-021-03716-6 | 10.3390/ijms25010277,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy. | HIF1α-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia. | FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells.,,,,GLUT1,,,,,,,,1,0,Low
PMID:36322658 | PMID:37164978 | PMID:24681606 | PMID:23685747 | PMID:20049725 | PMID:32642733 | PMID:18483311 | PMID:38203448 | PMID:37410426 | PMID:23535903 | PMID:35511749 | PMID:33032988,10.1126/sciadv.abo5442 | 10.1038/s41467-023-38432-6 | 10.18632/oncotarget.1609 | 10.1038/ng.2641 | 10.1002/emmm.200900027 | 10.1093/noajnl/vdz061 | 10.1158/1535-7163.MCT-07-2335 | 10.3390/ijms25010277 | 10.1158/1078-0432.CCR-23-0749 | 10.1158/2159-8290.CD-13-0081 | 10.1158/1535-7163.MCT-21-0947 | 10.1158/0008-5472.CAN-20-1365,"Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy. | Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities. | Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity. | Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis. | Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene. | KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors. | Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors. | FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells. | CDK4/6-MEK Inhibition in MPNSTs Causes Plasma Cell Infiltration, Sensitization to PD-L1 Blockade, and Tumor Regression. | Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance. | A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors. | Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.",,,,,STS26T,,,,,,,1,0,Low
PMID:36730269 | PMID:19191334,10.1371/journal.pone.0277305 | 10.1002/glia.20845,Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas. | Microarray analyses reveal regional astrocyte heterogeneity with implications for neurofibromatosis type 1 (NF1)-regulated glial proliferation.,,,,NG2,,,,,,,,1,0,Low
PMID:36730269 | PMID:31836666 | PMID:38502231 | PMID:37164978 | PMID:38481529 | PMID:38127282 | PMID:33658640 | PMID:36689660,10.1371/journal.pone.0277305 | 10.1074/jbc.RA119.010934 | 10.1172/JCI176748 | 10.1038/s41467-023-38432-6 | 10.3389/fcell.2024.1359561 | 10.1158/1078-0432.CCR-23-2548 | 10.1038/s41416-021-01270-8 | 10.1073/pnas.2208960120,Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas. | Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer. | STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy. | Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities. | Generation of heterozygous and homozygous NF1 lines from human-induced pluripotent stem cells using CRISPR/Cas9 to investigate bone defects associated with neurofibromatosis type 1. | Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression. | Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours. | Destabilizing NF1 variants act in a dominant negative manner through neurofibromin dimerization.,,,,Vinculin,,,,,,,,1,0,Low
PMID:36730269 | PMID:36322658 | PMID:38744290 | PMID:36241865 | PMID:24371224,10.1371/journal.pone.0277305 | 10.1126/sciadv.abo5442 | 10.1016/j.crmeth.2024.100772 | 10.1038/s12276-022-00850-9 | 10.1158/0008-5472.CAN-13-2062,Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas. | Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy. | A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening. | Transplanting neurofibromatosis-1 gene knockout neural stem cells improve functional recovery in rats with spinal cord injury by enhancing the mTORC2 pathway. | Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis.,,,,SOX2,,,,,,,,1,0,Low
PMID:36730269 | PMID:36689660,10.1371/journal.pone.0277305 | 10.1073/pnas.2208960120,Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas. | Destabilizing NF1 variants act in a dominant negative manner through neurofibromin dimerization.,,,,Ubiquitin,,,,,,,,1,0,Low
PMID:36730269 | PMID:40225167,10.1371/journal.pone.0277305 | 10.1155/2023/9628049,Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas. | Functional Assays Combined with Pre-mRNA-Splicing Analysis Improve Variant Classification and Diagnostics for Individuals with Neurofibromatosis Type 1 and Legius Syndrome.,,,,MYC,,,,,,,,1,0,Low
PMID:36730269 | PMID:41564118 | PMID:38481529,10.1371/journal.pone.0277305 | 10.1371/journal.pone.0340183 | 10.3389/fcell.2024.1359561,Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas. | Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas. | Generation of heterozygous and homozygous NF1 lines from human-induced pluripotent stem cells using CRISPR/Cas9 to investigate bone defects associated with neurofibromatosis type 1.,,,,Beta-Actin,,,,,,,,1,0,Low
PMID:36730269 | PMID:41564118 | PMID:41149489 | PMID:39129390 | PMID:29847659 | PMID:34257279 | PMID:38714355 | PMID:38216572 | PMID:18413802,10.1371/journal.pone.0277305 | 10.1371/journal.pone.0340183 | 10.3390/curroncol32100569 | 10.1002/1878-0261.13704 | 10.1167/iovs.17-22588 | 10.1038/s41467-021-24505-x | 10.1158/1535-7163.MCT-23-0510 | 10.1038/s41467-024-44755-9 | 10.1158/1535-7163.MCT-07-0518,Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas. | Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas. | Small Extracellular Vesicles Derived from NF2-Associated Schwannoma Cells Modulate Tumor Progression and Immunity via HSP90. | Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors. | Neurofibromin Deficiency Induces Endothelial Cell Proliferation and Retinal Neovascularization. | Neurofibromin regulates metabolic rate via neuronal mechanisms in Drosophila. | MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma. | Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance. | Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells.,,,,ERK,,,,,,,,1,0,Low
PMID:36890585 | PMID:25535838 | PMID:34930951 | PMID:36241865,10.1186/s40478-023-01525-w | 10.7554/eLife.05151 | 10.1038/s41536-021-00195-3 | 10.1038/s12276-022-00850-9,Neurofibromatosis type 1-dependent alterations in mouse microglia function are not cell-intrinsic. | Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1. | A bioinspired gelatin-hyaluronic acid-based hybrid interpenetrating network for the enhancement of retinal ganglion cells replacement therapy. | Transplanting neurofibromatosis-1 gene knockout neural stem cells improve functional recovery in rats with spinal cord injury by enhancing the mTORC2 pathway.,,,,NeuN,,,,,,,,1,0,Low
PMID:36890585 | PMID:35589737 | PMID:38502231 | PMID:36322658 | PMID:34040258 | PMID:37990867 | PMID:20554030 | PMID:34930951 | PMID:20551058,10.1186/s40478-023-01525-w | 10.1038/s41467-022-30466-6 | 10.1172/JCI176748 | 10.1126/sciadv.abo5442 | 10.1038/s41586-021-03580-6 | 10.1242/dmm.049861 | 10.1016/j.jneuroim.2010.05.002 | 10.1038/s41536-021-00195-3 | 10.1158/0008-5472.CAN-09-3769,Neurofibromatosis type 1-dependent alterations in mouse microglia function are not cell-intrinsic. | Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1. | STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy. | Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy. | NF1 mutation drives neuronal activity-dependent initiation of optic glioma. | Neurofibromin 1 mutations impair the function of human induced pluripotent stem cell-derived microglia. | CXCL12 alone is insufficient for gliomagenesis in Nf1 mutant mice. | A bioinspired gelatin-hyaluronic acid-based hybrid interpenetrating network for the enhancement of retinal ganglion cells replacement therapy. | Cyclic AMP suppression is sufficient to induce gliomagenesis in a mouse model of neurofibromatosis-1.,,,,Iba-1,,,,,,,,1,0,Low
PMID:37140985 | PMID:38127282,10.1172/JCI168227 | 10.1158/1078-0432.CCR-23-2548,Basement membrane proteins in extracellular matrix characterize NF1 neurofibroma development and response to MEK inhibitor. | Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,,,,hTERT ipn02.3 2λ,,,,,,,1,0,Low
PMID:37520682 | PMID:28256556,10.1016/j.omtn.2023.06.018 | 10.1038/srep43315,Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1. | An inflammatory gene signature distinguishes neurofibroma Schwann cells and macrophages from cells in the normal peripheral nervous system.,,,,p75 NGFR,,,,,,,,1,0,Low
PMID:38201517 | PMID:18367665,10.3390/cancers16010089 | 10.1124/jpet.107.135830,Synergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 Dendrimers. | Induction of apoptosis in neurofibromatosis type 1 malignant peripheral nerve sheath tumor cell lines by a combination of novel farnesyl transferase inhibitors and lovastatin.,,,,,iSC,,,,,,,1,0,Low
PMID:38203448 | PMID:24824755,10.3390/ijms25010277 | 10.1371/journal.pone.0096733,FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells. | BNIP3 regulates AT101 [(-)-gossypol] induced death in malignant peripheral nerve sheath tumor cells.,,,,LC3,,,,,,,,1,0,Low
PMID:38216123 | PMID:40507334,10.1016/j.molmet.2024.101876 | 10.3390/cancers17111852,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer. | Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs.,,,,,MCF7,,,,,,,1,0,Low
PMID:38502231 | PMID:30531922,10.1172/JCI176748 | 10.1038/s41591-018-0263-8,STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy. | The molecular landscape of glioma in patients with Neurofibromatosis 1.,,,,CD20,,,,,,,,1,0,Low
PMID:38502231 | PMID:39415595,10.1172/JCI176748 | 10.1242/dmm.050862,STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy. | Generation of a zebrafish neurofibromatosis model via inducible knockout of nf2a/b.,,,,p-H3,,,,,,,,1,0,Low
PMID:38744290 | PMID:24371224,10.1016/j.crmeth.2024.100772 | 10.1158/0008-5472.CAN-13-2062,A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening. | Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis.,,,,PanCytokeratin,,,,,,,,1,0,Low
PMID:39129390 | PMID:29847659 | PMID:34257279 | PMID:34011935 | PMID:38714355 | PMID:39472976 | PMID:18413802,10.1002/1878-0261.13704 | 10.1167/iovs.17-22588 | 10.1038/s41467-021-24505-x | 10.1038/s41419-021-03802-9 | 10.1158/1535-7163.MCT-23-0510 | 10.1186/s40478-024-01875-z | 10.1158/1535-7163.MCT-07-0518,Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors. | Neurofibromin Deficiency Induces Endothelial Cell Proliferation and Retinal Neovascularization. | Neurofibromin regulates metabolic rate via neuronal mechanisms in Drosophila. | Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine. | MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma. | NF1 expression profiling in IDH-wildtype glioblastoma: genomic associations and survival outcomes. | Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells.,,,,phospho-ERK,,,,,,,,1,0,Low
PMID:39129390 | PMID:38203448,10.1002/1878-0261.13704 | 10.3390/ijms25010277,Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors. | FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells.,,,,LC3B,,,,,,,,1,0,Low
PMID:39472976 | PMID:38714355,10.1186/s40478-024-01875-z | 10.1158/1535-7163.MCT-23-0510,NF1 expression profiling in IDH-wildtype glioblastoma: genomic associations and survival outcomes. | MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.,,,,,JHH-520 cell line,,,,,,,1,0,Low
PMID:40025578 | PMID:25026211 | PMID:26219339,10.1186/s40478-025-01965-6 | 10.1016/j.ccr.2014.05.001 | 10.18632/oncotarget.4858,Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment. | Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus. | A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.,,,,,293T cells,,,,,,,1,0,Low
PMID:40217315 | PMID:24371224,10.1186/s13073-025-01462-4 | 10.1158/0008-5472.CAN-13-2062,A single-cell atlas of Schwannoma across genetic backgrounds and anatomic locations. | Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis.,,,,CD24,,,,,,,,1,0,Low
PMID:40590220 | PMID:35789380 | PMID:31836666 | PMID:29402968 | PMID:31015291 | PMID:40225167 | PMID:34415582 | PMID:39269317 | PMID:23175151 | PMID:38216587 | PMID:20554030 | PMID:28166733 | PMID:33934112,10.1172/JCI188932 | 10.1158/2159-8290.CD-21-1671 | 10.1074/jbc.RA119.010934 | 10.1038/s41598-018-20894-0 | 10.1126/scisignal.aau8749 | 10.1155/2023/9628049 | 10.1002/glia.24075 | 10.1158/1078-0432.CCR-24-1750 | 10.1038/bjc.2012.518 | 10.1038/s41467-023-40408-5 | 10.1016/j.jneuroim.2010.05.002 | 10.1186/s12864-017-3519-7 | 10.1038/s41419-021-03716-6,A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice. | PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry. | Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer. | Integrating Functional Analysis in the Next-Generation Sequencing Diagnostic Pipeline of RASopathies. | Proximity biotinylation identifies a set of conformation-specific interactions between Merlin and cell junction proteins. | Functional Assays Combined with Pre-mRNA-Splicing Analysis Improve Variant Classification and Diagnostics for Individuals with Neurofibromatosis Type 1 and Legius Syndrome. | Notch signaling via Hey1 and Id2b regulates Müller glia's regenerative response to retinal injury. | MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor. | MicroRNA profiling of peripheral nerve sheath tumours identifies miR-29c as a tumour suppressor gene involved in tumour progression. | Epigenetic reprogramming shapes the cellular landscape of schwannoma. | CXCL12 alone is insufficient for gliomagenesis in Nf1 mutant mice. | A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma. | HIF1α-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia.,,,,,HEK293T cells,,,,,,,1,0,Low
PMID:40590220 | PMID:36420221 | PMID:31836666 | PMID:24595234 | PMID:36689660 | PMID:40225167 | PMID:16835260,10.1172/JCI188932 | 10.1016/j.omtn.2022.10.026 | 10.1074/jbc.RA119.010934 | 10.1371/journal.pone.0090853 | 10.1073/pnas.2208960120 | 10.1155/2023/9628049 | 10.1093/hmg/ddl165,A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice. | Antisense oligonucleotides targeting exon 11 are able to partially rescue the NF2-related schwannomatosis phenotype | Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer. | In vivo functional analysis of the human NF2 tumor suppressor gene in Drosophila. | Destabilizing NF1 variants act in a dominant negative manner through neurofibromin dimerization. | Functional Assays Combined with Pre-mRNA-Splicing Analysis Improve Variant Classification and Diagnostics for Individuals with Neurofibromatosis Type 1 and Legius Syndrome. | Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling.,,,,Flag,,,,,,,,1,0,Low
PMID:40590220 | PMID:36420221 | PMID:32383545,10.1172/JCI188932 | 10.1016/j.omtn.2022.10.026 | 10.15252/embr.201949117,A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice. | Antisense oligonucleotides targeting exon 11 are able to partially rescue the NF2-related schwannomatosis phenotype | Hexokinase 2 displacement from mitochondria-associated membranes prompts Ca,,,,,HeLa cells,,,,,,,1,0,Low
PMID:40684195 | PMID:28256556,10.1186/s40478-025-02075-z | 10.1038/srep43315,Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1. | An inflammatory gene signature distinguishes neurofibroma Schwann cells and macrophages from cells in the normal peripheral nervous system.,,,,F4/80,,,,,,,,1,0,Low
PMID:40684195 | PMID:34040258 | PMID:34010628,10.1186/s40478-025-02075-z | 10.1038/s41586-021-03580-6 | 10.1016/j.stem.2021.04.029,Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1. | NF1 mutation drives neuronal activity-dependent initiation of optic glioma. | Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression.,,,,,,EdU,,,,,,1,0,Low
PMID:41149489 | PMID:27956228,10.3390/curroncol32100569 | 10.1053/j.gastro.2016.12.002,Small Extracellular Vesicles Derived from NF2-Associated Schwannoma Cells Modulate Tumor Progression and Immunity via HSP90. | Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice.,,,,HSP90,,,,,,,,1,0,Low
